Introduction  ||| S:24 E:45 ||| NN
With  ||| S:45 E:50 ||| IN
the  ||| S:50 E:54 ||| DT
exception  ||| S:54 E:64 ||| NN
of  ||| S:64 E:67 ||| IN
counting  ||| S:67 E:76 ||| VBG
deaths  ||| S:76 E:83 ||| NNS
from  ||| S:83 E:88 ||| IN
all  ||| S:88 E:92 ||| DT
causes ||| S:92 E:98 ||| NNS
,  ||| S:98 E:100 ||| ,
a  ||| S:100 E:110 ||| DT
common  ||| S:110 E:117 ||| JJ
problem  ||| S:117 E:125 ||| NN
in  ||| S:125 E:128 ||| IN
clinical  ||| S:128 E:137 ||| JJ
trials  ||| S:137 E:144 ||| NNS
is  ||| S:144 E:147 ||| VBZ
the  ||| S:147 E:151 ||| DT
missing  ||| S:151 E:159 ||| JJ
data  ||| S:159 E:172 ||| NNS
caused  ||| S:172 E:179 ||| VBN
by  ||| S:179 E:182 ||| IN
patients  ||| S:182 E:191 ||| NNS
who  ||| S:191 E:195 ||| WP
do  ||| S:195 E:198 ||| VBP
not  ||| S:198 E:202 ||| RB
complete  ||| S:202 E:211 ||| VB
the  ||| S:211 E:215 ||| DT
study  ||| S:215 E:221 ||| NN
in  ||| S:221 E:224 ||| IN
full  ||| S:224 E:237 ||| JJ
schedule  ||| S:237 E:246 ||| NN
and  ||| S:246 E:250 ||| CC
drop  ||| S:250 E:255 ||| VB
out  ||| S:255 E:259 ||| RP
of  ||| S:259 E:262 ||| IN
the  ||| S:262 E:266 ||| DT
study  ||| S:266 E:272 ||| NN
without  ||| S:272 E:280 ||| IN
further  ||| S:280 E:296 ||| JJ
measurements ||| S:296 E:308 ||| NNS
.  ||| S:308 E:310 ||| .
Possible  ||| S:310 E:319 ||| JJ
reasons  ||| S:319 E:327 ||| NNS
for  ||| S:327 E:331 ||| IN
patients  ||| S:331 E:340 ||| NNS
dropping  ||| S:340 E:349 ||| VBG
out  ||| S:349 E:353 ||| RP
of  ||| S:353 E:364 ||| IN
the  ||| S:364 E:368 ||| DT
study  ||| S:368 E:374 ||| NN
( ||| S:374 E:375 ||| -LRB-
the  ||| S:375 E:379 ||| DT
so-called  ||| S:379 E:389 ||| NN
' ||| S:389 E:390 ||| POS
withdrawals ||| S:390 E:401 ||| NNS
' ||| S:401 E:402 ||| POS
)  ||| S:402 E:404 ||| -RRB-
include  ||| S:404 E:412 ||| VBP
death ||| S:412 E:417 ||| NN
,  ||| S:417 E:427 ||| ,
adverse  ||| S:427 E:435 ||| JJ
reactions ||| S:435 E:444 ||| NNS
,  ||| S:444 E:446 ||| ,
unpleasant  ||| S:446 E:457 ||| JJ
study  ||| S:457 E:463 ||| NN
procedures ||| S:463 E:473 ||| NNS
,  ||| S:473 E:475 ||| ,
lack  ||| S:475 E:480 ||| NN
of  ||| S:480 E:491 ||| IN
improvement ||| S:491 E:502 ||| NN
,  ||| S:502 E:504 ||| ,
early  ||| S:504 E:510 ||| JJ
recovery ||| S:510 E:518 ||| NN
,  ||| S:518 E:520 ||| ,
and  ||| S:520 E:524 ||| CC
other  ||| S:524 E:530 ||| JJ
factors  ||| S:530 E:538 ||| NNS
related  ||| S:538 E:546 ||| VBN
or  ||| S:546 E:557 ||| CC
unrelated  ||| S:557 E:567 ||| JJ
to  ||| S:567 E:570 ||| TO
trial  ||| S:570 E:576 ||| NN
procedure  ||| S:576 E:586 ||| NN
and  ||| S:586 E:590 ||| CC
treatments ||| S:590 E:600 ||| NNS
.  ||| S:600 E:602 ||| .
Missing  ||| S:602 E:610 ||| VBG
data  ||| S:610 E:623 ||| NNS
in  ||| S:623 E:626 ||| IN
a  ||| S:626 E:628 ||| DT
study  ||| S:628 E:634 ||| NN
because  ||| S:634 E:642 ||| IN
of  ||| S:642 E:645 ||| IN
dropouts  ||| S:645 E:654 ||| NNS
may  ||| S:654 E:658 ||| MD
cause  ||| S:658 E:664 ||| VB
the  ||| S:664 E:668 ||| DT
usual  ||| S:668 E:682 ||| JJ
statistical  ||| S:682 E:694 ||| JJ
analysis  ||| S:694 E:703 ||| NN
for  ||| S:703 E:707 ||| IN
complete  ||| S:707 E:716 ||| JJ
or  ||| S:716 E:719 ||| CC
available  ||| S:719 E:729 ||| JJ
data  ||| S:729 E:734 ||| NNS
to  ||| S:734 E:737 ||| TO
be  ||| S:737 E:748 ||| VB
subject  ||| S:748 E:756 ||| JJ
to  ||| S:756 E:759 ||| TO
a  ||| S:759 E:761 ||| DT
potential  ||| S:761 E:771 ||| JJ
bias ||| S:771 E:775 ||| NN
.  ||| S:775 E:777 ||| .
This  ||| S:777 E:782 ||| DT
review  ||| S:782 E:789 ||| NN
attempts  ||| S:789 E:798 ||| NNS
to  ||| S:798 E:801 ||| TO
raise  ||| S:801 E:815 ||| VB
the  ||| S:815 E:819 ||| DT
awareness  ||| S:819 E:829 ||| NN
of  ||| S:829 E:832 ||| IN
the  ||| S:832 E:836 ||| DT
problem  ||| S:836 E:844 ||| NN
and  ||| S:844 E:848 ||| CC
to  ||| S:848 E:851 ||| TO
provide  ||| S:851 E:859 ||| VB
some  ||| S:859 E:864 ||| DT
general  ||| S:864 E:880 ||| JJ
guidance  ||| S:880 E:889 ||| NN
to  ||| S:889 E:892 ||| TO
clinical  ||| S:892 E:901 ||| JJ
trial  ||| S:901 E:907 ||| NN
practitioners ||| S:907 E:920 ||| NNS
.  ||| S:920 E:944 ||| .
Examples  ||| S:944 E:972 ||| NNP
Example  ||| S:972 E:980 ||| NNP
1  ||| S:980 E:992 ||| CD
A  ||| S:992 E:994 ||| DT
multicenter ||| S:994 E:1005 ||| NN
,  ||| S:1005 E:1007 ||| ,
randomized ||| S:1007 E:1017 ||| NN
,  ||| S:1017 E:1019 ||| ,
double-blind ||| S:1019 E:1031 ||| NNP
,  ||| S:1031 E:1033 ||| ,
three  ||| S:1033 E:1049 ||| CD
parallel  ||| S:1049 E:1058 ||| JJ
groups  ||| S:1058 E:1065 ||| NNS
trial  ||| S:1065 E:1071 ||| NN
to  ||| S:1071 E:1074 ||| TO
compare  ||| S:1074 E:1082 ||| VB
placebo ||| S:1082 E:1089 ||| NN
,  ||| S:1089 E:1091 ||| ,
candesartan  ||| S:1091 E:1113 ||| JJ
ciltexetil  ||| S:1113 E:1124 ||| NN
and  ||| S:1124 E:1128 ||| CC
enalapril  ||| S:1128 E:1138 ||| NN
in  ||| S:1138 E:1141 ||| IN
patients  ||| S:1141 E:1150 ||| NNS
with  ||| S:1150 E:1155 ||| IN
mild  ||| S:1155 E:1160 ||| JJ
to  ||| S:1160 E:1173 ||| TO
moderate  ||| S:1173 E:1182 ||| VB
essential  ||| S:1182 E:1192 ||| JJ
hypertension  ||| S:1192 E:1205 ||| NN
[  ||| S:1205 E:1207 ||| -LRB-
1  ||| S:1207 E:1209 ||| LS
]  ||| S:1209 E:1211 ||| -RRB-
.  ||| S:1211 E:1213 ||| .
The  ||| S:1213 E:1217 ||| DT
study  ||| S:1217 E:1233 ||| NN
randomized  ||| S:1233 E:1244 ||| VBD
205  ||| S:1244 E:1248 ||| CD
to  ||| S:1248 E:1251 ||| TO
treatment ||| S:1251 E:1260 ||| NN
,  ||| S:1260 E:1262 ||| ,
however ||| S:1262 E:1269 ||| RB
,  ||| S:1269 E:1271 ||| ,
only  ||| S:1271 E:1276 ||| RB
178  ||| S:1276 E:1280 ||| CD
patients  ||| S:1280 E:1299 ||| NNS
were  ||| S:1299 E:1304 ||| VBD
evaluable  ||| S:1304 E:1314 ||| VBN
by  ||| S:1314 E:1317 ||| IN
protocol  ||| S:1317 E:1326 ||| NN
at  ||| S:1326 E:1329 ||| IN
the  ||| S:1329 E:1333 ||| DT
end  ||| S:1333 E:1337 ||| NN
of  ||| S:1337 E:1340 ||| IN
an  ||| S:1340 E:1343 ||| DT
8-week  ||| S:1343 E:1360 ||| JJ
treatment  ||| S:1360 E:1370 ||| NN
period ||| S:1370 E:1376 ||| NN
.  ||| S:1376 E:1378 ||| .
' ||| S:1378 E:1379 ||| ''
The  ||| S:1379 E:1383 ||| DT
remaining  ||| S:1383 E:1393 ||| JJ
patients  ||| S:1393 E:1402 ||| NNS
were  ||| S:1402 E:1407 ||| VBD
excluded  ||| S:1407 E:1426 ||| VBN
from  ||| S:1426 E:1431 ||| IN
the  ||| S:1431 E:1435 ||| DT
analysis  ||| S:1435 E:1444 ||| NN
of  ||| S:1444 E:1447 ||| IN
blood  ||| S:1447 E:1453 ||| NN
pressure  ||| S:1453 E:1462 ||| NN
( ||| S:1462 E:1463 ||| -LRB-
BP ||| S:1463 E:1465 ||| NNP
)  ||| S:1465 E:1467 ||| -RRB-
data  ||| S:1467 E:1472 ||| NNS
because  ||| S:1472 E:1480 ||| IN
of  ||| S:1480 E:1493 ||| IN
major  ||| S:1493 E:1499 ||| JJ
protocol  ||| S:1499 E:1508 ||| NN
violations ||| S:1508 E:1518 ||| NNS
,  ||| S:1518 E:1520 ||| ,
poor  ||| S:1520 E:1525 ||| JJ
compliance  ||| S:1525 E:1536 ||| NN
with  ||| S:1536 E:1541 ||| IN
medical  ||| S:1541 E:1559 ||| JJ
visits ||| S:1559 E:1565 ||| NNS
,  ||| S:1565 E:1567 ||| ,
or  ||| S:1567 E:1570 ||| CC
withdrawal  ||| S:1570 E:1581 ||| NN
because  ||| S:1581 E:1589 ||| IN
of  ||| S:1589 E:1592 ||| IN
adverse  ||| S:1592 E:1600 ||| JJ
events ||| S:1600 E:1606 ||| NNS
. ||| S:1606 E:1607 ||| .
'  ||| S:1607 E:1637 ||| POS
Example  ||| S:1637 E:1645 ||| NN
2  ||| S:1645 E:1657 ||| CD
A  ||| S:1657 E:1659 ||| DT
multicenter ||| S:1659 E:1670 ||| NN
,  ||| S:1670 E:1672 ||| ,
randomized ||| S:1672 E:1682 ||| NN
,  ||| S:1682 E:1684 ||| ,
open-label ||| S:1684 E:1694 ||| NNP
,  ||| S:1694 E:1696 ||| ,
parallel-design  ||| S:1696 E:1722 ||| JJ
study  ||| S:1722 E:1728 ||| NN
to  ||| S:1728 E:1731 ||| TO
compare  ||| S:1731 E:1739 ||| VB
the  ||| S:1739 E:1743 ||| DT
treatment  ||| S:1743 E:1753 ||| NN
effect  ||| S:1753 E:1760 ||| NN
of  ||| S:1760 E:1763 ||| IN
niacin  ||| S:1763 E:1770 ||| NN
and  ||| S:1770 E:1784 ||| CC
atorvastatin  ||| S:1784 E:1797 ||| NNS
( ||| S:1797 E:1798 ||| -LRB-
for  ||| S:1798 E:1802 ||| IN
12  ||| S:1802 E:1805 ||| CD
weeks ||| S:1805 E:1810 ||| NNS
)  ||| S:1810 E:1812 ||| -RRB-
on  ||| S:1812 E:1815 ||| IN
lipoprotein  ||| S:1815 E:1827 ||| JJ
subfractions  ||| S:1827 E:1850 ||| NN
in  ||| S:1850 E:1853 ||| IN
patients  ||| S:1853 E:1862 ||| NNS
with  ||| S:1862 E:1867 ||| IN
atherogenic  ||| S:1867 E:1879 ||| JJ
dyslipidemia  ||| S:1879 E:1892 ||| NNS
[  ||| S:1892 E:1894 ||| -LRB-
2  ||| S:1894 E:1896 ||| LS
]  ||| S:1896 E:1898 ||| -RRB-
.  ||| S:1898 E:1900 ||| .
' ||| S:1900 E:1901 ||| ''
Of  ||| S:1901 E:1904 ||| IN
the  ||| S:1904 E:1918 ||| DT
total  ||| S:1918 E:1924 ||| JJ
108  ||| S:1924 E:1928 ||| CD
patients  ||| S:1928 E:1937 ||| NNS
randomized  ||| S:1937 E:1948 ||| VBP
to  ||| S:1948 E:1951 ||| TO
treatment ||| S:1951 E:1960 ||| NN
,  ||| S:1960 E:1962 ||| ,
12  ||| S:1962 E:1965 ||| CD
withdrew  ||| S:1965 E:1984 ||| VBD
from  ||| S:1984 E:1989 ||| IN
the  ||| S:1989 E:1993 ||| DT
study ||| S:1993 E:1998 ||| NN
.  ||| S:1998 E:2000 ||| .
Of  ||| S:2000 E:2003 ||| IN
those  ||| S:2003 E:2009 ||| DT
who  ||| S:2009 E:2013 ||| WP
withdrew ||| S:2013 E:2021 ||| VBD
,  ||| S:2021 E:2023 ||| ,
nine  ||| S:2023 E:2028 ||| CD
were  ||| S:2028 E:2033 ||| VBD
due  ||| S:2033 E:2037 ||| JJ
to  ||| S:2037 E:2050 ||| TO
adverse  ||| S:2050 E:2058 ||| JJ
events ||| S:2058 E:2064 ||| NNS
,  ||| S:2064 E:2066 ||| ,
two  ||| S:2066 E:2070 ||| CD
were  ||| S:2070 E:2075 ||| VBD
lost  ||| S:2075 E:2080 ||| VBN
to  ||| S:2080 E:2083 ||| TO
follow-up ||| S:2083 E:2092 ||| JJ
,  ||| S:2092 E:2094 ||| ,
and  ||| S:2094 E:2098 ||| CC
one  ||| S:2098 E:2102 ||| PRP
did  ||| S:2102 E:2116 ||| VBD
not  ||| S:2116 E:2120 ||| RB
return  ||| S:2120 E:2127 ||| VB
for  ||| S:2127 E:2131 ||| IN
the  ||| S:2131 E:2135 ||| DT
final  ||| S:2135 E:2141 ||| JJ
visit ||| S:2141 E:2146 ||| NN
. ||| S:2146 E:2147 ||| .
'  ||| S:2147 E:2177 ||| POS
Example  ||| S:2177 E:2185 ||| NN
3  ||| S:2185 E:2197 ||| CD
A  ||| S:2197 E:2199 ||| DT
multicenter ||| S:2199 E:2210 ||| NN
,  ||| S:2210 E:2212 ||| ,
randomized ||| S:2212 E:2222 ||| NN
,  ||| S:2222 E:2224 ||| ,
double-blind ||| S:2224 E:2236 ||| NNP
,  ||| S:2236 E:2248 ||| ,
placebo-controlled  ||| S:2248 E:2267 ||| JJ
trial  ||| S:2267 E:2273 ||| NN
to  ||| S:2273 E:2276 ||| TO
assess  ||| S:2276 E:2283 ||| VB
treatment  ||| S:2283 E:2293 ||| NN
effect  ||| S:2293 E:2300 ||| NN
of  ||| S:2300 E:2313 ||| IN
pimobendan  ||| S:2313 E:2324 ||| NN
on  ||| S:2324 E:2327 ||| IN
exercise  ||| S:2327 E:2336 ||| NN
capacity  ||| S:2336 E:2345 ||| NN
in  ||| S:2345 E:2348 ||| IN
patients  ||| S:2348 E:2357 ||| NNS
with  ||| S:2357 E:2362 ||| IN
chronic  ||| S:2362 E:2380 ||| JJ
heart  ||| S:2380 E:2386 ||| NN
failure  ||| S:2386 E:2394 ||| NN
[  ||| S:2394 E:2396 ||| -LRB-
3  ||| S:2396 E:2398 ||| LS
]  ||| S:2398 E:2400 ||| -RRB-
.  ||| S:2400 E:2402 ||| .
' ||| S:2402 E:2403 ||| ''
The  ||| S:2403 E:2407 ||| DT
primary  ||| S:2407 E:2415 ||| JJ
pre-specified  ||| S:2415 E:2429 ||| JJ
analysis  ||| S:2429 E:2448 ||| NN
of  ||| S:2448 E:2451 ||| IN
exercise  ||| S:2451 E:2460 ||| NN
time  ||| S:2460 E:2465 ||| NN
was  ||| S:2465 E:2469 ||| VBD
limited  ||| S:2469 E:2477 ||| VBN
to  ||| S:2477 E:2480 ||| TO
those  ||| S:2480 E:2486 ||| DT
patients  ||| S:2486 E:2495 ||| NNS
who  ||| S:2495 E:2499 ||| WP
had  ||| S:2499 E:2503 ||| VBD
at  ||| S:2503 E:2516 ||| IN
least  ||| S:2516 E:2522 ||| JJS
the  ||| S:2522 E:2526 ||| DT
first  ||| S:2526 E:2532 ||| RB
follow  ||| S:2532 E:2539 ||| VB
up  ||| S:2539 E:2542 ||| RP
( ||| S:2542 E:2543 ||| -LRB-
four-week ||| S:2543 E:2552 ||| JJ
)  ||| S:2552 E:2554 ||| -RRB-
exercise  ||| S:2554 E:2563 ||| NN
test  ||| S:2563 E:2578 ||| NN
carried  ||| S:2578 E:2586 ||| VBD
out  ||| S:2586 E:2590 ||| RP
and  ||| S:2590 E:2594 ||| CC
had  ||| S:2594 E:2598 ||| VBD
shown  ||| S:2598 E:2604 ||| VBN
good  ||| S:2604 E:2609 ||| JJ
compliance  ||| S:2609 E:2620 ||| NN
up  ||| S:2620 E:2623 ||| RP
to  ||| S:2623 E:2626 ||| TO
the  ||| S:2626 E:2630 ||| DT
day  ||| S:2630 E:2644 ||| NN
of  ||| S:2644 E:2647 ||| IN
the  ||| S:2647 E:2651 ||| DT
test ||| S:2651 E:2655 ||| NN
.  ||| S:2655 E:2657 ||| .
If  ||| S:2657 E:2660 ||| IN
subsequent  ||| S:2660 E:2671 ||| JJ
tests  ||| S:2671 E:2677 ||| NNS
were  ||| S:2677 E:2682 ||| VBD
not  ||| S:2682 E:2686 ||| RB
performed ||| S:2686 E:2695 ||| VBN
,  ||| S:2695 E:2707 ||| ,
whatever  ||| S:2707 E:2716 ||| WDT
the  ||| S:2716 E:2720 ||| DT
reason ||| S:2720 E:2726 ||| NN
,  ||| S:2726 E:2728 ||| ,
or  ||| S:2728 E:2731 ||| CC
performed  ||| S:2731 E:2741 ||| VBN
although  ||| S:2741 E:2750 ||| IN
compliance  ||| S:2750 E:2771 ||| NN
between  ||| S:2771 E:2779 ||| IN
tests  ||| S:2779 E:2785 ||| NNS
had  ||| S:2785 E:2789 ||| VBD
been  ||| S:2789 E:2794 ||| VBN
poor ||| S:2794 E:2798 ||| JJ
,  ||| S:2798 E:2800 ||| ,
the  ||| S:2800 E:2804 ||| DT
last  ||| S:2804 E:2809 ||| JJ
exercise  ||| S:2809 E:2818 ||| NN
time  ||| S:2818 E:2823 ||| NN
value  ||| S:2823 E:2839 ||| NN
obtained  ||| S:2839 E:2848 ||| VBN
while  ||| S:2848 E:2854 ||| IN
compliance  ||| S:2854 E:2865 ||| NN
was  ||| S:2865 E:2869 ||| VBD
good  ||| S:2869 E:2874 ||| JJ
was  ||| S:2874 E:2878 ||| VBD
carried  ||| S:2878 E:2886 ||| VBN
forward ||| S:2886 E:2893 ||| RB
. ||| S:2893 E:2894 ||| .
'  ||| S:2894 E:2906 ||| POS
Two  ||| S:2906 E:2910 ||| CD
hundred  ||| S:2910 E:2918 ||| CD
and  ||| S:2918 E:2922 ||| CC
forty  ||| S:2922 E:2928 ||| NN
of  ||| S:2928 E:2931 ||| IN
the  ||| S:2931 E:2935 ||| DT
317  ||| S:2935 E:2939 ||| CD
randomized  ||| S:2939 E:2950 ||| CD
patients  ||| S:2950 E:2959 ||| NNS
had  ||| S:2959 E:2973 ||| VBD
exercise  ||| S:2973 E:2982 ||| NN
test  ||| S:2982 E:2987 ||| NN
done  ||| S:2987 E:2992 ||| VBN
with  ||| S:2992 E:2997 ||| IN
good  ||| S:2997 E:3002 ||| JJ
compliance  ||| S:3002 E:3013 ||| NN
at  ||| S:3013 E:3016 ||| IN
four ||| S:3016 E:3020 ||| CD
,  ||| S:3020 E:3022 ||| ,
12 ||| S:3022 E:3024 ||| CD
,  ||| S:3024 E:3026 ||| ,
and  ||| S:3026 E:3040 ||| CC
24  ||| S:3040 E:3043 ||| CD
weeks ||| S:3043 E:3048 ||| NNS
.  ||| S:3048 E:3050 ||| .
Listed  ||| S:3050 E:3057 ||| JJ
reasons  ||| S:3057 E:3065 ||| NNS
( ||| S:3065 E:3066 ||| -LRB-
and  ||| S:3066 E:3070 ||| CC
number  ||| S:3070 E:3077 ||| NN
of  ||| S:3077 E:3080 ||| IN
patients ||| S:3080 E:3088 ||| NNS
)  ||| S:3088 E:3090 ||| -RRB-
for  ||| S:3090 E:3104 ||| IN
missing  ||| S:3104 E:3112 ||| VBG
exercise  ||| S:3112 E:3121 ||| NN
time  ||| S:3121 E:3126 ||| NN
data  ||| S:3126 E:3131 ||| NNS
at  ||| S:3131 E:3134 ||| IN
24  ||| S:3134 E:3137 ||| CD
weeks  ||| S:3137 E:3143 ||| NNS
were ||| S:3143 E:3147 ||| VBD
:  ||| S:3147 E:3149 ||| :
' ||| S:3149 E:3150 ||| ''
exercise  ||| S:3150 E:3169 ||| NN
test  ||| S:3169 E:3174 ||| NN
not  ||| S:3174 E:3178 ||| RB
done  ||| S:3178 E:3183 ||| VBN
due  ||| S:3183 E:3187 ||| JJ
to  ||| S:3187 E:3190 ||| TO
death ||| S:3190 E:3195 ||| NN
'  ||| S:3195 E:3197 ||| ''
( ||| S:3197 E:3198 ||| -LRB-
n  ||| S:3198 E:3200 ||| CD
=  ||| S:3200 E:3202 ||| SYM
30 ||| S:3202 E:3204 ||| CD
) ||| S:3204 E:3205 ||| -RRB-
,  ||| S:3205 E:3207 ||| ,
' ||| S:3207 E:3208 ||| ''
exercise  ||| S:3208 E:3217 ||| NN
testing  ||| S:3217 E:3235 ||| NN
contraindicated ||| S:3235 E:3250 ||| NN
'  ||| S:3250 E:3252 ||| ''
( ||| S:3252 E:3253 ||| -LRB-
n  ||| S:3253 E:3255 ||| CD
=  ||| S:3255 E:3257 ||| SYM
9 ||| S:3257 E:3258 ||| CD
) ||| S:3258 E:3259 ||| -RRB-
,  ||| S:3259 E:3261 ||| ,
and  ||| S:3261 E:3265 ||| NNP
' ||| S:3265 E:3266 ||| POS
exercise  ||| S:3266 E:3275 ||| NN
test  ||| S:3275 E:3280 ||| NN
not  ||| S:3280 E:3284 ||| RB
done  ||| S:3284 E:3289 ||| VBN
for  ||| S:3289 E:3303 ||| IN
other  ||| S:3303 E:3309 ||| JJ
reasons ||| S:3309 E:3316 ||| NNS
'  ||| S:3316 E:3318 ||| ''
( ||| S:3318 E:3319 ||| -LRB-
n  ||| S:3319 E:3321 ||| CD
=  ||| S:3321 E:3323 ||| SYM
10 ||| S:3323 E:3325 ||| CD
) ||| S:3325 E:3326 ||| -RRB-
.  ||| S:3326 E:3356 ||| .
Example  ||| S:3356 E:3364 ||| NN
4  ||| S:3364 E:3376 ||| CD
A  ||| S:3376 E:3378 ||| DT
randomized ||| S:3378 E:3388 ||| NN
,  ||| S:3388 E:3390 ||| ,
double-blind  ||| S:3390 E:3403 ||| JJ
study  ||| S:3403 E:3409 ||| NN
to  ||| S:3409 E:3412 ||| TO
compare  ||| S:3412 E:3430 ||| VB
nifedipine-GITS  ||| S:3430 E:3446 ||| JJ
and  ||| S:3446 E:3450 ||| CC
verapamil-SR  ||| S:3450 E:3463 ||| JJ
on  ||| S:3463 E:3466 ||| IN
hemodynamics ||| S:3466 E:3478 ||| NN
,  ||| S:3478 E:3480 ||| ,
left  ||| S:3480 E:3495 ||| VBD
ventricular  ||| S:3495 E:3507 ||| JJ
mass ||| S:3507 E:3511 ||| NN
,  ||| S:3511 E:3513 ||| ,
and  ||| S:3513 E:3517 ||| CC
coronary  ||| S:3517 E:3526 ||| JJ
vasodilatory  ||| S:3526 E:3539 ||| NN
in  ||| S:3539 E:3542 ||| IN
patients  ||| S:3542 E:3561 ||| NNS
with  ||| S:3561 E:3566 ||| IN
advanced  ||| S:3566 E:3575 ||| JJ
hypertension  ||| S:3575 E:3588 ||| NN
[  ||| S:3588 E:3590 ||| -LRB-
4  ||| S:3590 E:3592 ||| LS
]  ||| S:3592 E:3594 ||| -RRB-
.  ||| S:3594 E:3596 ||| .
Fifty-four  ||| S:3596 E:3607 ||| JJ
patients  ||| S:3607 E:3626 ||| NNS
were  ||| S:3626 E:3631 ||| VBD
randomized  ||| S:3631 E:3642 ||| VBN
after  ||| S:3642 E:3648 ||| IN
the  ||| S:3648 E:3652 ||| DT
placebo  ||| S:3652 E:3660 ||| JJ
run-in  ||| S:3660 E:3667 ||| JJ
phase ||| S:3667 E:3672 ||| NN
.  ||| S:3672 E:3684 ||| .
' ||| S:3684 E:3685 ||| ''
Twenty-four  ||| S:3685 E:3697 ||| NNP
failed  ||| S:3697 E:3704 ||| VBD
to  ||| S:3704 E:3707 ||| TO
complete  ||| S:3707 E:3716 ||| VB
the  ||| S:3716 E:3720 ||| DT
( ||| S:3720 E:3721 ||| -LRB-
six-month ||| S:3721 E:3730 ||| JJ
)  ||| S:3730 E:3732 ||| -RRB-
trial ||| S:3732 E:3737 ||| NN
,  ||| S:3737 E:3749 ||| ,
and  ||| S:3749 E:3753 ||| CC
thus  ||| S:3753 E:3758 ||| RB
were  ||| S:3758 E:3763 ||| VBD
not  ||| S:3763 E:3767 ||| RB
included  ||| S:3767 E:3776 ||| VBN
for  ||| S:3776 E:3780 ||| IN
analysis  ||| S:3780 E:3789 ||| NN
because  ||| S:3789 E:3797 ||| IN
of  ||| S:3797 E:3800 ||| IN
1 ||| S:3800 E:3801 ||| CD
)  ||| S:3801 E:3813 ||| -RRB-
withdrawal  ||| S:3813 E:3824 ||| NN
for  ||| S:3824 E:3828 ||| IN
symptomatic  ||| S:3828 E:3840 ||| JJ
adverse  ||| S:3840 E:3848 ||| JJ
effects ||| S:3848 E:3855 ||| NNS
,  ||| S:3855 E:3857 ||| ,
2 ||| S:3857 E:3858 ||| LS
)  ||| S:3858 E:3860 ||| -RRB-
lack  ||| S:3860 E:3865 ||| NN
of  ||| S:3865 E:3878 ||| IN
response ||| S:3878 E:3886 ||| NN
,  ||| S:3886 E:3888 ||| ,
and  ||| S:3888 E:3892 ||| CC
3 ||| S:3892 E:3893 ||| LS
)  ||| S:3893 E:3895 ||| -RRB-
poor  ||| S:3895 E:3900 ||| JJ
compliance ||| S:3900 E:3910 ||| NN
. ||| S:3910 E:3911 ||| .
'  ||| S:3911 E:3913 ||| POS
' ||| S:3913 E:3914 ||| ''
Consequently ||| S:3914 E:3926 ||| RB
,  ||| S:3926 E:3928 ||| ,
there  ||| S:3928 E:3944 ||| EX
were  ||| S:3944 E:3949 ||| VBD
30  ||| S:3949 E:3952 ||| CD
subjects  ||| S:3952 E:3961 ||| NNS
with  ||| S:3961 E:3966 ||| IN
sufficient  ||| S:3966 E:3977 ||| JJ
data  ||| S:3977 E:3982 ||| NN
sets  ||| S:3982 E:3987 ||| NNS
for  ||| S:3987 E:3991 ||| IN
inclusion  ||| S:3991 E:4011 ||| NN
in  ||| S:4011 E:4014 ||| IN
analyses ||| S:4014 E:4022 ||| NNS
. ||| S:4022 E:4023 ||| .
'  ||| S:4023 E:4053 ||| POS
Example  ||| S:4053 E:4061 ||| NN
5  ||| S:4061 E:4073 ||| CD
A  ||| S:4073 E:4075 ||| DT
randomized ||| S:4075 E:4085 ||| NN
,  ||| S:4085 E:4087 ||| ,
double-blind ||| S:4087 E:4099 ||| NNP
,  ||| S:4099 E:4101 ||| ,
titration  ||| S:4101 E:4111 ||| JJ
study  ||| S:4111 E:4117 ||| NN
of  ||| S:4117 E:4130 ||| IN
omapatrilat  ||| S:4130 E:4142 ||| NN
with  ||| S:4142 E:4147 ||| IN
hydrochlorothiazide  ||| S:4147 E:4167 ||| NN
in  ||| S:4167 E:4170 ||| IN
comparison  ||| S:4170 E:4181 ||| NN
with  ||| S:4181 E:4196 ||| IN
hydrochlorothiazide  ||| S:4196 E:4216 ||| NNS
( ||| S:4216 E:4217 ||| -LRB-
HCTZ ||| S:4217 E:4221 ||| NNP
)  ||| S:4221 E:4223 ||| -RRB-
plus  ||| S:4223 E:4228 ||| CC
placebo  ||| S:4228 E:4236 ||| NN
for  ||| S:4236 E:4240 ||| IN
the  ||| S:4240 E:4244 ||| DT
treatment  ||| S:4244 E:4264 ||| NN
of  ||| S:4264 E:4267 ||| IN
hypertension  ||| S:4267 E:4280 ||| NN
[  ||| S:4280 E:4282 ||| -LRB-
5  ||| S:4282 E:4284 ||| LS
]  ||| S:4284 E:4286 ||| -RRB-
.  ||| S:4286 E:4288 ||| .
After  ||| S:4288 E:4294 ||| IN
2  ||| S:4294 E:4296 ||| CD
weeks  ||| S:4296 E:4302 ||| NNS
of  ||| S:4302 E:4305 ||| IN
placebo  ||| S:4305 E:4313 ||| JJ
lead  ||| S:4313 E:4318 ||| NN
in  ||| S:4318 E:4331 ||| IN
and  ||| S:4331 E:4335 ||| CC
four  ||| S:4335 E:4340 ||| CD
weeks  ||| S:4340 E:4346 ||| NNS
of  ||| S:4346 E:4349 ||| IN
HCTZ  ||| S:4349 E:4354 ||| NNP
period ||| S:4354 E:4360 ||| NN
,  ||| S:4360 E:4362 ||| ,
274  ||| S:4362 E:4366 ||| CD
subjects  ||| S:4366 E:4375 ||| NNS
were  ||| S:4375 E:4390 ||| VBD
randomized  ||| S:4390 E:4401 ||| VBN
into  ||| S:4401 E:4406 ||| IN
three  ||| S:4406 E:4412 ||| CD
treatment  ||| S:4412 E:4422 ||| NN
groups ||| S:4422 E:4428 ||| NNS
.  ||| S:4428 E:4430 ||| .
' ||| S:4430 E:4431 ||| ''
A  ||| S:4431 E:4433 ||| DT
total  ||| S:4433 E:4439 ||| NN
of  ||| S:4439 E:4442 ||| IN
235  ||| S:4442 E:4456 ||| CD
subjects  ||| S:4456 E:4465 ||| NNS
completed  ||| S:4465 E:4475 ||| VBD
the  ||| S:4475 E:4479 ||| DT
( ||| S:4479 E:4480 ||| -LRB-
eight-week  ||| S:4480 E:4491 ||| JJ
double-blind  ||| S:4491 E:4504 ||| JJ
period ||| S:4504 E:4510 ||| NN
)  ||| S:4510 E:4522 ||| -RRB-
study ||| S:4522 E:4527 ||| NN
. ||| S:4527 E:4528 ||| .
'  ||| S:4528 E:4561 ||| POS
Effect  ||| S:4561 E:4568 ||| NN
of  ||| S:4568 E:4571 ||| IN
withdrawals  ||| S:4571 E:4583 ||| NNS
on  ||| S:4583 E:4586 ||| IN
the  ||| S:4586 E:4590 ||| DT
data  ||| S:4590 E:4595 ||| NN
analysis  ||| S:4595 E:4612 ||| NN
To  ||| S:4612 E:4615 ||| TO
demonstrate  ||| S:4615 E:4627 ||| VB
with  ||| S:4627 E:4632 ||| IN
simple  ||| S:4632 E:4639 ||| JJ
algebra  ||| S:4639 E:4647 ||| NNS
the  ||| S:4647 E:4651 ||| DT
effects  ||| S:4651 E:4659 ||| NNS
and  ||| S:4659 E:4663 ||| CC
key  ||| S:4663 E:4675 ||| JJ
statistical  ||| S:4675 E:4687 ||| JJ
concepts  ||| S:4687 E:4696 ||| NNS
surrounding  ||| S:4696 E:4708 ||| VBG
missing  ||| S:4708 E:4716 ||| JJ
data ||| S:4716 E:4720 ||| NNS
,  ||| S:4720 E:4722 ||| ,
I  ||| S:4722 E:4724 ||| PRP
use  ||| S:4724 E:4728 ||| VBP
the  ||| S:4728 E:4740 ||| DT
data  ||| S:4740 E:4745 ||| NNS
from  ||| S:4745 E:4750 ||| IN
Example  ||| S:4750 E:4758 ||| NNP
4  ||| S:4758 E:4760 ||| CD
above ||| S:4760 E:4765 ||| IN
.  ||| S:4765 E:4767 ||| .
In  ||| S:4767 E:4770 ||| IN
that  ||| S:4770 E:4775 ||| DT
study ||| S:4775 E:4780 ||| NN
,  ||| S:4780 E:4782 ||| ,
54  ||| S:4782 E:4785 ||| CD
patients  ||| S:4785 E:4794 ||| NNS
were  ||| S:4794 E:4807 ||| VBD
randomized ||| S:4807 E:4817 ||| VBN
.  ||| S:4817 E:4819 ||| .
However ||| S:4819 E:4826 ||| RB
,  ||| S:4826 E:4828 ||| ,
only  ||| S:4828 E:4833 ||| RB
the  ||| S:4833 E:4837 ||| DT
30  ||| S:4837 E:4840 ||| CD
patients  ||| S:4840 E:4849 ||| NNS
who  ||| S:4849 E:4853 ||| WP
completed  ||| S:4853 E:4863 ||| VBD
the  ||| S:4863 E:4875 ||| DT
trial  ||| S:4875 E:4881 ||| NN
were  ||| S:4881 E:4886 ||| VBD
included  ||| S:4886 E:4895 ||| VBN
in  ||| S:4895 E:4898 ||| IN
the  ||| S:4898 E:4902 ||| DT
paper ||| S:4902 E:4907 ||| NN
's  ||| S:4907 E:4910 ||| POS
analysis ||| S:4910 E:4918 ||| NN
.  ||| S:4918 E:4920 ||| .
The  ||| S:4920 E:4924 ||| DT
authors  ||| S:4924 E:4940 ||| NNS
excluded  ||| S:4940 E:4949 ||| VBN
from  ||| S:4949 E:4954 ||| IN
the  ||| S:4954 E:4958 ||| DT
analysis  ||| S:4958 E:4967 ||| NN
the  ||| S:4967 E:4971 ||| DT
other  ||| S:4971 E:4977 ||| JJ
24  ||| S:4977 E:4980 ||| CD
patients  ||| S:4980 E:4989 ||| NNS
who  ||| S:4989 E:5001 ||| WP
withdrew  ||| S:5001 E:5010 ||| VBD
early  ||| S:5010 E:5016 ||| RB
because  ||| S:5016 E:5024 ||| IN
of  ||| S:5024 E:5027 ||| IN
adverse  ||| S:5027 E:5035 ||| JJ
effects ||| S:5035 E:5042 ||| NNS
,  ||| S:5042 E:5044 ||| ,
lack  ||| S:5044 E:5049 ||| NN
of  ||| S:5049 E:5052 ||| IN
response  ||| S:5052 E:5069 ||| NN
or  ||| S:5069 E:5072 ||| CC
poor  ||| S:5072 E:5077 ||| JJ
compliance ||| S:5077 E:5087 ||| NN
.  ||| S:5087 E:5089 ||| .
Defining  ||| S:5089 E:5098 ||| VBG
effective  ||| S:5098 E:5108 ||| JJ
control  ||| S:5108 E:5116 ||| NN
of  ||| S:5116 E:5119 ||| IN
BP  ||| S:5119 E:5122 ||| NNP
by  ||| S:5122 E:5125 ||| IN
the  ||| S:5125 E:5137 ||| DT
criteria  ||| S:5137 E:5146 ||| NNS
of  ||| S:5146 E:5149 ||| IN
either  ||| S:5149 E:5156 ||| DT
maintaining  ||| S:5156 E:5168 ||| VBG
diastolic  ||| S:5168 E:5178 ||| JJ
blood  ||| S:5178 E:5184 ||| NN
pressure  ||| S:5184 E:5201 ||| NN
( ||| S:5201 E:5202 ||| -LRB-
DBP ||| S:5202 E:5205 ||| NNP
)  ||| S:5205 E:5207 ||| -RRB-
≤  ||| S:5207 E:5209 ||| CD
95  ||| S:5209 E:5212 ||| CD
mmHg  ||| S:5212 E:5217 ||| JJ
or  ||| S:5217 E:5220 ||| CC
achieving  ||| S:5220 E:5230 ||| VBG
a  ||| S:5230 E:5232 ||| DT
least  ||| S:5232 E:5238 ||| JJS
≥  ||| S:5238 E:5240 ||| CD
15  ||| S:5240 E:5243 ||| CD
mmHg  ||| S:5243 E:5248 ||| JJ
decrease  ||| S:5248 E:5257 ||| NN
in  ||| S:5257 E:5268 ||| IN
DBP ||| S:5268 E:5271 ||| NNP
,  ||| S:5271 E:5273 ||| ,
the  ||| S:5273 E:5277 ||| DT
authors  ||| S:5277 E:5285 ||| NNS
summarized  ||| S:5285 E:5296 ||| VBD
the  ||| S:5296 E:5300 ||| DT
following  ||| S:5300 E:5310 ||| JJ
results ||| S:5310 E:5317 ||| NNS
:  ||| S:5317 E:5319 ||| :
' ||| S:5319 E:5320 ||| ''
Eighty  ||| S:5320 E:5335 ||| NNP
per  ||| S:5335 E:5339 ||| IN
cent  ||| S:5339 E:5344 ||| NN
of  ||| S:5344 E:5347 ||| IN
randomized  ||| S:5347 E:5358 ||| JJ
patients  ||| S:5358 E:5367 ||| NNS
completed  ||| S:5367 E:5377 ||| VBD
the  ||| S:5377 E:5381 ||| DT
protocol  ||| S:5381 E:5390 ||| NN
with  ||| S:5390 E:5403 ||| IN
effective  ||| S:5403 E:5413 ||| JJ
control  ||| S:5413 E:5421 ||| NN
of  ||| S:5421 E:5424 ||| IN
BP  ||| S:5424 E:5427 ||| NNP
and  ||| S:5427 E:5431 ||| CC
no  ||| S:5431 E:5434 ||| DT
side  ||| S:5434 E:5439 ||| NN
effects ||| S:5439 E:5446 ||| NNS
. ||| S:5446 E:5447 ||| .
'  ||| S:5447 E:5449 ||| POS
Obviously ||| S:5449 E:5458 ||| RB
,  ||| S:5458 E:5468 ||| ,
the  ||| S:5468 E:5472 ||| DT
authors  ||| S:5472 E:5480 ||| NNS
only  ||| S:5480 E:5485 ||| RB
counted  ||| S:5485 E:5493 ||| VBN
24  ||| S:5493 E:5496 ||| CD
patients  ||| S:5496 E:5505 ||| NNS
out  ||| S:5505 E:5509 ||| RP
of  ||| S:5509 E:5512 ||| IN
the  ||| S:5512 E:5516 ||| DT
30  ||| S:5516 E:5527 ||| CD
completers  ||| S:5527 E:5538 ||| NNS
and  ||| S:5538 E:5542 ||| CC
obtained  ||| S:5542 E:5551 ||| VBD
80 ||| S:5551 E:5553 ||| CD
%  ||| S:5553 E:5555 ||| NN
and  ||| S:5555 E:5559 ||| CC
ignored  ||| S:5559 E:5567 ||| VBD
the  ||| S:5567 E:5571 ||| DT
24  ||| S:5571 E:5574 ||| CD
patients  ||| S:5574 E:5583 ||| NNS
who  ||| S:5583 E:5595 ||| WP
dropped  ||| S:5595 E:5603 ||| VBD
out  ||| S:5603 E:5607 ||| RP
prior  ||| S:5607 E:5613 ||| RB
to  ||| S:5613 E:5616 ||| TO
the  ||| S:5616 E:5620 ||| DT
scheduled  ||| S:5620 E:5630 ||| JJ
end  ||| S:5630 E:5634 ||| NN
of  ||| S:5634 E:5637 ||| IN
the  ||| S:5637 E:5641 ||| DT
study  ||| S:5641 E:5647 ||| NN
at  ||| S:5647 E:5650 ||| IN
six  ||| S:5650 E:5662 ||| CD
months ||| S:5662 E:5668 ||| NNS
.  ||| S:5668 E:5670 ||| .
To  ||| S:5670 E:5673 ||| TO
distinguish  ||| S:5673 E:5685 ||| VB
the  ||| S:5685 E:5689 ||| DT
different  ||| S:5689 E:5699 ||| JJ
24  ||| S:5699 E:5702 ||| CD
patients  ||| S:5702 E:5711 ||| NNS
in  ||| S:5711 E:5714 ||| IN
this  ||| S:5714 E:5727 ||| DT
example ||| S:5727 E:5734 ||| NN
,  ||| S:5734 E:5736 ||| ,
we  ||| S:5736 E:5739 ||| PRP
denote  ||| S:5739 E:5746 ||| VBD
24  ||| S:5746 E:5749 ||| CD
( ||| S:5749 E:5750 ||| -LRB-
cr ||| S:5750 E:5752 ||| LS
) ||| S:5752 E:5753 ||| -RRB-
for  ||| S:5753 E:5757 ||| IN
the  ||| S:5757 E:5761 ||| DT
former  ||| S:5761 E:5768 ||| JJ
and  ||| S:5768 E:5772 ||| CC
24  ||| S:5772 E:5775 ||| CD
( ||| S:5775 E:5776 ||| -LRB-
d ||| S:5776 E:5777 ||| LS
) ||| S:5777 E:5778 ||| -RRB-
for  ||| S:5778 E:5782 ||| IN
the  ||| S:5782 E:5794 ||| DT
latter ||| S:5794 E:5800 ||| NN
,  ||| S:5800 E:5802 ||| ,
that  ||| S:5802 E:5807 ||| WDT
is ||| S:5807 E:5809 ||| VBZ
,  ||| S:5809 E:5811 ||| ,
dropouts ||| S:5811 E:5819 ||| NNS
.  ||| S:5819 E:5821 ||| .
It  ||| S:5821 E:5824 ||| PRP
is  ||| S:5824 E:5827 ||| VBZ
easily  ||| S:5827 E:5834 ||| RB
seen  ||| S:5834 E:5839 ||| VBN
that  ||| S:5839 E:5844 ||| IN
the  ||| S:5844 E:5856 ||| DT
correct  ||| S:5856 E:5864 ||| JJ
summary  ||| S:5864 E:5872 ||| NN
should  ||| S:5872 E:5879 ||| MD
be  ||| S:5879 E:5882 ||| VB
24  ||| S:5882 E:5885 ||| CD
( ||| S:5885 E:5886 ||| -LRB-
cr ||| S:5886 E:5888 ||| LS
) ||| S:5888 E:5889 ||| -RRB-
/ ||| S:5889 E:5890 ||| CD
54  ||| S:5890 E:5893 ||| CD
=  ||| S:5893 E:5895 ||| SYM
44.4 ||| S:5895 E:5899 ||| CD
%  ||| S:5899 E:5901 ||| NN
completed  ||| S:5901 E:5911 ||| VBD
the  ||| S:5911 E:5923 ||| DT
protocol  ||| S:5923 E:5932 ||| NN
with  ||| S:5932 E:5937 ||| IN
effective  ||| S:5937 E:5947 ||| JJ
control  ||| S:5947 E:5955 ||| NN
of  ||| S:5955 E:5958 ||| IN
BP  ||| S:5958 E:5961 ||| NNP
and  ||| S:5961 E:5965 ||| CC
no  ||| S:5965 E:5968 ||| DT
side  ||| S:5968 E:5973 ||| NN
effects ||| S:5973 E:5980 ||| NNS
,  ||| S:5980 E:5990 ||| ,
rather  ||| S:5990 E:5997 ||| RB
than  ||| S:5997 E:6002 ||| IN
the  ||| S:6002 E:6006 ||| DT
reported  ||| S:6006 E:6015 ||| VBD
24  ||| S:6015 E:6018 ||| CD
( ||| S:6018 E:6019 ||| -LRB-
cr ||| S:6019 E:6021 ||| LS
) ||| S:6021 E:6022 ||| -RRB-
/ ||| S:6022 E:6023 ||| CD
30  ||| S:6023 E:6026 ||| CD
=  ||| S:6026 E:6028 ||| SYM
80 ||| S:6028 E:6030 ||| CD
% ||| S:6030 E:6031 ||| NN
.  ||| S:6031 E:6033 ||| .
( ||| S:6033 E:6034 ||| -LRB-
See  ||| S:6034 E:6038 ||| VB
Table  ||| S:6038 E:6052 ||| NNP
1 ||| S:6052 E:6053 ||| CD
. ||| S:6053 E:6054 ||| .
)  ||| S:6054 E:6064 ||| -RRB-
If  ||| S:6064 E:6067 ||| IN
the  ||| S:6067 E:6071 ||| DT
authors  ||| S:6071 E:6079 ||| NNS
really  ||| S:6079 E:6086 ||| RB
intended  ||| S:6086 E:6095 ||| VBN
to  ||| S:6095 E:6098 ||| TO
estimate  ||| S:6098 E:6107 ||| VB
the  ||| S:6107 E:6111 ||| DT
chance  ||| S:6111 E:6126 ||| NN
for  ||| S:6126 E:6130 ||| IN
patients  ||| S:6130 E:6139 ||| NNS
to  ||| S:6139 E:6142 ||| TO
have  ||| S:6142 E:6147 ||| VB
effective  ||| S:6147 E:6157 ||| JJ
control  ||| S:6157 E:6165 ||| NN
of  ||| S:6165 E:6168 ||| IN
BP  ||| S:6168 E:6171 ||| NNP
with  ||| S:6171 E:6176 ||| IN
no  ||| S:6176 E:6179 ||| DT
side  ||| S:6179 E:6192 ||| NN
effects  ||| S:6192 E:6200 ||| NNS
with  ||| S:6200 E:6205 ||| IN
the  ||| S:6205 E:6209 ||| DT
study  ||| S:6209 E:6215 ||| NN
therapies  ||| S:6215 E:6225 ||| NNS
at  ||| S:6225 E:6228 ||| IN
Month  ||| S:6228 E:6234 ||| NNP
6  ||| S:6234 E:6236 ||| CD
( ||| S:6236 E:6237 ||| -LRB-
' ||| S:6237 E:6238 ||| FW
responders ||| S:6238 E:6248 ||| FW
'  ||| S:6248 E:6258 ||| ''
in  ||| S:6258 E:6261 ||| IN
brief ||| S:6261 E:6266 ||| JJ
) ||| S:6266 E:6267 ||| -RRB-
,  ||| S:6267 E:6269 ||| ,
then  ||| S:6269 E:6274 ||| RB
we  ||| S:6274 E:6277 ||| PRP
need  ||| S:6277 E:6282 ||| VBP
to  ||| S:6282 E:6285 ||| TO
do  ||| S:6285 E:6288 ||| VB
more  ||| S:6288 E:6293 ||| JJR
work ||| S:6293 E:6297 ||| NN
.  ||| S:6297 E:6299 ||| .
First ||| S:6299 E:6304 ||| NNP
,  ||| S:6304 E:6306 ||| ,
the  ||| S:6306 E:6318 ||| DT
calculation  ||| S:6318 E:6330 ||| NN
should  ||| S:6330 E:6337 ||| MD
always  ||| S:6337 E:6344 ||| RB
use  ||| S:6344 E:6348 ||| VB
54  ||| S:6348 E:6351 ||| CD
as  ||| S:6351 E:6354 ||| IN
the  ||| S:6354 E:6358 ||| DT
denominator  ||| S:6358 E:6370 ||| NN
because  ||| S:6370 E:6386 ||| IN
that  ||| S:6386 E:6391 ||| WDT
was  ||| S:6391 E:6395 ||| VBD
the  ||| S:6395 E:6399 ||| DT
number  ||| S:6399 E:6406 ||| NN
of  ||| S:6406 E:6409 ||| IN
patients  ||| S:6409 E:6418 ||| NNS
randomized  ||| S:6418 E:6429 ||| VBP
to  ||| S:6429 E:6432 ||| TO
the  ||| S:6432 E:6436 ||| DT
study ||| S:6436 E:6441 ||| NN
;  ||| S:6441 E:6451 ||| :
however ||| S:6451 E:6458 ||| RB
,  ||| S:6458 E:6460 ||| ,
only  ||| S:6460 E:6465 ||| RB
30  ||| S:6465 E:6468 ||| CD
patients  ||| S:6468 E:6477 ||| NNS
had  ||| S:6477 E:6481 ||| VBD
BP  ||| S:6481 E:6484 ||| NNP
measurement  ||| S:6484 E:6496 ||| NN
at  ||| S:6496 E:6499 ||| IN
Month  ||| S:6499 E:6505 ||| NNP
6 ||| S:6505 E:6506 ||| CD
;  ||| S:6506 E:6508 ||| :
of  ||| S:6508 E:6519 ||| IN
them ||| S:6519 E:6523 ||| PRP
,  ||| S:6523 E:6525 ||| ,
24  ||| S:6525 E:6528 ||| CD
( ||| S:6528 E:6529 ||| -LRB-
cr ||| S:6529 E:6531 ||| LS
) ||| S:6531 E:6532 ||| -RRB-
were  ||| S:6532 E:6537 ||| VBD
responders ||| S:6537 E:6547 ||| VBN
.  ||| S:6547 E:6549 ||| .
This  ||| S:6549 E:6554 ||| DT
means  ||| S:6554 E:6560 ||| NNS
that  ||| S:6560 E:6565 ||| IN
the  ||| S:6565 E:6569 ||| DT
true  ||| S:6569 E:6582 ||| JJ
answer  ||| S:6582 E:6589 ||| NN
should  ||| S:6589 E:6596 ||| MD
be  ||| S:6596 E:6599 ||| VB
( ||| S:6599 E:6600 ||| -LRB-
24  ||| S:6600 E:6603 ||| CD
( ||| S:6603 E:6604 ||| -LRB-
cr ||| S:6604 E:6606 ||| LS
) ||| S:6606 E:6607 ||| -RRB-
+ ||| S:6607 E:6608 ||| CD
? ||| S:6608 E:6609 ||| CD
) ||| S:6609 E:6610 ||| -RRB-
/ ||| S:6610 E:6611 ||| NNP
( ||| S:6611 E:6612 ||| -LRB-
30+24  ||| S:6612 E:6618 ||| NNP
( ||| S:6618 E:6619 ||| -LRB-
d ||| S:6619 E:6620 ||| LS
) ||| S:6620 E:6621 ||| -RRB-
)  ||| S:6621 E:6623 ||| -RRB-
=  ||| S:6623 E:6625 ||| SYM
( ||| S:6625 E:6626 ||| -LRB-
24+ ||| S:6626 E:6629 ||| NNP
? ||| S:6629 E:6630 ||| NNP
) ||| S:6630 E:6631 ||| -RRB-
/ ||| S:6631 E:6632 ||| CD
54 ||| S:6632 E:6634 ||| CD
,  ||| S:6634 E:6636 ||| ,
where  ||| S:6636 E:6650 ||| WRB
the  ||| S:6650 E:6654 ||| DT
question  ||| S:6654 E:6663 ||| NN
mark  ||| S:6663 E:6668 ||| NN
represents  ||| S:6668 E:6679 ||| VBZ
the  ||| S:6679 E:6683 ||| DT
unknown  ||| S:6683 E:6691 ||| JJ
number  ||| S:6691 E:6698 ||| NN
of  ||| S:6698 E:6709 ||| IN
responders  ||| S:6709 E:6720 ||| NN
among  ||| S:6720 E:6726 ||| IN
the  ||| S:6726 E:6730 ||| DT
24  ||| S:6730 E:6733 ||| CD
( ||| S:6733 E:6734 ||| -LRB-
d ||| S:6734 E:6735 ||| LS
) ||| S:6735 E:6736 ||| -RRB-
withdrawals  ||| S:6736 E:6748 ||| NNS
counted  ||| S:6748 E:6756 ||| VBN
in  ||| S:6756 E:6759 ||| IN
the  ||| S:6759 E:6771 ||| DT
denominator ||| S:6771 E:6782 ||| NN
.  ||| S:6782 E:6784 ||| .
Next ||| S:6784 E:6788 ||| JJ
,  ||| S:6788 E:6790 ||| ,
we  ||| S:6790 E:6793 ||| PRP
calculate  ||| S:6793 E:6803 ||| VBP
the  ||| S:6803 E:6807 ||| DT
extreme  ||| S:6807 E:6815 ||| JJ
possibilities  ||| S:6815 E:6837 ||| NNS
as  ||| S:6837 E:6840 ||| IN
( ||| S:6840 E:6841 ||| -LRB-
a ||| S:6841 E:6842 ||| LS
)  ||| S:6842 E:6844 ||| -RRB-
( ||| S:6844 E:6845 ||| -LRB-
24  ||| S:6845 E:6848 ||| CD
( ||| S:6848 E:6849 ||| -LRB-
cr ||| S:6849 E:6851 ||| LS
) ||| S:6851 E:6852 ||| -RRB-
+0 ||| S:6852 E:6854 ||| CD
) ||| S:6854 E:6855 ||| -RRB-
/ ||| S:6855 E:6856 ||| CD
54  ||| S:6856 E:6859 ||| CD
=  ||| S:6859 E:6861 ||| SYM
44.4 ||| S:6861 E:6865 ||| CD
%  ||| S:6865 E:6867 ||| NN
and  ||| S:6867 E:6871 ||| CC
( ||| S:6871 E:6872 ||| -LRB-
b ||| S:6872 E:6873 ||| LS
)  ||| S:6873 E:6875 ||| -RRB-
( ||| S:6875 E:6876 ||| -LRB-
24  ||| S:6876 E:6879 ||| CD
( ||| S:6879 E:6880 ||| -LRB-
cr ||| S:6880 E:6882 ||| LS
) ||| S:6882 E:6883 ||| -RRB-
+24 ||| S:6883 E:6886 ||| CD
) ||| S:6886 E:6887 ||| -RRB-
/ ||| S:6887 E:6888 ||| CD
54  ||| S:6888 E:6891 ||| CD
=  ||| S:6891 E:6901 ||| SYM
48 ||| S:6901 E:6903 ||| CD
/ ||| S:6903 E:6904 ||| CD
54  ||| S:6904 E:6907 ||| CD
=  ||| S:6907 E:6909 ||| SYM
88.9 ||| S:6909 E:6913 ||| CD
% ||| S:6913 E:6914 ||| NN
.  ||| S:6914 E:6924 ||| .
In  ||| S:6924 E:6927 ||| IN
( ||| S:6927 E:6928 ||| -LRB-
a ||| S:6928 E:6929 ||| LS
)  ||| S:6929 E:6931 ||| -RRB-
we  ||| S:6931 E:6934 ||| PRP
assumed  ||| S:6934 E:6942 ||| VBD
that  ||| S:6942 E:6947 ||| DT
none  ||| S:6947 E:6952 ||| NN
of  ||| S:6952 E:6955 ||| IN
24  ||| S:6955 E:6958 ||| CD
( ||| S:6958 E:6959 ||| -LRB-
d ||| S:6959 E:6960 ||| LS
) ||| S:6960 E:6961 ||| -RRB-
withdrawals  ||| S:6961 E:6973 ||| NNS
( ||| S:6973 E:6974 ||| -LRB-
0 ||| S:6974 E:6975 ||| CD
% ||| S:6975 E:6976 ||| NN
)  ||| S:6976 E:6986 ||| -RRB-
responded ||| S:6986 E:6995 ||| VBD
,  ||| S:6995 E:6997 ||| ,
while  ||| S:6997 E:7003 ||| IN
in  ||| S:7003 E:7006 ||| IN
( ||| S:7006 E:7007 ||| -LRB-
b ||| S:7007 E:7008 ||| LS
)  ||| S:7008 E:7010 ||| -RRB-
we  ||| S:7010 E:7013 ||| PRP
assume  ||| S:7013 E:7020 ||| VBP
all  ||| S:7020 E:7024 ||| DT
24  ||| S:7024 E:7027 ||| CD
( ||| S:7027 E:7028 ||| -LRB-
d ||| S:7028 E:7029 ||| LS
) ||| S:7029 E:7030 ||| -RRB-
withdrawals  ||| S:7030 E:7050 ||| NNS
( ||| S:7050 E:7051 ||| -LRB-
100 ||| S:7051 E:7054 ||| CD
% ||| S:7054 E:7055 ||| NN
)  ||| S:7055 E:7057 ||| -RRB-
responded ||| S:7057 E:7066 ||| VBD
.  ||| S:7066 E:7068 ||| .
Of  ||| S:7068 E:7071 ||| IN
course ||| S:7071 E:7077 ||| NN
,  ||| S:7077 E:7079 ||| ,
we  ||| S:7079 E:7082 ||| PRP
know  ||| S:7082 E:7087 ||| VBP
that  ||| S:7087 E:7092 ||| IN
( ||| S:7092 E:7093 ||| -LRB-
b ||| S:7093 E:7094 ||| LS
)  ||| S:7094 E:7096 ||| -RRB-
is  ||| S:7096 E:7107 ||| VBZ
unrealistic  ||| S:7107 E:7119 ||| VBN
since  ||| S:7119 E:7125 ||| IN
some  ||| S:7125 E:7130 ||| DT
people  ||| S:7130 E:7137 ||| NNS
withdrew  ||| S:7137 E:7146 ||| VBD
because  ||| S:7146 E:7154 ||| IN
of  ||| S:7154 E:7157 ||| IN
lack  ||| S:7157 E:7162 ||| NN
of  ||| S:7162 E:7173 ||| IN
response  ||| S:7173 E:7182 ||| NN
and  ||| S:7182 E:7186 ||| CC
some  ||| S:7186 E:7191 ||| DT
because  ||| S:7191 E:7199 ||| RB
of  ||| S:7199 E:7202 ||| IN
side  ||| S:7202 E:7207 ||| NN
effects ||| S:7207 E:7214 ||| NNS
,  ||| S:7214 E:7216 ||| ,
but  ||| S:7216 E:7220 ||| CC
the  ||| S:7220 E:7224 ||| DT
paper  ||| S:7224 E:7238 ||| NN
did  ||| S:7238 E:7242 ||| VBD
not  ||| S:7242 E:7246 ||| RB
provide  ||| S:7246 E:7254 ||| VB
the  ||| S:7254 E:7258 ||| DT
exact  ||| S:7258 E:7264 ||| JJ
numbers ||| S:7264 E:7271 ||| NNS
.  ||| S:7271 E:7273 ||| .
In  ||| S:7273 E:7276 ||| IN
general ||| S:7276 E:7283 ||| JJ
,  ||| S:7283 E:7285 ||| ,
we  ||| S:7285 E:7288 ||| PRP
usually  ||| S:7288 E:7304 ||| RB
do  ||| S:7304 E:7307 ||| VBP
not  ||| S:7307 E:7311 ||| RB
feel  ||| S:7311 E:7316 ||| VB
comfortable  ||| S:7316 E:7328 ||| JJ
with  ||| S:7328 E:7333 ||| IN
either  ||| S:7333 E:7340 ||| DT
extreme ||| S:7340 E:7347 ||| JJ
,  ||| S:7347 E:7349 ||| ,
but  ||| S:7349 E:7353 ||| CC
we  ||| S:7353 E:7364 ||| PRP
understand  ||| S:7364 E:7375 ||| VBP
that  ||| S:7375 E:7380 ||| IN
they  ||| S:7380 E:7385 ||| PRP
provide  ||| S:7385 E:7393 ||| VBP
an  ||| S:7393 E:7396 ||| DT
idea  ||| S:7396 E:7401 ||| NN
of  ||| S:7401 E:7404 ||| IN
the  ||| S:7404 E:7408 ||| DT
uncertainty  ||| S:7408 E:7420 ||| NN
in  ||| S:7420 E:7431 ||| IN
the  ||| S:7431 E:7435 ||| DT
data  ||| S:7435 E:7440 ||| NNS
because  ||| S:7440 E:7448 ||| IN
of  ||| S:7448 E:7451 ||| IN
withdrawals ||| S:7451 E:7462 ||| NNS
.  ||| S:7462 E:7472 ||| .
An  ||| S:7472 E:7475 ||| DT
estimate  ||| S:7475 E:7484 ||| NN
between  ||| S:7484 E:7492 ||| IN
the  ||| S:7492 E:7496 ||| DT
extremes  ||| S:7496 E:7505 ||| NN
is  ||| S:7505 E:7508 ||| VBZ
( ||| S:7508 E:7509 ||| -LRB-
c ||| S:7509 E:7510 ||| LS
) ||| S:7510 E:7511 ||| -RRB-
:  ||| S:7511 E:7513 ||| :
to  ||| S:7513 E:7516 ||| TO
substitute  ||| S:7516 E:7535 ||| VB
the  ||| S:7535 E:7539 ||| DT
unknown  ||| S:7539 E:7547 ||| JJ
number  ||| S:7547 E:7554 ||| NN
by  ||| S:7554 E:7557 ||| IN
24  ||| S:7557 E:7560 ||| CD
( ||| S:7560 E:7561 ||| -LRB-
d ||| S:7561 E:7562 ||| LS
) ||| S:7562 E:7563 ||| -RRB-
×  ||| S:7563 E:7565 ||| NNP
( ||| S:7565 E:7566 ||| -LRB-
24  ||| S:7566 E:7569 ||| CD
( ||| S:7569 E:7570 ||| -LRB-
cr ||| S:7570 E:7572 ||| LS
) ||| S:7572 E:7573 ||| -RRB-
/ ||| S:7573 E:7574 ||| CD
30 ||| S:7574 E:7576 ||| CD
)  ||| S:7576 E:7578 ||| -RRB-
=  ||| S:7578 E:7580 ||| SYM
24  ||| S:7580 E:7583 ||| CD
( ||| S:7583 E:7584 ||| -LRB-
d ||| S:7584 E:7585 ||| LS
) ||| S:7585 E:7586 ||| -RRB-
×  ||| S:7586 E:7588 ||| CD
0.80  ||| S:7588 E:7593 ||| CD
=  ||| S:7593 E:7603 ||| SYM
19.2 ||| S:7603 E:7607 ||| CD
,  ||| S:7607 E:7609 ||| ,
where  ||| S:7609 E:7615 ||| WRB
24  ||| S:7615 E:7618 ||| CD
( ||| S:7618 E:7619 ||| -LRB-
cr ||| S:7619 E:7621 ||| LS
) ||| S:7621 E:7622 ||| -RRB-
/ ||| S:7622 E:7623 ||| CD
30  ||| S:7623 E:7626 ||| CD
=  ||| S:7626 E:7628 ||| SYM
80 ||| S:7628 E:7630 ||| CD
%  ||| S:7630 E:7632 ||| NN
is  ||| S:7632 E:7635 ||| VBZ
the  ||| S:7635 E:7639 ||| DT
proportion  ||| S:7639 E:7650 ||| NN
of  ||| S:7650 E:7661 ||| IN
responders  ||| S:7661 E:7672 ||| NN
among  ||| S:7672 E:7678 ||| IN
those  ||| S:7678 E:7684 ||| DT
who  ||| S:7684 E:7688 ||| WP
completed  ||| S:7688 E:7698 ||| VBD
the  ||| S:7698 E:7702 ||| DT
trial ||| S:7702 E:7707 ||| NN
.  ||| S:7707 E:7709 ||| .
That  ||| S:7709 E:7714 ||| WDT
is ||| S:7714 E:7716 ||| VBZ
,  ||| S:7716 E:7726 ||| ,
when  ||| S:7726 E:7731 ||| WRB
no  ||| S:7731 E:7734 ||| DT
particular  ||| S:7734 E:7745 ||| JJ
information  ||| S:7745 E:7757 ||| NN
was  ||| S:7757 E:7761 ||| VBD
available ||| S:7761 E:7770 ||| JJ
,  ||| S:7770 E:7772 ||| ,
we  ||| S:7772 E:7775 ||| PRP
may  ||| S:7775 E:7779 ||| MD
assume  ||| S:7779 E:7794 ||| VB
that  ||| S:7794 E:7799 ||| IN
the  ||| S:7799 E:7803 ||| DT
same  ||| S:7803 E:7808 ||| JJ
proportion  ||| S:7808 E:7819 ||| NN
of  ||| S:7819 E:7822 ||| IN
patients  ||| S:7822 E:7831 ||| NNS
( ||| S:7831 E:7832 ||| -LRB-
80 ||| S:7832 E:7834 ||| CD
% ||| S:7834 E:7835 ||| NN
)  ||| S:7835 E:7837 ||| -RRB-
among  ||| S:7837 E:7843 ||| IN
the  ||| S:7843 E:7847 ||| DT
24  ||| S:7847 E:7858 ||| CD
( ||| S:7858 E:7859 ||| -LRB-
d ||| S:7859 E:7860 ||| LS
) ||| S:7860 E:7861 ||| -RRB-
dropouts  ||| S:7861 E:7870 ||| NNS
would  ||| S:7870 E:7876 ||| MD
have  ||| S:7876 E:7881 ||| VB
also  ||| S:7881 E:7886 ||| RB
responded ||| S:7886 E:7895 ||| VBD
,  ||| S:7895 E:7897 ||| ,
had  ||| S:7897 E:7901 ||| VBD
they  ||| S:7901 E:7906 ||| PRP
completed  ||| S:7906 E:7924 ||| VBD
six  ||| S:7924 E:7928 ||| CD
months ||| S:7928 E:7934 ||| NNS
.  ||| S:7934 E:7936 ||| .
Unsurprisingly ||| S:7936 E:7950 ||| NNP
,  ||| S:7950 E:7952 ||| ,
when  ||| S:7952 E:7957 ||| WRB
we  ||| S:7957 E:7960 ||| PRP
do  ||| S:7960 E:7963 ||| VBP
the  ||| S:7963 E:7967 ||| DT
calculation ||| S:7967 E:7978 ||| NN
,  ||| S:7978 E:7980 ||| ,
the  ||| S:7980 E:7992 ||| DT
estimate  ||| S:7992 E:8001 ||| NN
becomes  ||| S:8001 E:8009 ||| VBZ
( ||| S:8009 E:8010 ||| -LRB-
24  ||| S:8010 E:8013 ||| CD
( ||| S:8013 E:8014 ||| -LRB-
cr ||| S:8014 E:8016 ||| LS
) ||| S:8016 E:8017 ||| -RRB-
+19.2 ||| S:8017 E:8022 ||| CD
) ||| S:8022 E:8023 ||| -RRB-
/ ||| S:8023 E:8024 ||| CD
54  ||| S:8024 E:8027 ||| CD
=  ||| S:8027 E:8029 ||| SYM
43.2 ||| S:8029 E:8033 ||| CD
/ ||| S:8033 E:8034 ||| CD
54  ||| S:8034 E:8037 ||| CD
=  ||| S:8037 E:8039 ||| SYM
80 ||| S:8039 E:8041 ||| CD
% ||| S:8041 E:8042 ||| NN
,  ||| S:8042 E:8044 ||| ,
the  ||| S:8044 E:8056 ||| DT
same  ||| S:8056 E:8061 ||| JJ
answer  ||| S:8061 E:8068 ||| NN
as  ||| S:8068 E:8071 ||| IN
that  ||| S:8071 E:8076 ||| DT
using  ||| S:8076 E:8082 ||| VBG
only  ||| S:8082 E:8087 ||| RB
the  ||| S:8087 E:8091 ||| DT
completers ||| S:8091 E:8101 ||| NN
.  ||| S:8101 E:8103 ||| .
In  ||| S:8103 E:8106 ||| IN
fact ||| S:8106 E:8110 ||| NN
,  ||| S:8110 E:8112 ||| ,
a  ||| S:8112 E:8122 ||| DT
simple  ||| S:8122 E:8129 ||| JJ
algebra  ||| S:8129 E:8137 ||| NN
can  ||| S:8137 E:8141 ||| MD
show  ||| S:8141 E:8146 ||| VB
that  ||| S:8146 E:8151 ||| IN
this  ||| S:8151 E:8156 ||| DT
is  ||| S:8156 E:8159 ||| VBZ
always  ||| S:8159 E:8166 ||| RB
so ||| S:8166 E:8168 ||| RB
.  ||| S:8168 E:8170 ||| .
We  ||| S:8170 E:8173 ||| PRP
can  ||| S:8173 E:8177 ||| MD
see  ||| S:8177 E:8189 ||| VB
that  ||| S:8189 E:8194 ||| IN
( ||| S:8194 E:8195 ||| -LRB-
c ||| S:8195 E:8196 ||| LS
)  ||| S:8196 E:8198 ||| -RRB-
is  ||| S:8198 E:8201 ||| VBZ
in-between  ||| S:8201 E:8212 ||| JJ
( ||| S:8212 E:8213 ||| -LRB-
a ||| S:8213 E:8214 ||| LS
)  ||| S:8214 E:8216 ||| -RRB-
and  ||| S:8216 E:8220 ||| CC
( ||| S:8220 E:8221 ||| -LRB-
b ||| S:8221 E:8222 ||| LS
) ||| S:8222 E:8223 ||| -RRB-
,  ||| S:8223 E:8225 ||| ,
and  ||| S:8225 E:8229 ||| CC
in  ||| S:8229 E:8232 ||| IN
this  ||| S:8232 E:8237 ||| DT
case ||| S:8237 E:8241 ||| NN
,  ||| S:8241 E:8243 ||| ,
leans  ||| S:8243 E:8257 ||| VBZ
toward  ||| S:8257 E:8264 ||| IN
( ||| S:8264 E:8265 ||| -LRB-
b ||| S:8265 E:8266 ||| LS
) ||| S:8266 E:8267 ||| -RRB-
.  ||| S:8267 E:8269 ||| .
See  ||| S:8269 E:8273 ||| VB
Table  ||| S:8273 E:8279 ||| NNP
2 ||| S:8279 E:8280 ||| CD
.  ||| S:8280 E:8290 ||| .
Notice  ||| S:8290 E:8297 ||| NN
that  ||| S:8297 E:8302 ||| IN
the  ||| S:8302 E:8306 ||| DT
paper  ||| S:8306 E:8312 ||| NN
reported  ||| S:8312 E:8321 ||| VBD
that  ||| S:8321 E:8326 ||| IN
a  ||| S:8326 E:8328 ||| DT
proportion  ||| S:8328 E:8339 ||| NN
of  ||| S:8339 E:8342 ||| IN
80 ||| S:8342 E:8344 ||| CD
%  ||| S:8344 E:8354 ||| NN
of  ||| S:8354 E:8357 ||| IN
' ||| S:8357 E:8358 ||| POS
randomized  ||| S:8358 E:8369 ||| JJ
patients  ||| S:8369 E:8378 ||| NNS
completed  ||| S:8378 E:8388 ||| VBD
the  ||| S:8388 E:8392 ||| DT
protocol  ||| S:8392 E:8401 ||| NN
with  ||| S:8401 E:8414 ||| IN
effective  ||| S:8414 E:8424 ||| JJ
control  ||| S:8424 E:8432 ||| NN
of  ||| S:8432 E:8435 ||| IN
BP  ||| S:8435 E:8438 ||| NNP
and  ||| S:8438 E:8442 ||| CC
no  ||| S:8442 E:8445 ||| DT
side  ||| S:8445 E:8450 ||| NN
effects ||| S:8450 E:8457 ||| NNS
'  ||| S:8457 E:8459 ||| ''
( ||| S:8459 E:8460 ||| -LRB-
as  ||| S:8460 E:8463 ||| RB
explained  ||| S:8463 E:8481 ||| VBD
earlier ||| S:8481 E:8488 ||| RBR
,  ||| S:8488 E:8490 ||| ,
the  ||| S:8490 E:8494 ||| DT
figure  ||| S:8494 E:8501 ||| NN
should  ||| S:8501 E:8508 ||| MD
instead  ||| S:8508 E:8516 ||| RB
be  ||| S:8516 E:8519 ||| VB
44.4 ||| S:8519 E:8523 ||| CD
% ||| S:8523 E:8524 ||| NN
) ||| S:8524 E:8525 ||| -RRB-
,  ||| S:8525 E:8527 ||| ,
while  ||| S:8527 E:8533 ||| IN
the  ||| S:8533 E:8537 ||| DT
80 ||| S:8537 E:8539 ||| CD
%  ||| S:8539 E:8549 ||| NN
in  ||| S:8549 E:8552 ||| IN
( ||| S:8552 E:8553 ||| -LRB-
c ||| S:8553 E:8554 ||| LS
)  ||| S:8554 E:8556 ||| -RRB-
is  ||| S:8556 E:8559 ||| VBZ
an  ||| S:8559 E:8562 ||| DT
estimate  ||| S:8562 E:8571 ||| NN
of  ||| S:8571 E:8574 ||| IN
the  ||| S:8574 E:8578 ||| DT
chance  ||| S:8578 E:8585 ||| NN
of  ||| S:8585 E:8588 ||| IN
effective  ||| S:8588 E:8598 ||| JJ
control  ||| S:8598 E:8606 ||| NN
of  ||| S:8606 E:8617 ||| IN
BP  ||| S:8617 E:8620 ||| NNP
without  ||| S:8620 E:8628 ||| IN
side  ||| S:8628 E:8633 ||| NN
effects  ||| S:8633 E:8641 ||| NNS
with  ||| S:8641 E:8646 ||| IN
the  ||| S:8646 E:8650 ||| DT
study  ||| S:8650 E:8656 ||| NN
therapies  ||| S:8656 E:8666 ||| NNS
at  ||| S:8666 E:8669 ||| IN
Month  ||| S:8669 E:8683 ||| NNP
6 ||| S:8683 E:8684 ||| CD
,  ||| S:8684 E:8686 ||| ,
under  ||| S:8686 E:8692 ||| IN
an  ||| S:8692 E:8695 ||| DT
assumption  ||| S:8695 E:8706 ||| NN
of  ||| S:8706 E:8709 ||| IN
' ||| S:8709 E:8710 ||| ''
no  ||| S:8710 E:8713 ||| DT
information  ||| S:8713 E:8725 ||| NN
available  ||| S:8725 E:8735 ||| JJ
for  ||| S:8735 E:8739 ||| IN
the  ||| S:8739 E:8751 ||| DT
missing  ||| S:8751 E:8759 ||| JJ
data ||| S:8759 E:8763 ||| NNS
' ||| S:8763 E:8764 ||| POS
.  ||| S:8764 E:8766 ||| .
We  ||| S:8766 E:8769 ||| PRP
should  ||| S:8769 E:8776 ||| MD
not  ||| S:8776 E:8780 ||| RB
be  ||| S:8780 E:8783 ||| VB
confused  ||| S:8783 E:8792 ||| VBN
with  ||| S:8792 E:8797 ||| IN
these  ||| S:8797 E:8803 ||| DT
two  ||| S:8803 E:8815 ||| CD
' ||| S:8815 E:8816 ||| POS
80 ||| S:8816 E:8818 ||| CD
% ||| S:8818 E:8819 ||| NN
' ||| S:8819 E:8820 ||| POS
.  ||| S:8820 E:8822 ||| .
The  ||| S:8822 E:8826 ||| DT
former  ||| S:8826 E:8833 ||| JJ
80 ||| S:8833 E:8835 ||| CD
%  ||| S:8835 E:8837 ||| NN
is  ||| S:8837 E:8840 ||| VBZ
a  ||| S:8840 E:8842 ||| DT
wrong  ||| S:8842 E:8848 ||| JJ
summary  ||| S:8848 E:8856 ||| NN
number ||| S:8856 E:8862 ||| NN
;  ||| S:8862 E:8864 ||| :
the  ||| S:8864 E:8868 ||| DT
latter  ||| S:8868 E:8883 ||| NN
is  ||| S:8883 E:8886 ||| VBZ
an  ||| S:8886 E:8889 ||| DT
estimate  ||| S:8889 E:8898 ||| NN
of  ||| S:8898 E:8901 ||| IN
the  ||| S:8901 E:8905 ||| DT
quantity  ||| S:8905 E:8914 ||| NN
of  ||| S:8914 E:8917 ||| IN
interest  ||| S:8917 E:8926 ||| NN
with  ||| S:8926 E:8931 ||| IN
a  ||| S:8931 E:8941 ||| DT
particular  ||| S:8941 E:8952 ||| JJ
assumption  ||| S:8952 E:8963 ||| NN
about  ||| S:8963 E:8969 ||| IN
the  ||| S:8969 E:8973 ||| DT
missing  ||| S:8973 E:8981 ||| JJ
data ||| S:8981 E:8985 ||| NNS
.  ||| S:8985 E:8987 ||| .
This  ||| S:8987 E:9000 ||| DT
assumption  ||| S:9000 E:9011 ||| NN
is  ||| S:9011 E:9014 ||| VBZ
not  ||| S:9014 E:9018 ||| RB
likely  ||| S:9018 E:9025 ||| JJ
to  ||| S:9025 E:9028 ||| TO
be  ||| S:9028 E:9031 ||| VB
appropriate  ||| S:9031 E:9043 ||| JJ
for  ||| S:9043 E:9047 ||| IN
all  ||| S:9047 E:9051 ||| PDT
the  ||| S:9051 E:9063 ||| DT
dropouts ||| S:9063 E:9071 ||| NN
,  ||| S:9071 E:9073 ||| ,
especially  ||| S:9073 E:9084 ||| RB
for  ||| S:9084 E:9088 ||| IN
those  ||| S:9088 E:9094 ||| DT
patients  ||| S:9094 E:9103 ||| NNS
who  ||| S:9103 E:9107 ||| WP
dropped  ||| S:9107 E:9115 ||| VBD
out  ||| S:9115 E:9127 ||| RP
because  ||| S:9127 E:9135 ||| IN
of  ||| S:9135 E:9138 ||| IN
ineffective  ||| S:9138 E:9150 ||| JJ
therapy ||| S:9150 E:9157 ||| NN
;  ||| S:9157 E:9159 ||| :
more  ||| S:9159 E:9164 ||| JJR
discussion  ||| S:9164 E:9175 ||| NN
is  ||| S:9175 E:9178 ||| VBZ
given  ||| S:9178 E:9192 ||| VBN
later ||| S:9192 E:9197 ||| RB
.  ||| S:9197 E:9199 ||| .
We  ||| S:9199 E:9202 ||| PRP
do  ||| S:9202 E:9205 ||| VBP
not  ||| S:9205 E:9209 ||| RB
know  ||| S:9209 E:9214 ||| VB
whether  ||| S:9214 E:9222 ||| IN
the  ||| S:9222 E:9226 ||| DT
authors  ||| S:9226 E:9234 ||| NNS
might  ||| S:9234 E:9240 ||| MD
have  ||| S:9240 E:9253 ||| VB
intended  ||| S:9253 E:9262 ||| VBN
to  ||| S:9262 E:9265 ||| TO
make  ||| S:9265 E:9270 ||| VB
the  ||| S:9270 E:9274 ||| DT
latter  ||| S:9274 E:9281 ||| JJ
estimate  ||| S:9281 E:9290 ||| NN
but  ||| S:9290 E:9294 ||| CC
gave  ||| S:9294 E:9299 ||| VBD
a  ||| S:9299 E:9301 ||| DT
wrong  ||| S:9301 E:9315 ||| JJ
summary  ||| S:9315 E:9323 ||| NN
instead ||| S:9323 E:9330 ||| RB
.  ||| S:9330 E:9340 ||| .
Even  ||| S:9340 E:9345 ||| RB
more  ||| S:9345 E:9350 ||| RBR
interesting  ||| S:9350 E:9362 ||| JJ
and  ||| S:9362 E:9366 ||| CC
useful  ||| S:9366 E:9373 ||| JJ
would  ||| S:9373 E:9379 ||| MD
be  ||| S:9379 E:9382 ||| VB
the  ||| S:9382 E:9386 ||| DT
same  ||| S:9386 E:9399 ||| JJ
calculations  ||| S:9399 E:9412 ||| NNS
within  ||| S:9412 E:9419 ||| IN
each  ||| S:9419 E:9424 ||| DT
treatment  ||| S:9424 E:9434 ||| NN
group  ||| S:9434 E:9440 ||| NN
along  ||| S:9440 E:9446 ||| IN
with  ||| S:9446 E:9451 ||| IN
a  ||| S:9451 E:9461 ||| DT
comparison  ||| S:9461 E:9472 ||| NN
of  ||| S:9472 E:9475 ||| IN
the  ||| S:9475 E:9479 ||| DT
estimates ||| S:9479 E:9488 ||| NNS
.  ||| S:9488 E:9490 ||| .
Unfortunately ||| S:9490 E:9503 ||| RB
,  ||| S:9503 E:9505 ||| ,
the  ||| S:9505 E:9509 ||| DT
paper  ||| S:9509 E:9515 ||| NN
did  ||| S:9515 E:9527 ||| VBD
not  ||| S:9527 E:9531 ||| RB
give  ||| S:9531 E:9536 ||| VB
the  ||| S:9536 E:9540 ||| DT
number  ||| S:9540 E:9547 ||| NN
of  ||| S:9547 E:9550 ||| IN
dropouts  ||| S:9550 E:9559 ||| NNS
according  ||| S:9559 E:9569 ||| VBG
to  ||| S:9569 E:9572 ||| TO
their  ||| S:9572 E:9586 ||| PRP$
treatment  ||| S:9586 E:9596 ||| NN
groups ||| S:9596 E:9602 ||| NNS
.  ||| S:9602 E:9612 ||| .
Using  ||| S:9612 E:9618 ||| VBG
proportions  ||| S:9618 E:9630 ||| NNS
simplifies  ||| S:9630 E:9641 ||| VBP
the  ||| S:9641 E:9645 ||| DT
illustration ||| S:9645 E:9657 ||| NN
,  ||| S:9657 E:9659 ||| ,
but  ||| S:9659 E:9663 ||| CC
the  ||| S:9663 E:9675 ||| DT
idea  ||| S:9675 E:9680 ||| NN
can  ||| S:9680 E:9684 ||| MD
easily  ||| S:9684 E:9691 ||| RB
be  ||| S:9691 E:9694 ||| VB
conveyed  ||| S:9694 E:9703 ||| VBN
to  ||| S:9703 E:9706 ||| TO
the  ||| S:9706 E:9710 ||| DT
estimation  ||| S:9710 E:9721 ||| NN
of  ||| S:9721 E:9724 ||| IN
continuous  ||| S:9724 E:9743 ||| JJ
data  ||| S:9743 E:9748 ||| NNS
as  ||| S:9748 E:9751 ||| IN
well ||| S:9751 E:9755 ||| RB
,  ||| S:9755 E:9757 ||| ,
such  ||| S:9757 E:9762 ||| JJ
as  ||| S:9762 E:9765 ||| IN
BP ||| S:9765 E:9767 ||| NNP
,  ||| S:9767 E:9769 ||| ,
exercise  ||| S:9769 E:9778 ||| NN
time ||| S:9778 E:9782 ||| NN
,  ||| S:9782 E:9784 ||| ,
hemodynamic  ||| S:9784 E:9804 ||| JJ
measures ||| S:9804 E:9812 ||| NNS
,  ||| S:9812 E:9814 ||| ,
and  ||| S:9814 E:9818 ||| CC
lipoprotein  ||| S:9818 E:9830 ||| JJ
levels ||| S:9830 E:9836 ||| NNS
.  ||| S:9836 E:9860 ||| .
Lessons  ||| S:9860 E:9868 ||| NNS
learned  ||| S:9868 E:9884 ||| VBD
Several  ||| S:9884 E:9892 ||| JJ
points  ||| S:9892 E:9899 ||| NNS
can  ||| S:9899 E:9903 ||| MD
be  ||| S:9903 E:9906 ||| VB
generalized  ||| S:9906 E:9918 ||| VBN
from  ||| S:9918 E:9923 ||| IN
the  ||| S:9923 E:9927 ||| DT
simple  ||| S:9927 E:9942 ||| JJ
illustration  ||| S:9942 E:9955 ||| NN
given  ||| S:9955 E:9961 ||| VBN
above  ||| S:9961 E:9967 ||| IN
and  ||| S:9967 E:9971 ||| CC
closer  ||| S:9971 E:9978 ||| JJR
examinations  ||| S:9978 E:9991 ||| NNS
of  ||| S:9991 E:9994 ||| IN
the  ||| S:9994 E:10006 ||| DT
other  ||| S:10006 E:10012 ||| JJ
examples.  ||| S:10012 E:10030 ||| CD
•  ||| S:10030 E:10032 ||| CD
It  ||| S:10032 E:10035 ||| PRP
does  ||| S:10035 E:10040 ||| VBZ
not  ||| S:10040 E:10044 ||| RB
take  ||| S:10044 E:10049 ||| VB
very  ||| S:10049 E:10054 ||| RB
much  ||| S:10054 E:10059 ||| RB
missing  ||| S:10059 E:10067 ||| VBG
data  ||| S:10067 E:10072 ||| NNS
to  ||| S:10072 E:10075 ||| TO
mislead  ||| S:10075 E:10083 ||| VB
an  ||| S:10083 E:10094 ||| DT
investigator ||| S:10094 E:10106 ||| NN
.  ||| S:10106 E:10108 ||| .
A  ||| S:10108 E:10110 ||| DT
good  ||| S:10110 E:10115 ||| JJ
principle  ||| S:10115 E:10125 ||| NN
to  ||| S:10125 E:10128 ||| TO
avoid  ||| S:10128 E:10134 ||| VB
being  ||| S:10134 E:10140 ||| VBG
misled  ||| S:10140 E:10147 ||| NN
is  ||| S:10147 E:10150 ||| VBZ
to  ||| S:10150 E:10161 ||| TO
always  ||| S:10161 E:10168 ||| RB
account  ||| S:10168 E:10176 ||| VBP
for  ||| S:10176 E:10180 ||| IN
every  ||| S:10180 E:10186 ||| DT
subject  ||| S:10186 E:10194 ||| JJ
randomized  ||| S:10194 E:10205 ||| NN
to  ||| S:10205 E:10208 ||| TO
the  ||| S:10208 E:10212 ||| DT
study  ||| S:10212 E:10218 ||| NN
in  ||| S:10218 E:10229 ||| IN
the  ||| S:10229 E:10233 ||| DT
analysis ||| S:10233 E:10241 ||| NN
.  ||| S:10241 E:10243 ||| .
Using  ||| S:10243 E:10249 ||| VBG
the  ||| S:10249 E:10253 ||| DT
total  ||| S:10253 E:10259 ||| JJ
number  ||| S:10259 E:10266 ||| NN
of  ||| S:10266 E:10269 ||| IN
randomized  ||| S:10269 E:10280 ||| JJ
subjects  ||| S:10280 E:10297 ||| NNS
in  ||| S:10297 E:10300 ||| IN
the  ||| S:10300 E:10304 ||| DT
denominator  ||| S:10304 E:10316 ||| NN
is  ||| S:10316 E:10319 ||| VBZ
a  ||| S:10319 E:10321 ||| DT
step  ||| S:10321 E:10326 ||| NN
towards  ||| S:10326 E:10334 ||| IN
accomplishing  ||| S:10334 E:10348 ||| VBG
this  ||| S:10348 E:10361 ||| DT
principle ||| S:10361 E:10370 ||| NN
,  ||| S:10370 E:10372 ||| ,
whether  ||| S:10372 E:10380 ||| IN
it  ||| S:10380 E:10383 ||| PRP
is  ||| S:10383 E:10386 ||| VBZ
to  ||| S:10386 E:10389 ||| TO
calculate  ||| S:10389 E:10399 ||| VB
an  ||| S:10399 E:10402 ||| DT
average  ||| S:10402 E:10410 ||| NN
or  ||| S:10410 E:10413 ||| CC
a  ||| S:10413 E:10423 ||| DT
proportion ||| S:10423 E:10433 ||| NN
.  ||| S:10433 E:10435 ||| .
This  ||| S:10435 E:10440 ||| DT
principle  ||| S:10440 E:10450 ||| NN
is  ||| S:10450 E:10453 ||| VBZ
known  ||| S:10453 E:10459 ||| VBN
as  ||| S:10459 E:10462 ||| IN
intent  ||| S:10462 E:10469 ||| NN
to  ||| S:10469 E:10472 ||| TO
treat  ||| S:10472 E:10486 ||| VB
( ||| S:10486 E:10487 ||| -LRB-
ITT ||| S:10487 E:10490 ||| NNP
) ||| S:10490 E:10491 ||| -RRB-
.  ||| S:10491 E:10493 ||| .
However ||| S:10493 E:10500 ||| RB
,  ||| S:10500 E:10502 ||| ,
the  ||| S:10502 E:10506 ||| DT
much  ||| S:10506 E:10511 ||| RB
harder  ||| S:10511 E:10518 ||| JJR
job  ||| S:10518 E:10522 ||| NN
for  ||| S:10522 E:10526 ||| IN
ITT  ||| S:10526 E:10530 ||| NNP
is  ||| S:10530 E:10533 ||| VBZ
to  ||| S:10533 E:10536 ||| TO
account  ||| S:10536 E:10552 ||| VB
for  ||| S:10552 E:10556 ||| IN
the  ||| S:10556 E:10560 ||| DT
dropouts  ||| S:10560 E:10569 ||| NN
in  ||| S:10569 E:10572 ||| IN
the  ||| S:10572 E:10576 ||| DT
numerator ||| S:10576 E:10585 ||| NN
.  ||| S:10585 E:10587 ||| .
This  ||| S:10587 E:10592 ||| DT
requires  ||| S:10592 E:10601 ||| VBZ
further  ||| S:10601 E:10617 ||| JJ
consideration ||| S:10617 E:10630 ||| NN
,  ||| S:10630 E:10632 ||| ,
which  ||| S:10632 E:10638 ||| WDT
follows  ||| S:10638 E:10646 ||| VBZ
below.  ||| S:10646 E:10661 ||| CD
•  ||| S:10661 E:10663 ||| CD
It  ||| S:10663 E:10666 ||| PRP
is  ||| S:10666 E:10669 ||| VBZ
important  ||| S:10669 E:10679 ||| JJ
to  ||| S:10679 E:10682 ||| TO
record  ||| S:10682 E:10689 ||| VB
and  ||| S:10689 E:10693 ||| CC
report  ||| S:10693 E:10700 ||| VB
the  ||| S:10700 E:10704 ||| DT
reasons  ||| S:10704 E:10712 ||| NNS
for  ||| S:10712 E:10724 ||| IN
withdrawal  ||| S:10724 E:10735 ||| NN
and  ||| S:10735 E:10739 ||| CC
the  ||| S:10739 E:10743 ||| DT
number  ||| S:10743 E:10750 ||| NN
of  ||| S:10750 E:10753 ||| IN
subjects  ||| S:10753 E:10762 ||| NNS
in  ||| S:10762 E:10765 ||| IN
each  ||| S:10765 E:10770 ||| DT
category  ||| S:10770 E:10779 ||| NN
of  ||| S:10779 E:10790 ||| IN
withdrawal  ||| S:10790 E:10801 ||| NN
according  ||| S:10801 E:10811 ||| VBG
to  ||| S:10811 E:10814 ||| TO
their  ||| S:10814 E:10820 ||| PRP$
treatment  ||| S:10820 E:10830 ||| NN
group ||| S:10830 E:10835 ||| NN
.  ||| S:10835 E:10837 ||| .
The  ||| S:10837 E:10841 ||| DT
reasons  ||| S:10841 E:10857 ||| NNS
for  ||| S:10857 E:10861 ||| IN
patients  ||| S:10861 E:10870 ||| NNS
dropping  ||| S:10870 E:10879 ||| VBG
out  ||| S:10879 E:10883 ||| RP
can  ||| S:10883 E:10887 ||| MD
be  ||| S:10887 E:10890 ||| VB
used  ||| S:10890 E:10895 ||| VBN
to  ||| S:10895 E:10898 ||| TO
help  ||| S:10898 E:10903 ||| VB
properly  ||| S:10903 E:10920 ||| RB
assess  ||| S:10920 E:10927 ||| VB
the  ||| S:10927 E:10931 ||| DT
nature  ||| S:10931 E:10938 ||| NN
of  ||| S:10938 E:10941 ||| IN
the  ||| S:10941 E:10945 ||| DT
missing  ||| S:10945 E:10953 ||| JJ
data ||| S:10953 E:10957 ||| NNS
.  ||| S:10957 E:10959 ||| .
For  ||| S:10959 E:10963 ||| IN
example ||| S:10963 E:10970 ||| NN
,  ||| S:10970 E:10972 ||| ,
if  ||| S:10972 E:10975 ||| IN
all  ||| S:10975 E:10987 ||| PDT
the  ||| S:10987 E:10991 ||| DT
dropouts  ||| S:10991 E:11000 ||| NNS
were  ||| S:11000 E:11005 ||| VBD
because  ||| S:11005 E:11013 ||| IN
of  ||| S:11013 E:11016 ||| IN
a  ||| S:11016 E:11018 ||| DT
lack  ||| S:11018 E:11023 ||| NN
of  ||| S:11023 E:11026 ||| IN
response  ||| S:11026 E:11035 ||| NN
or  ||| S:11035 E:11038 ||| CC
side  ||| S:11038 E:11051 ||| NN
effects ||| S:11051 E:11058 ||| NNS
,  ||| S:11058 E:11060 ||| ,
then  ||| S:11060 E:11065 ||| RB
the  ||| S:11065 E:11069 ||| DT
calculation  ||| S:11069 E:11081 ||| NN
in  ||| S:11081 E:11084 ||| IN
( ||| S:11084 E:11085 ||| -LRB-
a ||| S:11085 E:11086 ||| LS
)  ||| S:11086 E:11088 ||| -RRB-
would  ||| S:11088 E:11094 ||| MD
be  ||| S:11094 E:11097 ||| VB
appropriate ||| S:11097 E:11108 ||| JJ
.  ||| S:11108 E:11118 ||| .
In  ||| S:11118 E:11121 ||| IN
statistical  ||| S:11121 E:11133 ||| JJ
terms ||| S:11133 E:11138 ||| NNS
,  ||| S:11138 E:11140 ||| ,
they  ||| S:11140 E:11145 ||| PRP
would  ||| S:11145 E:11151 ||| MD
be  ||| S:11151 E:11154 ||| VB
called  ||| S:11154 E:11161 ||| VBN
informative  ||| S:11161 E:11181 ||| JJ
missing  ||| S:11181 E:11189 ||| JJ
data ||| S:11189 E:11193 ||| NNS
.  ||| S:11193 E:11195 ||| .
This  ||| S:11195 E:11200 ||| DT
is  ||| S:11200 E:11203 ||| VBZ
because  ||| S:11203 E:11211 ||| IN
useful  ||| S:11211 E:11218 ||| JJ
information  ||| S:11218 E:11230 ||| NN
can  ||| S:11230 E:11234 ||| MD
be  ||| S:11234 E:11245 ||| VB
found  ||| S:11245 E:11251 ||| VBN
in  ||| S:11251 E:11254 ||| IN
the  ||| S:11254 E:11258 ||| DT
reason  ||| S:11258 E:11265 ||| NN
for  ||| S:11265 E:11269 ||| IN
the  ||| S:11269 E:11273 ||| DT
dropout  ||| S:11273 E:11281 ||| NN
and  ||| S:11281 E:11285 ||| CC
this  ||| S:11285 E:11290 ||| DT
can  ||| S:11290 E:11294 ||| MD
be  ||| S:11294 E:11297 ||| VB
used  ||| S:11297 E:11302 ||| VBN
to  ||| S:11302 E:11313 ||| TO
estimate  ||| S:11313 E:11322 ||| VB
the  ||| S:11322 E:11326 ||| DT
true  ||| S:11326 E:11331 ||| JJ
response ||| S:11331 E:11339 ||| NN
.  ||| S:11339 E:11341 ||| .
Outcome-related  ||| S:11341 E:11357 ||| JJ
dropouts  ||| S:11357 E:11366 ||| NNS
are  ||| S:11366 E:11378 ||| VBP
informative  ||| S:11378 E:11390 ||| JJ
and  ||| S:11390 E:11394 ||| CC
should  ||| S:11394 E:11401 ||| MD
not  ||| S:11401 E:11405 ||| RB
be  ||| S:11405 E:11408 ||| VB
disregarded  ||| S:11408 E:11420 ||| VBN
in  ||| S:11420 E:11423 ||| IN
analytical  ||| S:11423 E:11442 ||| JJ
study  ||| S:11442 E:11448 ||| NN
without  ||| S:11448 E:11456 ||| IN
careful  ||| S:11456 E:11464 ||| JJ
thought ||| S:11464 E:11471 ||| NN
.  ||| S:11471 E:11473 ||| .
In  ||| S:11473 E:11476 ||| IN
particular ||| S:11476 E:11486 ||| JJ
,  ||| S:11486 E:11488 ||| ,
when  ||| S:11488 E:11493 ||| WRB
a  ||| S:11493 E:11503 ||| DT
patient  ||| S:11503 E:11511 ||| NN
dies ||| S:11511 E:11515 ||| VBZ
,  ||| S:11515 E:11517 ||| ,
whatever  ||| S:11517 E:11526 ||| WDT
the  ||| S:11526 E:11530 ||| DT
cause  ||| S:11530 E:11536 ||| NN
of  ||| S:11536 E:11539 ||| IN
the  ||| S:11539 E:11543 ||| DT
death  ||| S:11543 E:11549 ||| NN
might  ||| S:11549 E:11555 ||| MD
be ||| S:11555 E:11557 ||| VB
,  ||| S:11557 E:11567 ||| ,
such  ||| S:11567 E:11572 ||| JJ
as  ||| S:11572 E:11575 ||| IN
in  ||| S:11575 E:11578 ||| IN
Example  ||| S:11578 E:11586 ||| NNP
3 ||| S:11586 E:11587 ||| CD
,  ||| S:11587 E:11589 ||| ,
all  ||| S:11589 E:11593 ||| DT
of  ||| S:11593 E:11596 ||| IN
the  ||| S:11596 E:11600 ||| DT
subsequent  ||| S:11600 E:11611 ||| JJ
physiological  ||| S:11611 E:11633 ||| NN
and  ||| S:11633 E:11637 ||| CC
quality  ||| S:11637 E:11645 ||| NN
of  ||| S:11645 E:11648 ||| IN
life  ||| S:11648 E:11653 ||| NN
data  ||| S:11653 E:11658 ||| NNS
should  ||| S:11658 E:11665 ||| MD
not  ||| S:11665 E:11669 ||| RB
even  ||| S:11669 E:11674 ||| RB
be  ||| S:11674 E:11677 ||| VB
regarded  ||| S:11677 E:11686 ||| VBN
as  ||| S:11686 E:11697 ||| IN
missing ||| S:11697 E:11704 ||| VBG
,  ||| S:11704 E:11706 ||| ,
but  ||| S:11706 E:11710 ||| CC
as  ||| S:11710 E:11713 ||| IN
having  ||| S:11713 E:11720 ||| VBG
values  ||| S:11720 E:11727 ||| NNS
equal  ||| S:11727 E:11733 ||| VBP
to  ||| S:11733 E:11736 ||| TO
zero  ||| S:11736 E:11741 ||| CD
or  ||| S:11741 E:11744 ||| CC
the  ||| S:11744 E:11748 ||| DT
worst  ||| S:11748 E:11762 ||| JJS
category ||| S:11762 E:11770 ||| NN
.  ||| S:11770 E:11772 ||| .
When  ||| S:11772 E:11777 ||| WRB
a  ||| S:11777 E:11779 ||| DT
patient ||| S:11779 E:11786 ||| NN
's  ||| S:11786 E:11789 ||| POS
clinical  ||| S:11789 E:11798 ||| JJ
status  ||| S:11798 E:11805 ||| NN
has  ||| S:11805 E:11809 ||| VBZ
reached  ||| S:11809 E:11817 ||| VBN
a  ||| S:11817 E:11827 ||| DT
terminal  ||| S:11827 E:11836 ||| NN
disease  ||| S:11836 E:11844 ||| NN
progression  ||| S:11844 E:11856 ||| NN
stage  ||| S:11856 E:11862 ||| NN
( ||| S:11862 E:11863 ||| -LRB-
such  ||| S:11863 E:11868 ||| JJ
as  ||| S:11868 E:11871 ||| IN
New  ||| S:11871 E:11875 ||| NNP
York  ||| S:11875 E:11880 ||| NNP
Heart  ||| S:11880 E:11894 ||| NNP
Association  ||| S:11894 E:11906 ||| NNP
class  ||| S:11906 E:11912 ||| NN
IV ||| S:11912 E:11914 ||| NNP
)  ||| S:11914 E:11916 ||| -RRB-
and  ||| S:11916 E:11920 ||| CC
they  ||| S:11920 E:11925 ||| PRP
are  ||| S:11925 E:11929 ||| VBP
unable  ||| S:11929 E:11936 ||| JJ
to  ||| S:11936 E:11939 ||| TO
perform  ||| S:11939 E:11955 ||| VB
exercise  ||| S:11955 E:11964 ||| NN
testing ||| S:11964 E:11971 ||| NN
,  ||| S:11971 E:11973 ||| ,
as  ||| S:11973 E:11976 ||| RB
in  ||| S:11976 E:11979 ||| IN
Example  ||| S:11979 E:11987 ||| NNP
3 ||| S:11987 E:11988 ||| CD
,  ||| S:11988 E:11990 ||| ,
the  ||| S:11990 E:11994 ||| DT
exercise  ||| S:11994 E:12003 ||| NN
time  ||| S:12003 E:12008 ||| NN
should  ||| S:12008 E:12023 ||| MD
also  ||| S:12023 E:12028 ||| RB
be  ||| S:12028 E:12031 ||| VB
equal  ||| S:12031 E:12037 ||| JJ
to  ||| S:12037 E:12040 ||| TO
zero  ||| S:12040 E:12045 ||| CD
seconds ||| S:12045 E:12052 ||| NNS
,  ||| S:12052 E:12054 ||| ,
and  ||| S:12054 E:12058 ||| CC
not  ||| S:12058 E:12062 ||| RB
simply  ||| S:12062 E:12069 ||| RB
regarded  ||| S:12069 E:12078 ||| VBN
as  ||| S:12078 E:12089 ||| IN
missing  ||| S:12089 E:12097 ||| VBG
data ||| S:12097 E:12101 ||| NNS
.  ||| S:12101 E:12103 ||| .
For  ||| S:12103 E:12107 ||| IN
the  ||| S:12107 E:12111 ||| DT
same  ||| S:12111 E:12116 ||| JJ
reason ||| S:12116 E:12122 ||| NN
,  ||| S:12122 E:12124 ||| ,
the  ||| S:12124 E:12128 ||| DT
remaining  ||| S:12128 E:12138 ||| JJ
survival  ||| S:12138 E:12155 ||| NN
time  ||| S:12155 E:12160 ||| NN
after  ||| S:12160 E:12166 ||| IN
death  ||| S:12166 E:12172 ||| NN
( ||| S:12172 E:12173 ||| -LRB-
of  ||| S:12173 E:12176 ||| IN
any  ||| S:12176 E:12180 ||| DT
cause ||| S:12180 E:12185 ||| NN
)  ||| S:12185 E:12187 ||| -RRB-
would  ||| S:12187 E:12193 ||| MD
be  ||| S:12193 E:12196 ||| VB
zero  ||| S:12196 E:12201 ||| CD
days  ||| S:12201 E:12206 ||| NNS
as  ||| S:12206 E:12209 ||| IN
well ||| S:12209 E:12213 ||| RB
,  ||| S:12213 E:12223 ||| ,
not  ||| S:12223 E:12227 ||| RB
a  ||| S:12227 E:12229 ||| DT
censored  ||| S:12229 E:12238 ||| JJ
observation  ||| S:12238 E:12250 ||| NN
when  ||| S:12250 E:12255 ||| WRB
doing ||| S:12255 E:12260 ||| VBG
,  ||| S:12260 E:12262 ||| ,
say  ||| S:12262 E:12266 ||| VBP
Kaplan-Meier ||| S:12266 E:12278 ||| JJ
,  ||| S:12278 E:12288 ||| ,
survival  ||| S:12288 E:12297 ||| NN
analysis  ||| S:12297 E:12306 ||| NN
for  ||| S:12306 E:12310 ||| IN
an  ||| S:12310 E:12313 ||| DT
endpoint  ||| S:12313 E:12322 ||| JJ
such  ||| S:12322 E:12327 ||| JJ
as  ||| S:12327 E:12330 ||| IN
cardiovascular  ||| S:12330 E:12353 ||| JJ
death ||| S:12353 E:12358 ||| NN
.  ||| S:12358 E:12360 ||| .
Treating  ||| S:12360 E:12369 ||| VBG
non-cardiovascular  ||| S:12369 E:12388 ||| JJ
death  ||| S:12388 E:12394 ||| NN
as  ||| S:12394 E:12397 ||| IN
equivalent  ||| S:12397 E:12408 ||| JJ
to  ||| S:12408 E:12419 ||| TO
censoring  ||| S:12419 E:12429 ||| VB
because  ||| S:12429 E:12437 ||| IN
of  ||| S:12437 E:12440 ||| IN
loss-to-follow-up  ||| S:12440 E:12458 ||| JJ
or  ||| S:12458 E:12469 ||| CC
end-of-observation  ||| S:12469 E:12488 ||| JJ
for  ||| S:12488 E:12492 ||| IN
an  ||| S:12492 E:12495 ||| DT
endpoint  ||| S:12495 E:12504 ||| NN
of  ||| S:12504 E:12507 ||| IN
cardiovascular  ||| S:12507 E:12522 ||| JJ
death  ||| S:12522 E:12536 ||| NN
has  ||| S:12536 E:12540 ||| VBZ
unfortunately  ||| S:12540 E:12554 ||| RB
become  ||| S:12554 E:12561 ||| VB
a  ||| S:12561 E:12563 ||| DT
popular  ||| S:12563 E:12571 ||| JJ
practice  ||| S:12571 E:12580 ||| NN
in  ||| S:12580 E:12583 ||| IN
many  ||| S:12583 E:12588 ||| JJ
medical  ||| S:12588 E:12604 ||| JJ
journal  ||| S:12604 E:12612 ||| NN
articles ||| S:12612 E:12620 ||| NNS
.  ||| S:12620 E:12622 ||| .
This  ||| S:12622 E:12627 ||| DT
needs  ||| S:12627 E:12633 ||| VBZ
to  ||| S:12633 E:12636 ||| TO
be  ||| S:12636 E:12639 ||| VB
corrected.  ||| S:12639 E:12658 ||| CD
•  ||| S:12658 E:12660 ||| CD
The  ||| S:12660 E:12664 ||| DT
extreme  ||| S:12664 E:12672 ||| JJ
calculations  ||| S:12672 E:12685 ||| NNS
in  ||| S:12685 E:12688 ||| IN
( ||| S:12688 E:12689 ||| -LRB-
a ||| S:12689 E:12690 ||| LS
)  ||| S:12690 E:12692 ||| -RRB-
and  ||| S:12692 E:12696 ||| CC
( ||| S:12696 E:12697 ||| -LRB-
b ||| S:12697 E:12698 ||| LS
)  ||| S:12698 E:12700 ||| -RRB-
enable  ||| S:12700 E:12707 ||| VB
us  ||| S:12707 E:12710 ||| PRP
to  ||| S:12710 E:12721 ||| TO
assess  ||| S:12721 E:12728 ||| VB
the  ||| S:12728 E:12732 ||| DT
uncertainty  ||| S:12732 E:12744 ||| NN
of  ||| S:12744 E:12747 ||| IN
the  ||| S:12747 E:12751 ||| DT
data  ||| S:12751 E:12756 ||| NNS
which  ||| S:12756 E:12762 ||| WDT
contains  ||| S:12762 E:12771 ||| VBZ
missing  ||| S:12771 E:12787 ||| VBG
values ||| S:12787 E:12793 ||| NNS
,  ||| S:12793 E:12795 ||| ,
especially  ||| S:12795 E:12806 ||| RB
if  ||| S:12806 E:12809 ||| IN
we  ||| S:12809 E:12812 ||| PRP
do  ||| S:12812 E:12815 ||| VBP
the  ||| S:12815 E:12819 ||| DT
calculation  ||| S:12819 E:12831 ||| NN
for  ||| S:12831 E:12835 ||| IN
each  ||| S:12835 E:12848 ||| DT
treatment  ||| S:12848 E:12858 ||| NN
group  ||| S:12858 E:12864 ||| NN
separately ||| S:12864 E:12874 ||| RB
.  ||| S:12874 E:12876 ||| .
The  ||| S:12876 E:12880 ||| DT
bias  ||| S:12880 E:12885 ||| NN
seen  ||| S:12885 E:12890 ||| VBN
in  ||| S:12890 E:12893 ||| IN
the  ||| S:12893 E:12897 ||| DT
medical  ||| S:12897 E:12913 ||| JJ
publishing  ||| S:12913 E:12924 ||| NN
industry  ||| S:12924 E:12933 ||| NN
in  ||| S:12933 E:12936 ||| IN
the  ||| S:12936 E:12940 ||| DT
decisions  ||| S:12940 E:12950 ||| NNS
over  ||| S:12950 E:12955 ||| IN
which  ||| S:12955 E:12961 ||| WDT
articles  ||| S:12961 E:12978 ||| NNS
are  ||| S:12978 E:12982 ||| VBP
chosen  ||| S:12982 E:12989 ||| VBN
for  ||| S:12989 E:12993 ||| IN
publication  ||| S:12993 E:13005 ||| NN
is  ||| S:13005 E:13008 ||| VBZ
a  ||| S:13008 E:13010 ||| DT
mirror  ||| S:13010 E:13017 ||| NN
image  ||| S:13017 E:13023 ||| NN
of  ||| S:13023 E:13026 ||| IN
the  ||| S:13026 E:13030 ||| DT
dropout  ||| S:13030 E:13046 ||| JJ
problem  ||| S:13046 E:13054 ||| NN
in  ||| S:13054 E:13057 ||| IN
patient  ||| S:13057 E:13065 ||| JJ
studies ||| S:13065 E:13072 ||| NNS
.  ||| S:13072 E:13074 ||| .
In  ||| S:13074 E:13077 ||| IN
the  ||| S:13077 E:13081 ||| DT
former ||| S:13081 E:13087 ||| JJ
,  ||| S:13087 E:13089 ||| ,
positive  ||| S:13089 E:13098 ||| JJ
studies  ||| S:13098 E:13114 ||| NNS
have  ||| S:13114 E:13119 ||| VBP
better  ||| S:13119 E:13126 ||| JJR
chance  ||| S:13126 E:13133 ||| NN
of  ||| S:13133 E:13136 ||| IN
getting  ||| S:13136 E:13144 ||| VBG
published ||| S:13144 E:13153 ||| VBN
,  ||| S:13153 E:13155 ||| ,
while  ||| S:13155 E:13161 ||| IN
negative  ||| S:13161 E:13178 ||| JJ
studies  ||| S:13178 E:13186 ||| NNS
have  ||| S:13186 E:13191 ||| VBP
a  ||| S:13191 E:13193 ||| DT
higher  ||| S:13193 E:13200 ||| JJR
chance  ||| S:13200 E:13207 ||| NN
of  ||| S:13207 E:13210 ||| IN
being  ||| S:13210 E:13216 ||| VBG
rejected ||| S:13216 E:13224 ||| VBN
.  ||| S:13224 E:13226 ||| .
The  ||| S:13226 E:13230 ||| DT
same  ||| S:13230 E:13235 ||| JJ
is  ||| S:13235 E:13246 ||| VBZ
true  ||| S:13246 E:13251 ||| JJ
for  ||| S:13251 E:13255 ||| IN
the  ||| S:13255 E:13259 ||| DT
latter ||| S:13259 E:13265 ||| NN
:  ||| S:13265 E:13267 ||| :
patients  ||| S:13267 E:13276 ||| NNS
responding  ||| S:13276 E:13287 ||| VBG
to  ||| S:13287 E:13290 ||| TO
treatment  ||| S:13290 E:13300 ||| NN
tend  ||| S:13300 E:13313 ||| VBP
to  ||| S:13313 E:13316 ||| TO
continue  ||| S:13316 E:13325 ||| VB
in  ||| S:13325 E:13328 ||| IN
the  ||| S:13328 E:13332 ||| DT
study ||| S:13332 E:13337 ||| NN
,  ||| S:13337 E:13339 ||| ,
while  ||| S:13339 E:13345 ||| IN
patients  ||| S:13345 E:13354 ||| NNS
failing  ||| S:13354 E:13362 ||| VBG
to  ||| S:13362 E:13365 ||| TO
respond  ||| S:13365 E:13381 ||| VB
tend  ||| S:13381 E:13386 ||| VBN
to  ||| S:13386 E:13389 ||| TO
drop  ||| S:13389 E:13394 ||| VB
out  ||| S:13394 E:13398 ||| RP
prematurely ||| S:13398 E:13409 ||| RB
.  ||| S:13409 E:13411 ||| .
Using  ||| S:13411 E:13417 ||| VBG
only  ||| S:13417 E:13422 ||| RB
the  ||| S:13422 E:13426 ||| DT
available  ||| S:13426 E:13436 ||| JJ
data  ||| S:13436 E:13449 ||| NNS
or  ||| S:13449 E:13452 ||| CC
only  ||| S:13452 E:13457 ||| RB
the  ||| S:13457 E:13461 ||| DT
subgroup  ||| S:13461 E:13470 ||| NN
of  ||| S:13470 E:13473 ||| IN
those  ||| S:13473 E:13479 ||| DT
who  ||| S:13479 E:13483 ||| WP
complete  ||| S:13483 E:13492 ||| VB
the  ||| S:13492 E:13496 ||| DT
study  ||| S:13496 E:13502 ||| NN
leads  ||| S:13502 E:13516 ||| VBZ
to  ||| S:13516 E:13519 ||| TO
a  ||| S:13519 E:13521 ||| DT
biased  ||| S:13521 E:13528 ||| JJ
result ||| S:13528 E:13534 ||| NN
.  ||| S:13534 E:13536 ||| .
The  ||| S:13536 E:13540 ||| DT
approaches  ||| S:13540 E:13551 ||| NNS
in  ||| S:13551 E:13554 ||| IN
( ||| S:13554 E:13555 ||| -LRB-
a ||| S:13555 E:13556 ||| LS
)  ||| S:13556 E:13558 ||| -RRB-
and  ||| S:13558 E:13562 ||| CC
( ||| S:13562 E:13563 ||| -LRB-
b ||| S:13563 E:13564 ||| LS
)  ||| S:13564 E:13566 ||| -RRB-
take  ||| S:13566 E:13571 ||| VB
this  ||| S:13571 E:13584 ||| DT
consideration  ||| S:13584 E:13598 ||| NN
into  ||| S:13598 E:13603 ||| IN
account ||| S:13603 E:13610 ||| NN
,  ||| S:13610 E:13612 ||| ,
although  ||| S:13612 E:13621 ||| IN
they  ||| S:13621 E:13626 ||| PRP
may  ||| S:13626 E:13630 ||| MD
also  ||| S:13630 E:13635 ||| RB
be  ||| S:13635 E:13646 ||| VB
biased  ||| S:13646 E:13653 ||| VBN
by  ||| S:13653 E:13656 ||| IN
over-correction.  ||| S:13656 E:13681 ||| CD
•  ||| S:13681 E:13683 ||| CD
The  ||| S:13683 E:13687 ||| DT
assumption  ||| S:13687 E:13698 ||| NN
underlying  ||| S:13698 E:13709 ||| VBG
the  ||| S:13709 E:13713 ||| DT
approach  ||| S:13713 E:13722 ||| NN
in  ||| S:13722 E:13725 ||| IN
( ||| S:13725 E:13726 ||| -LRB-
c ||| S:13726 E:13727 ||| LS
)  ||| S:13727 E:13729 ||| -RRB-
is  ||| S:13729 E:13740 ||| VBZ
interesting ||| S:13740 E:13751 ||| JJ
.  ||| S:13751 E:13753 ||| .
When  ||| S:13753 E:13758 ||| WRB
no  ||| S:13758 E:13761 ||| DT
particular  ||| S:13761 E:13772 ||| JJ
information  ||| S:13772 E:13784 ||| NN
is  ||| S:13784 E:13787 ||| VBZ
known  ||| S:13787 E:13793 ||| VBN
about  ||| S:13793 E:13807 ||| IN
the  ||| S:13807 E:13811 ||| DT
missing  ||| S:13811 E:13819 ||| JJ
data ||| S:13819 E:13823 ||| NNS
,  ||| S:13823 E:13825 ||| ,
we  ||| S:13825 E:13828 ||| PRP
are  ||| S:13828 E:13832 ||| VBP
essentially  ||| S:13832 E:13844 ||| RB
assuming  ||| S:13844 E:13853 ||| VBG
that  ||| S:13853 E:13858 ||| IN
the  ||| S:13858 E:13870 ||| DT
dropouts  ||| S:13870 E:13879 ||| NNS
are  ||| S:13879 E:13883 ||| VBP
not  ||| S:13883 E:13887 ||| RB
much  ||| S:13887 E:13892 ||| RB
different  ||| S:13892 E:13902 ||| JJ
from  ||| S:13902 E:13907 ||| IN
the  ||| S:13907 E:13911 ||| DT
completers ||| S:13911 E:13921 ||| NN
.  ||| S:13921 E:13923 ||| .
This  ||| S:13923 E:13936 ||| DT
is  ||| S:13936 E:13939 ||| VBZ
generally  ||| S:13939 E:13949 ||| RB
described  ||| S:13949 E:13959 ||| VBN
statistically  ||| S:13959 E:13973 ||| RB
as  ||| S:13973 E:13976 ||| IN
missing  ||| S:13976 E:13984 ||| VBG
completely  ||| S:13984 E:14003 ||| RB
at  ||| S:14003 E:14006 ||| IN
random  ||| S:14006 E:14013 ||| JJ
( ||| S:14013 E:14014 ||| -LRB-
MCAR ||| S:14014 E:14018 ||| NNP
) ||| S:14018 E:14019 ||| -RRB-
,  ||| S:14019 E:14021 ||| ,
meaning  ||| S:14021 E:14029 ||| VBG
that  ||| S:14029 E:14034 ||| IN
the  ||| S:14034 E:14038 ||| DT
process  ||| S:14038 E:14046 ||| NN
which  ||| S:14046 E:14052 ||| WDT
caused  ||| S:14052 E:14059 ||| VBD
the  ||| S:14059 E:14071 ||| DT
missing  ||| S:14071 E:14079 ||| JJ
data  ||| S:14079 E:14084 ||| NN
is  ||| S:14084 E:14087 ||| VBZ
not  ||| S:14087 E:14091 ||| RB
informative  ||| S:14091 E:14103 ||| VBN
about  ||| S:14103 E:14109 ||| IN
the  ||| S:14109 E:14113 ||| DT
parameter  ||| S:14113 E:14123 ||| NN
that  ||| S:14123 E:14128 ||| IN
we  ||| S:14128 E:14139 ||| PRP
are  ||| S:14139 E:14143 ||| VBP
trying  ||| S:14143 E:14150 ||| VBG
to  ||| S:14150 E:14153 ||| TO
estimate ||| S:14153 E:14161 ||| VB
.  ||| S:14161 E:14163 ||| .
A  ||| S:14163 E:14165 ||| DT
good  ||| S:14165 E:14170 ||| JJ
way  ||| S:14170 E:14174 ||| NN
to  ||| S:14174 E:14177 ||| TO
think  ||| S:14177 E:14183 ||| VB
of  ||| S:14183 E:14186 ||| IN
MCAR  ||| S:14186 E:14191 ||| NNP
is  ||| S:14191 E:14194 ||| VBZ
that  ||| S:14194 E:14207 ||| IN
the  ||| S:14207 E:14211 ||| DT
dropouts  ||| S:14211 E:14220 ||| NNS
are  ||| S:14220 E:14224 ||| VBP
a  ||| S:14224 E:14226 ||| DT
simple ||| S:14226 E:14232 ||| JJ
,  ||| S:14232 E:14234 ||| ,
random  ||| S:14234 E:14241 ||| JJ
sample  ||| S:14241 E:14248 ||| NN
of  ||| S:14248 E:14251 ||| IN
the  ||| S:14251 E:14255 ||| DT
study  ||| S:14255 E:14269 ||| NN
sample ||| S:14269 E:14275 ||| NN
.  ||| S:14275 E:14277 ||| .
Examples  ||| S:14277 E:14286 ||| NNS
of  ||| S:14286 E:14289 ||| IN
MCAR  ||| S:14289 E:14294 ||| NNP
include  ||| S:14294 E:14302 ||| VBP
patients  ||| S:14302 E:14311 ||| NNS
who  ||| S:14311 E:14315 ||| WP
have  ||| S:14315 E:14320 ||| VBP
moved  ||| S:14320 E:14334 ||| VBN
away ||| S:14334 E:14338 ||| RB
,  ||| S:14338 E:14340 ||| ,
or  ||| S:14340 E:14343 ||| CC
study  ||| S:14343 E:14349 ||| NN
that  ||| S:14349 E:14354 ||| WDT
has  ||| S:14354 E:14358 ||| VBZ
closed  ||| S:14358 E:14365 ||| VBN
and  ||| S:14365 E:14369 ||| CC
the  ||| S:14369 E:14373 ||| DT
late  ||| S:14373 E:14378 ||| JJ
entry  ||| S:14378 E:14384 ||| NN
of  ||| S:14384 E:14395 ||| IN
patients  ||| S:14395 E:14404 ||| NNS
being  ||| S:14404 E:14410 ||| VBG
administratively  ||| S:14410 E:14427 ||| NN
' ||| S:14427 E:14428 ||| POS
censored ||| S:14428 E:14436 ||| NN
' ||| S:14436 E:14437 ||| POS
.  ||| S:14437 E:14439 ||| .
We  ||| S:14439 E:14442 ||| PRP
have  ||| S:14442 E:14447 ||| VBP
seen  ||| S:14447 E:14460 ||| VBN
the  ||| S:14460 E:14464 ||| DT
convenience  ||| S:14464 E:14476 ||| NN
of  ||| S:14476 E:14479 ||| IN
MCAR  ||| S:14479 E:14484 ||| NNP
in  ||| S:14484 E:14487 ||| IN
the  ||| S:14487 E:14491 ||| DT
above  ||| S:14491 E:14497 ||| JJ
illustration ||| S:14497 E:14509 ||| NN
:  ||| S:14509 E:14511 ||| :
simply  ||| S:14511 E:14526 ||| RB
use  ||| S:14526 E:14530 ||| VB
the  ||| S:14530 E:14534 ||| DT
completers  ||| S:14534 E:14545 ||| NN
and  ||| S:14545 E:14549 ||| CC
we  ||| S:14549 E:14552 ||| PRP
get  ||| S:14552 E:14556 ||| VBP
the  ||| S:14556 E:14560 ||| DT
same  ||| S:14560 E:14565 ||| JJ
result ||| S:14565 E:14571 ||| NN
.  ||| S:14571 E:14573 ||| .
However ||| S:14573 E:14580 ||| RB
,  ||| S:14580 E:14590 ||| ,
whether  ||| S:14590 E:14598 ||| IN
this  ||| S:14598 E:14603 ||| DT
assumption  ||| S:14603 E:14614 ||| NN
is  ||| S:14614 E:14617 ||| VBZ
valid  ||| S:14617 E:14623 ||| JJ
or  ||| S:14623 E:14626 ||| CC
not  ||| S:14626 E:14630 ||| RB
should  ||| S:14630 E:14637 ||| MD
be  ||| S:14637 E:14640 ||| VB
examined  ||| S:14640 E:14657 ||| VBN
carefully  ||| S:14657 E:14667 ||| RB
in  ||| S:14667 E:14670 ||| IN
each  ||| S:14670 E:14675 ||| DT
individual  ||| S:14675 E:14686 ||| JJ
case ||| S:14686 E:14690 ||| NN
.  ||| S:14690 E:14692 ||| .
In  ||| S:14692 E:14695 ||| IN
many  ||| S:14695 E:14700 ||| JJ
situations ||| S:14700 E:14710 ||| NNS
,  ||| S:14710 E:14720 ||| ,
dropouts  ||| S:14720 E:14729 ||| NNS
are  ||| S:14729 E:14733 ||| VBP
not  ||| S:14733 E:14737 ||| RB
the  ||| S:14737 E:14741 ||| DT
same  ||| S:14741 E:14746 ||| JJ
patient  ||| S:14746 E:14754 ||| NN
population  ||| S:14754 E:14765 ||| NN
as  ||| S:14765 E:14768 ||| IN
those  ||| S:14768 E:14774 ||| DT
who  ||| S:14774 E:14786 ||| WP
stayed  ||| S:14786 E:14793 ||| VBD
within  ||| S:14793 E:14800 ||| IN
the  ||| S:14800 E:14804 ||| DT
trial ||| S:14804 E:14809 ||| NN
.  ||| S:14809 E:14811 ||| .
MCAR  ||| S:14811 E:14816 ||| NNP
certainly  ||| S:14816 E:14826 ||| RB
is  ||| S:14826 E:14829 ||| VBZ
less  ||| S:14829 E:14834 ||| RBR
restrictive  ||| S:14834 E:14854 ||| JJ
than  ||| S:14854 E:14859 ||| IN
the  ||| S:14859 E:14863 ||| DT
assumptions  ||| S:14863 E:14875 ||| NNS
in  ||| S:14875 E:14878 ||| IN
( ||| S:14878 E:14879 ||| -LRB-
a ||| S:14879 E:14880 ||| LS
)  ||| S:14880 E:14882 ||| -RRB-
or  ||| S:14882 E:14885 ||| CC
( ||| S:14885 E:14886 ||| -LRB-
b ||| S:14886 E:14887 ||| LS
) ||| S:14887 E:14888 ||| -RRB-
.  ||| S:14888 E:14890 ||| .
Still ||| S:14890 E:14895 ||| RB
,  ||| S:14895 E:14897 ||| ,
other  ||| S:14897 E:14903 ||| JJ
less  ||| S:14903 E:14916 ||| RBR
restrictive  ||| S:14916 E:14928 ||| JJ
assumptions  ||| S:14928 E:14940 ||| NNS
than  ||| S:14940 E:14945 ||| IN
MCAR  ||| S:14945 E:14950 ||| NNP
exist ||| S:14950 E:14955 ||| VBP
,  ||| S:14955 E:14957 ||| ,
and  ||| S:14957 E:14961 ||| CC
these  ||| S:14961 E:14967 ||| DT
are  ||| S:14967 E:14979 ||| VBP
discussed  ||| S:14979 E:14989 ||| VBN
later.  ||| S:14989 E:15004 ||| CD
•  ||| S:15004 E:15006 ||| CD
All  ||| S:15006 E:15010 ||| DT
three  ||| S:15010 E:15016 ||| CD
estimates  ||| S:15016 E:15026 ||| NNS
given  ||| S:15026 E:15032 ||| VBN
by  ||| S:15032 E:15035 ||| IN
( ||| S:15035 E:15036 ||| -LRB-
a ||| S:15036 E:15037 ||| LS
) ||| S:15037 E:15038 ||| -RRB-
,  ||| S:15038 E:15040 ||| ,
( ||| S:15040 E:15041 ||| -LRB-
b ||| S:15041 E:15042 ||| LS
) ||| S:15042 E:15043 ||| -RRB-
,  ||| S:15043 E:15045 ||| ,
and  ||| S:15045 E:15049 ||| CC
( ||| S:15049 E:15050 ||| -LRB-
c ||| S:15050 E:15051 ||| LS
)  ||| S:15051 E:15053 ||| -RRB-
are  ||| S:15053 E:15065 ||| VBP
biased  ||| S:15065 E:15072 ||| VBN
to  ||| S:15072 E:15075 ||| TO
a  ||| S:15075 E:15077 ||| DT
certain  ||| S:15077 E:15085 ||| JJ
extent ||| S:15085 E:15091 ||| NN
.  ||| S:15091 E:15093 ||| .
Had  ||| S:15093 E:15097 ||| VBD
the  ||| S:15097 E:15101 ||| DT
authors  ||| S:15101 E:15109 ||| NNS
given  ||| S:15109 E:15115 ||| VBN
the  ||| S:15115 E:15127 ||| DT
detail  ||| S:15127 E:15134 ||| NN
about  ||| S:15134 E:15140 ||| IN
the  ||| S:15140 E:15144 ||| DT
numbers  ||| S:15144 E:15152 ||| NNS
of  ||| S:15152 E:15155 ||| IN
dropout  ||| S:15155 E:15163 ||| JJ
categories  ||| S:15163 E:15174 ||| NNS
of  ||| S:15174 E:15177 ||| IN
' ||| S:15177 E:15178 ||| POS
lack  ||| S:15178 E:15183 ||| NN
of  ||| S:15183 E:15194 ||| IN
response ||| S:15194 E:15202 ||| NN
'  ||| S:15202 E:15204 ||| POS
and  ||| S:15204 E:15208 ||| NN
' ||| S:15208 E:15209 ||| POS
side  ||| S:15209 E:15214 ||| NN
effects ||| S:15214 E:15221 ||| NNS
' ||| S:15221 E:15222 ||| POS
,  ||| S:15222 E:15224 ||| ,
a  ||| S:15224 E:15226 ||| DT
better  ||| S:15226 E:15233 ||| JJR
estimate  ||| S:15233 E:15242 ||| NN
could  ||| S:15242 E:15248 ||| MD
be  ||| S:15248 E:15259 ||| VB
derived.  ||| S:15259 E:15276 ||| CD
•  ||| S:15276 E:15278 ||| CD
We  ||| S:15278 E:15281 ||| PRP
would  ||| S:15281 E:15287 ||| MD
certainly  ||| S:15287 E:15297 ||| RB
feel  ||| S:15297 E:15302 ||| VB
more  ||| S:15302 E:15307 ||| RBR
comfortable  ||| S:15307 E:15319 ||| JJ
with  ||| S:15319 E:15324 ||| IN
a  ||| S:15324 E:15326 ||| DT
study  ||| S:15326 E:15340 ||| NN
conclusion  ||| S:15340 E:15351 ||| NN
when  ||| S:15351 E:15356 ||| WRB
it  ||| S:15356 E:15359 ||| PRP
is  ||| S:15359 E:15362 ||| VBZ
not  ||| S:15362 E:15366 ||| RB
altered  ||| S:15366 E:15374 ||| VBN
by  ||| S:15374 E:15377 ||| IN
different  ||| S:15377 E:15387 ||| JJ
approaches ||| S:15387 E:15397 ||| NNS
.  ||| S:15397 E:15407 ||| .
Sensitivity  ||| S:15407 E:15419 ||| JJ
analysis  ||| S:15419 E:15428 ||| NN
is  ||| S:15428 E:15431 ||| VBZ
actually  ||| S:15431 E:15440 ||| RB
the  ||| S:15440 E:15444 ||| DT
best  ||| S:15444 E:15449 ||| JJS
way  ||| S:15449 E:15453 ||| NN
to  ||| S:15453 E:15456 ||| TO
analyze  ||| S:15456 E:15472 ||| VB
data  ||| S:15472 E:15477 ||| NNS
in  ||| S:15477 E:15480 ||| IN
the  ||| S:15480 E:15484 ||| DT
presence  ||| S:15484 E:15493 ||| NN
of  ||| S:15493 E:15496 ||| IN
dropouts ||| S:15496 E:15504 ||| NNS
.  ||| S:15504 E:15506 ||| .
Medical  ||| S:15506 E:15514 ||| JJ
investigators  ||| S:15514 E:15536 ||| NNS
should  ||| S:15536 E:15543 ||| MD
consult  ||| S:15543 E:15551 ||| VB
with  ||| S:15551 E:15556 ||| IN
statisticians  ||| S:15556 E:15570 ||| NNS
when  ||| S:15570 E:15575 ||| WRB
dealing  ||| S:15575 E:15583 ||| VBG
with  ||| S:15583 E:15588 ||| IN
missing  ||| S:15588 E:15604 ||| VBG
data  ||| S:15604 E:15609 ||| NNS
because  ||| S:15609 E:15617 ||| IN
there  ||| S:15617 E:15623 ||| EX
are  ||| S:15623 E:15627 ||| VBP
many  ||| S:15627 E:15632 ||| JJ
possible  ||| S:15632 E:15641 ||| JJ
methods  ||| S:15641 E:15649 ||| NNS
available ||| S:15649 E:15658 ||| JJ
.  ||| S:15658 E:15668 ||| .
Some  ||| S:15668 E:15673 ||| DT
popular  ||| S:15673 E:15681 ||| JJ
approaches  ||| S:15681 E:15692 ||| NNS
are  ||| S:15692 E:15696 ||| VBP
reviewed  ||| S:15696 E:15705 ||| VBN
below ||| S:15705 E:15710 ||| RB
.  ||| S:15710 E:15734 ||| .
More  ||| S:15734 E:15739 ||| RBR
about  ||| S:15739 E:15745 ||| IN
methods  ||| S:15745 E:15753 ||| NNS
handling  ||| S:15753 E:15762 ||| VBG
missing  ||| S:15762 E:15770 ||| JJ
data  ||| S:15770 E:15794 ||| NNS
Objectives  ||| S:15794 E:15815 ||| NNP
As  ||| S:15815 E:15818 ||| IN
in  ||| S:15818 E:15821 ||| IN
any  ||| S:15821 E:15825 ||| DT
data  ||| S:15825 E:15830 ||| NN
analysis ||| S:15830 E:15838 ||| NN
,  ||| S:15838 E:15840 ||| ,
the  ||| S:15840 E:15844 ||| DT
first  ||| S:15844 E:15850 ||| JJ
consideration  ||| S:15850 E:15864 ||| NN
is  ||| S:15864 E:15877 ||| VBZ
the  ||| S:15877 E:15881 ||| DT
objective  ||| S:15881 E:15891 ||| NN
of  ||| S:15891 E:15894 ||| IN
the  ||| S:15894 E:15898 ||| DT
analysis ||| S:15898 E:15906 ||| NN
.  ||| S:15906 E:15908 ||| .
In  ||| S:15908 E:15911 ||| IN
the  ||| S:15911 E:15915 ||| DT
presence  ||| S:15915 E:15924 ||| NN
of  ||| S:15924 E:15937 ||| IN
dropouts ||| S:15937 E:15945 ||| NNS
,  ||| S:15945 E:15947 ||| ,
there  ||| S:15947 E:15953 ||| EX
can  ||| S:15953 E:15957 ||| MD
be  ||| S:15957 E:15960 ||| VB
two  ||| S:15960 E:15964 ||| CD
types  ||| S:15964 E:15970 ||| NNS
of  ||| S:15970 E:15973 ||| IN
questions ||| S:15973 E:15982 ||| NNS
:  ||| S:15982 E:15984 ||| :
( ||| S:15984 E:15985 ||| -LRB-
i ||| S:15985 E:15986 ||| FW
)  ||| S:15986 E:15988 ||| -RRB-
What  ||| S:15988 E:16003 ||| WP
would  ||| S:16003 E:16009 ||| MD
be  ||| S:16009 E:16012 ||| VB
the  ||| S:16012 E:16016 ||| DT
treatment  ||| S:16016 E:16026 ||| NN
effect  ||| S:16026 E:16033 ||| NN
without  ||| S:16033 E:16041 ||| IN
dropouts ||| S:16041 E:16049 ||| JJ
?  ||| S:16049 E:16051 ||| NN
and  ||| S:16051 E:16055 ||| CC
( ||| S:16055 E:16056 ||| -LRB-
ii ||| S:16056 E:16058 ||| LS
)  ||| S:16058 E:16070 ||| -RRB-
What  ||| S:16070 E:16075 ||| WP
would  ||| S:16075 E:16081 ||| MD
be  ||| S:16081 E:16084 ||| VB
the  ||| S:16084 E:16088 ||| DT
treatment  ||| S:16088 E:16098 ||| NN
effect  ||| S:16098 E:16105 ||| NN
in  ||| S:16105 E:16108 ||| IN
the  ||| S:16108 E:16112 ||| DT
presence  ||| S:16112 E:16121 ||| NN
of  ||| S:16121 E:16134 ||| IN
dropouts ||| S:16134 E:16142 ||| NNS
?  ||| S:16142 E:16144 ||| .
Question  ||| S:16144 E:16153 ||| NN
( ||| S:16153 E:16154 ||| -LRB-
i ||| S:16154 E:16155 ||| FW
)  ||| S:16155 E:16157 ||| -RRB-
is  ||| S:16157 E:16160 ||| VBZ
concerned  ||| S:16160 E:16170 ||| VBN
with  ||| S:16170 E:16175 ||| IN
an  ||| S:16175 E:16178 ||| DT
ideal  ||| S:16178 E:16194 ||| JJ
situation ||| S:16194 E:16203 ||| NN
.  ||| S:16203 E:16205 ||| .
It  ||| S:16205 E:16208 ||| PRP
is  ||| S:16208 E:16211 ||| VBZ
also  ||| S:16211 E:16216 ||| RB
known  ||| S:16216 E:16222 ||| VBN
as  ||| S:16222 E:16225 ||| IN
a  ||| S:16225 E:16227 ||| DT
' ||| S:16227 E:16228 ||| POS
question  ||| S:16228 E:16237 ||| NN
for  ||| S:16237 E:16251 ||| IN
explanatory  ||| S:16251 E:16263 ||| JJ
trials ||| S:16263 E:16269 ||| NNS
'  ||| S:16269 E:16271 ||| ''
[  ||| S:16271 E:16273 ||| -LRB-
6  ||| S:16273 E:16275 ||| CD
]  ||| S:16275 E:16277 ||| -RRB-
.  ||| S:16277 E:16279 ||| .
It  ||| S:16279 E:16282 ||| PRP
is  ||| S:16282 E:16285 ||| VBZ
often  ||| S:16285 E:16291 ||| RB
concerned  ||| S:16291 E:16301 ||| VBN
with  ||| S:16301 E:16316 ||| IN
the  ||| S:16316 E:16320 ||| DT
human  ||| S:16320 E:16326 ||| JJ
pharmacological  ||| S:16326 E:16342 ||| JJ
properties  ||| S:16342 E:16353 ||| NNS
of  ||| S:16353 E:16356 ||| IN
new  ||| S:16356 E:16360 ||| JJ
drugs  ||| S:16360 E:16366 ||| NNS
under  ||| S:16366 E:16382 ||| IN
investigation  ||| S:16382 E:16396 ||| NN
rather  ||| S:16396 E:16403 ||| RB
than  ||| S:16403 E:16408 ||| IN
practical  ||| S:16408 E:16418 ||| JJ
usage ||| S:16418 E:16423 ||| NN
.  ||| S:16423 E:16425 ||| .
Regarding  ||| S:16425 E:16445 ||| VBG
question  ||| S:16445 E:16454 ||| NN
( ||| S:16454 E:16455 ||| -LRB-
ii ||| S:16455 E:16457 ||| LS
) ||| S:16457 E:16458 ||| -RRB-
,  ||| S:16458 E:16460 ||| ,
we  ||| S:16460 E:16463 ||| PRP
need  ||| S:16463 E:16468 ||| VBP
to  ||| S:16468 E:16471 ||| TO
further  ||| S:16471 E:16479 ||| RBR
differentiate  ||| S:16479 E:16493 ||| JJ
two  ||| S:16493 E:16507 ||| CD
situations ||| S:16507 E:16517 ||| NNS
:  ||| S:16517 E:16519 ||| :
patients  ||| S:16519 E:16528 ||| NNS
drop  ||| S:16528 E:16533 ||| VB
out  ||| S:16533 E:16537 ||| RP
either  ||| S:16537 E:16544 ||| DT
( ||| S:16544 E:16545 ||| -LRB-
a ||| S:16545 E:16546 ||| LS
)  ||| S:16546 E:16548 ||| -RRB-
totally  ||| S:16548 E:16556 ||| RB
from  ||| S:16556 E:16561 ||| IN
the  ||| S:16561 E:16575 ||| DT
study  ||| S:16575 E:16581 ||| NN
and  ||| S:16581 E:16585 ||| CC
no  ||| S:16585 E:16588 ||| DT
data  ||| S:16588 E:16593 ||| NNS
are  ||| S:16593 E:16597 ||| VBP
collected  ||| S:16597 E:16607 ||| VBN
after  ||| S:16607 E:16613 ||| IN
withdrawal ||| S:16613 E:16623 ||| NN
,  ||| S:16623 E:16625 ||| ,
or  ||| S:16625 E:16628 ||| CC
( ||| S:16628 E:16629 ||| -LRB-
b ||| S:16629 E:16630 ||| LS
)  ||| S:16630 E:16642 ||| -RRB-
merely  ||| S:16642 E:16649 ||| RB
from  ||| S:16649 E:16654 ||| IN
the  ||| S:16654 E:16658 ||| DT
study  ||| S:16658 E:16664 ||| NN
assigned  ||| S:16664 E:16673 ||| VBN
treatment  ||| S:16673 E:16683 ||| NN
with  ||| S:16683 E:16688 ||| IN
data  ||| S:16688 E:16693 ||| NNS
still  ||| S:16693 E:16709 ||| RB
being  ||| S:16709 E:16715 ||| VBG
collected ||| S:16715 E:16724 ||| VBN
.  ||| S:16724 E:16726 ||| .
For  ||| S:16726 E:16730 ||| IN
( ||| S:16730 E:16731 ||| -LRB-
b ||| S:16731 E:16732 ||| LS
)  ||| S:16732 E:16734 ||| -RRB-
there  ||| S:16734 E:16740 ||| EX
will  ||| S:16740 E:16745 ||| MD
be  ||| S:16745 E:16748 ||| VB
no  ||| S:16748 E:16751 ||| DT
missing  ||| S:16751 E:16759 ||| JJ
data ||| S:16759 E:16763 ||| NNS
.  ||| S:16763 E:16775 ||| .
If  ||| S:16775 E:16778 ||| IN
we  ||| S:16778 E:16781 ||| PRP
can  ||| S:16781 E:16785 ||| MD
design  ||| S:16785 E:16792 ||| VB
trials  ||| S:16792 E:16799 ||| NNS
that  ||| S:16799 E:16804 ||| WDT
will  ||| S:16804 E:16809 ||| MD
allow  ||| S:16809 E:16815 ||| VB
patients  ||| S:16815 E:16824 ||| NNS
to  ||| S:16824 E:16827 ||| TO
be  ||| S:16827 E:16840 ||| VB
followed  ||| S:16840 E:16849 ||| VBN
until  ||| S:16849 E:16855 ||| IN
the  ||| S:16855 E:16859 ||| DT
end  ||| S:16859 E:16863 ||| NN
of  ||| S:16863 E:16866 ||| IN
the  ||| S:16866 E:16870 ||| DT
study  ||| S:16870 E:16876 ||| NN
despite  ||| S:16876 E:16884 ||| IN
the  ||| S:16884 E:16888 ||| DT
patient ||| S:16888 E:16895 ||| NN
's  ||| S:16895 E:16908 ||| POS
lack  ||| S:16908 E:16913 ||| NN
of  ||| S:16913 E:16916 ||| IN
compliance ||| S:16916 E:16926 ||| NN
,  ||| S:16926 E:16928 ||| ,
then  ||| S:16928 E:16933 ||| RB
( ||| S:16933 E:16934 ||| -LRB-
ii ||| S:16934 E:16936 ||| LS
)  ||| S:16936 E:16938 ||| -RRB-
is  ||| S:16938 E:16941 ||| VBZ
a  ||| S:16941 E:16943 ||| DT
very  ||| S:16943 E:16948 ||| RB
practical  ||| S:16948 E:16968 ||| JJ
question ||| S:16968 E:16976 ||| NN
,  ||| S:16976 E:16978 ||| ,
also  ||| S:16978 E:16983 ||| RB
known  ||| S:16983 E:16989 ||| VBN
as  ||| S:16989 E:16992 ||| IN
the  ||| S:16992 E:16996 ||| DT
' ||| S:16996 E:16997 ||| POS
question  ||| S:16997 E:17006 ||| NN
for  ||| S:17006 E:17010 ||| IN
pragmatic  ||| S:17010 E:17030 ||| JJ
trials ||| S:17030 E:17036 ||| NNS
'  ||| S:17036 E:17038 ||| ''
[  ||| S:17038 E:17040 ||| -LRB-
7  ||| S:17040 E:17042 ||| CD
]  ||| S:17042 E:17044 ||| -RRB-
.  ||| S:17044 E:17046 ||| .
Prevention  ||| S:17046 E:17057 ||| NN
studies  ||| S:17057 E:17065 ||| NNS
with  ||| S:17065 E:17070 ||| IN
all-cause  ||| S:17070 E:17090 ||| JJ
mortality  ||| S:17090 E:17100 ||| NN
as  ||| S:17100 E:17103 ||| IN
the  ||| S:17103 E:17107 ||| DT
primary  ||| S:17107 E:17115 ||| JJ
endpoint  ||| S:17115 E:17124 ||| NNS
usually  ||| S:17124 E:17132 ||| RB
follow  ||| S:17132 E:17139 ||| VB
this  ||| S:17139 E:17154 ||| DT
design ||| S:17154 E:17160 ||| NN
.  ||| S:17160 E:17162 ||| .
However ||| S:17162 E:17169 ||| RB
,  ||| S:17169 E:17171 ||| ,
other  ||| S:17171 E:17177 ||| JJ
endpoints  ||| S:17177 E:17187 ||| NN
may  ||| S:17187 E:17191 ||| MD
also  ||| S:17191 E:17196 ||| RB
be  ||| S:17196 E:17199 ||| VB
followed-up  ||| S:17199 E:17221 ||| JJ
( ||| S:17221 E:17222 ||| -LRB-
until  ||| S:17222 E:17228 ||| IN
death ||| S:17228 E:17233 ||| NN
)  ||| S:17233 E:17235 ||| -RRB-
in  ||| S:17235 E:17238 ||| IN
such  ||| S:17238 E:17243 ||| PDT
a  ||| S:17243 E:17245 ||| DT
design ||| S:17245 E:17251 ||| NN
.  ||| S:17251 E:17253 ||| .
A  ||| S:17253 E:17255 ||| DT
recent  ||| S:17255 E:17262 ||| JJ
example  ||| S:17262 E:17270 ||| NN
is  ||| S:17270 E:17273 ||| VBZ
[  ||| S:17273 E:17275 ||| -LRB-
8  ||| S:17275 E:17277 ||| CD
]  ||| S:17277 E:17289 ||| -RRB-
,  ||| S:17289 E:17291 ||| ,
in  ||| S:17291 E:17294 ||| IN
which  ||| S:17294 E:17300 ||| WDT
all  ||| S:17300 E:17304 ||| DT
participants ||| S:17304 E:17316 ||| NNS
,  ||| S:17316 E:17318 ||| ,
even  ||| S:17318 E:17323 ||| RB
those  ||| S:17323 E:17329 ||| DT
who  ||| S:17329 E:17333 ||| WP
discontinued  ||| S:17333 E:17356 ||| JJ
treatment  ||| S:17356 E:17366 ||| NN
( ||| S:17366 E:17367 ||| -LRB-
lovastatin  ||| S:17367 E:17378 ||| NN
or  ||| S:17378 E:17381 ||| CC
placebo ||| S:17381 E:17388 ||| CD
) ||| S:17388 E:17389 ||| -RRB-
,  ||| S:17389 E:17391 ||| ,
were  ||| S:17391 E:17396 ||| VBD
contacted  ||| S:17396 E:17416 ||| VBN
annually  ||| S:17416 E:17425 ||| RB
for  ||| S:17425 E:17429 ||| IN
vital  ||| S:17429 E:17435 ||| JJ
status ||| S:17435 E:17441 ||| NN
,  ||| S:17441 E:17443 ||| ,
cardiovascular  ||| S:17443 E:17458 ||| JJ
events ||| S:17458 E:17464 ||| NNS
,  ||| S:17464 E:17466 ||| ,
and  ||| S:17466 E:17480 ||| CC
cancer  ||| S:17480 E:17487 ||| NN
history ||| S:17487 E:17494 ||| NN
.  ||| S:17494 E:17496 ||| .
Since  ||| S:17496 E:17502 ||| IN
no  ||| S:17502 E:17505 ||| DT
missing  ||| S:17505 E:17513 ||| JJ
data  ||| S:17513 E:17518 ||| NNS
would  ||| S:17518 E:17524 ||| MD
occur ||| S:17524 E:17529 ||| VB
,  ||| S:17529 E:17531 ||| ,
the  ||| S:17531 E:17545 ||| DT
design  ||| S:17545 E:17552 ||| NN
of  ||| S:17552 E:17555 ||| IN
( ||| S:17555 E:17556 ||| -LRB-
b ||| S:17556 E:17557 ||| LS
)  ||| S:17557 E:17559 ||| -RRB-
is  ||| S:17559 E:17562 ||| VBZ
highly  ||| S:17562 E:17569 ||| RB
recommended  ||| S:17569 E:17581 ||| VBN
for  ||| S:17581 E:17585 ||| IN
all  ||| S:17585 E:17589 ||| DT
trials  ||| S:17589 E:17596 ||| NNS
if  ||| S:17596 E:17599 ||| IN
at  ||| S:17599 E:17612 ||| IN
all  ||| S:17612 E:17616 ||| DT
possible ||| S:17616 E:17624 ||| JJ
.  ||| S:17624 E:17626 ||| .
In  ||| S:17626 E:17629 ||| IN
fact ||| S:17629 E:17633 ||| NN
,  ||| S:17633 E:17635 ||| ,
the  ||| S:17635 E:17639 ||| DT
ITT  ||| S:17639 E:17643 ||| NNP
principle  ||| S:17643 E:17653 ||| NN
originally  ||| S:17653 E:17664 ||| RB
aims  ||| S:17664 E:17679 ||| VBZ
to  ||| S:17679 E:17682 ||| TO
answer  ||| S:17682 E:17689 ||| VB
question  ||| S:17689 E:17698 ||| NN
( ||| S:17698 E:17699 ||| -LRB-
ii ||| S:17699 E:17701 ||| LS
)  ||| S:17701 E:17703 ||| -RRB-
with  ||| S:17703 E:17708 ||| IN
( ||| S:17708 E:17709 ||| -LRB-
b ||| S:17709 E:17710 ||| LS
)  ||| S:17710 E:17712 ||| -RRB-
type  ||| S:17712 E:17717 ||| NN
of  ||| S:17717 E:17720 ||| IN
dropouts ||| S:17720 E:17728 ||| NNS
,  ||| S:17728 E:17730 ||| ,
where  ||| S:17730 E:17746 ||| WRB
no  ||| S:17746 E:17749 ||| DT
missing  ||| S:17749 E:17757 ||| JJ
data  ||| S:17757 E:17762 ||| NNS
would  ||| S:17762 E:17768 ||| MD
occur ||| S:17768 E:17773 ||| VB
.  ||| S:17773 E:17775 ||| .
However ||| S:17775 E:17782 ||| RB
,  ||| S:17782 E:17784 ||| ,
more  ||| S:17784 E:17789 ||| RBR
often  ||| S:17789 E:17795 ||| RB
than  ||| S:17795 E:17800 ||| IN
not  ||| S:17800 E:17814 ||| RB
we  ||| S:17814 E:17817 ||| PRP
face  ||| S:17817 E:17822 ||| VBP
studies  ||| S:17822 E:17830 ||| NNS
in  ||| S:17830 E:17833 ||| IN
which  ||| S:17833 E:17839 ||| WDT
patients  ||| S:17839 E:17848 ||| NNS
have  ||| S:17848 E:17853 ||| VBP
withdrawn  ||| S:17853 E:17863 ||| VBN
from  ||| S:17863 E:17868 ||| IN
the  ||| S:17868 E:17882 ||| DT
study  ||| S:17882 E:17888 ||| NN
entirely  ||| S:17888 E:17897 ||| RB
and  ||| S:17897 E:17901 ||| CC
caused  ||| S:17901 E:17908 ||| VBD
the  ||| S:17908 E:17912 ||| DT
missing  ||| S:17912 E:17920 ||| JJ
data  ||| S:17920 E:17925 ||| NN
problem ||| S:17925 E:17932 ||| NN
,  ||| S:17932 E:17934 ||| ,
ie ||| S:17934 E:17936 ||| NN
,  ||| S:17936 E:17948 ||| ,
type  ||| S:17948 E:17953 ||| NN
( ||| S:17953 E:17954 ||| -LRB-
a ||| S:17954 E:17955 ||| LS
) ||| S:17955 E:17956 ||| -RRB-
,  ||| S:17956 E:17958 ||| ,
as  ||| S:17958 E:17961 ||| IN
the  ||| S:17961 E:17965 ||| DT
Examples  ||| S:17965 E:17974 ||| NNP
1-5  ||| S:17974 E:17978 ||| NNP
( ||| S:17978 E:17979 ||| -LRB-
with  ||| S:17979 E:17984 ||| IN
the  ||| S:17984 E:17988 ||| DT
exception  ||| S:17988 E:17998 ||| NN
of  ||| S:17998 E:18011 ||| IN
Example  ||| S:18011 E:18019 ||| NNP
3 ||| S:18019 E:18020 ||| CD
)  ||| S:18020 E:18022 ||| -RRB-
above  ||| S:18022 E:18028 ||| RB
have  ||| S:18028 E:18033 ||| VBP
demonstrated ||| S:18033 E:18045 ||| VBN
.  ||| S:18045 E:18047 ||| .
Unless  ||| S:18047 E:18054 ||| IN
the  ||| S:18054 E:18058 ||| DT
patient ||| S:18058 E:18065 ||| NN
's  ||| S:18065 E:18078 ||| POS
clinical  ||| S:18078 E:18087 ||| JJ
status  ||| S:18087 E:18094 ||| NN
does  ||| S:18094 E:18099 ||| VBZ
not  ||| S:18099 E:18103 ||| RB
permit  ||| S:18103 E:18110 ||| VB
further  ||| S:18110 E:18118 ||| JJ
testing  ||| S:18118 E:18126 ||| NN
after  ||| S:18126 E:18142 ||| IN
discontinuing  ||| S:18142 E:18156 ||| VBG
the  ||| S:18156 E:18160 ||| DT
study  ||| S:18160 E:18166 ||| NN
treatment ||| S:18166 E:18175 ||| NN
,  ||| S:18175 E:18177 ||| ,
type  ||| S:18177 E:18182 ||| NN
( ||| S:18182 E:18183 ||| -LRB-
a ||| S:18183 E:18184 ||| LS
)  ||| S:18184 E:18186 ||| -RRB-
dropout  ||| S:18186 E:18204 ||| JJ
problem  ||| S:18204 E:18212 ||| NN
is  ||| S:18212 E:18215 ||| VBZ
a  ||| S:18215 E:18217 ||| DT
common  ||| S:18217 E:18224 ||| JJ
design  ||| S:18224 E:18231 ||| NN
flaw  ||| S:18231 E:18236 ||| NN
and  ||| S:18236 E:18240 ||| CC
should  ||| S:18240 E:18247 ||| MD
be  ||| S:18247 E:18250 ||| VB
corrected ||| S:18250 E:18259 ||| VBN
.  ||| S:18259 E:18271 ||| .
Nevertheless ||| S:18271 E:18283 ||| RB
,  ||| S:18283 E:18285 ||| ,
the  ||| S:18285 E:18289 ||| DT
problem  ||| S:18289 E:18297 ||| NN
of  ||| S:18297 E:18300 ||| IN
no  ||| S:18300 E:18303 ||| DT
follow-up  ||| S:18303 E:18313 ||| JJ
data  ||| S:18313 E:18318 ||| NN
prevails  ||| S:18318 E:18337 ||| VBZ
in  ||| S:18337 E:18340 ||| IN
clinical  ||| S:18340 E:18349 ||| JJ
trials ||| S:18349 E:18355 ||| NNS
.  ||| S:18355 E:18357 ||| .
For  ||| S:18357 E:18361 ||| IN
clinical  ||| S:18361 E:18370 ||| JJ
trials  ||| S:18370 E:18377 ||| NNS
conducted  ||| S:18377 E:18387 ||| VBN
for  ||| S:18387 E:18401 ||| IN
drug  ||| S:18401 E:18406 ||| NN
registrations  ||| S:18406 E:18420 ||| VBD
it  ||| S:18420 E:18423 ||| PRP
is  ||| S:18423 E:18426 ||| VBZ
possible  ||| S:18426 E:18435 ||| JJ
that ||| S:18435 E:18439 ||| IN
,  ||| S:18439 E:18441 ||| ,
in  ||| S:18441 E:18444 ||| IN
light  ||| S:18444 E:18450 ||| NN
of  ||| S:18450 E:18453 ||| IN
the  ||| S:18453 E:18467 ||| DT
International  ||| S:18467 E:18481 ||| NNP
Conference  ||| S:18481 E:18492 ||| NNP
on  ||| S:18492 E:18495 ||| IN
Harmonization  ||| S:18495 E:18509 ||| NNP
( ||| S:18509 E:18510 ||| -LRB-
ICH ||| S:18510 E:18513 ||| NNP
) ||| S:18513 E:18514 ||| -RRB-
-E9  ||| S:18514 E:18528 ||| FW
guideline  ||| S:18528 E:18538 ||| FW
[  ||| S:18538 E:18540 ||| -LRB-
9  ||| S:18540 E:18542 ||| CD
]  ||| S:18542 E:18544 ||| -RRB-
,  ||| S:18544 E:18546 ||| ,
the  ||| S:18546 E:18550 ||| DT
data  ||| S:18550 E:18555 ||| NN
analyses  ||| S:18555 E:18564 ||| NNS
have  ||| S:18564 E:18569 ||| VBP
to  ||| S:18569 E:18572 ||| TO
address  ||| S:18572 E:18580 ||| VB
both  ||| S:18580 E:18595 ||| DT
questions  ||| S:18595 E:18605 ||| NNS
( ||| S:18605 E:18606 ||| -LRB-
i ||| S:18606 E:18607 ||| FW
)  ||| S:18607 E:18609 ||| -RRB-
and  ||| S:18609 E:18613 ||| CC
( ||| S:18613 E:18614 ||| -LRB-
ii ||| S:18614 E:18616 ||| LS
) ||| S:18616 E:18617 ||| -RRB-
.  ||| S:18617 E:18647 ||| .
Imputation  ||| S:18647 E:18658 ||| JJ
methods  ||| S:18658 E:18676 ||| NNS
The  ||| S:18676 E:18680 ||| DT
analyses  ||| S:18680 E:18689 ||| JJ
illustrated  ||| S:18689 E:18701 ||| NN
in  ||| S:18701 E:18704 ||| IN
Table  ||| S:18704 E:18710 ||| NNP
2were  ||| S:18710 E:18716 ||| NNP
methods  ||| S:18716 E:18724 ||| NNS
in  ||| S:18724 E:18727 ||| IN
the  ||| S:18727 E:18741 ||| DT
general  ||| S:18741 E:18749 ||| JJ
category  ||| S:18749 E:18758 ||| NN
of  ||| S:18758 E:18761 ||| IN
imputation ||| S:18761 E:18771 ||| NN
.  ||| S:18771 E:18773 ||| .
In  ||| S:18773 E:18776 ||| IN
general ||| S:18776 E:18783 ||| JJ
,  ||| S:18783 E:18785 ||| ,
the  ||| S:18785 E:18789 ||| DT
basic  ||| S:18789 E:18805 ||| JJ
idea  ||| S:18805 E:18810 ||| NN
of  ||| S:18810 E:18813 ||| IN
imputation  ||| S:18813 E:18824 ||| NN
is  ||| S:18824 E:18827 ||| VBZ
to  ||| S:18827 E:18830 ||| TO
fill  ||| S:18830 E:18835 ||| VB
in  ||| S:18835 E:18838 ||| IN
the  ||| S:18838 E:18842 ||| DT
missing  ||| S:18842 E:18850 ||| JJ
data  ||| S:18850 E:18855 ||| NNS
by  ||| S:18855 E:18868 ||| IN
using  ||| S:18868 E:18874 ||| VBG
values  ||| S:18874 E:18881 ||| NNS
based  ||| S:18881 E:18887 ||| VBN
on  ||| S:18887 E:18890 ||| IN
a  ||| S:18890 E:18892 ||| DT
certain  ||| S:18892 E:18900 ||| JJ
model  ||| S:18900 E:18906 ||| NN
with  ||| S:18906 E:18911 ||| IN
assumptions ||| S:18911 E:18922 ||| NNS
.  ||| S:18922 E:18934 ||| .
There  ||| S:18934 E:18940 ||| EX
are  ||| S:18940 E:18944 ||| VBP
methods  ||| S:18944 E:18952 ||| NNS
based  ||| S:18952 E:18958 ||| VBN
on  ||| S:18958 E:18961 ||| IN
a  ||| S:18961 E:18963 ||| DT
single  ||| S:18963 E:18970 ||| JJ
imputation  ||| S:18970 E:18981 ||| NN
and  ||| S:18981 E:18995 ||| CC
methods  ||| S:18995 E:19003 ||| NNS
based  ||| S:19003 E:19009 ||| VBN
on  ||| S:19009 E:19012 ||| IN
multiple  ||| S:19012 E:19021 ||| JJ
imputation ||| S:19021 E:19031 ||| NN
,  ||| S:19031 E:19033 ||| ,
which ||| S:19033 E:19038 ||| WDT
,  ||| S:19038 E:19040 ||| ,
instead  ||| S:19040 E:19048 ||| RB
of  ||| S:19048 E:19061 ||| IN
filling  ||| S:19061 E:19069 ||| VBG
in  ||| S:19069 E:19072 ||| IN
a  ||| S:19072 E:19074 ||| DT
single  ||| S:19074 E:19081 ||| JJ
value  ||| S:19081 E:19087 ||| NN
for  ||| S:19087 E:19091 ||| IN
each  ||| S:19091 E:19096 ||| DT
missing  ||| S:19096 E:19104 ||| JJ
value ||| S:19104 E:19109 ||| NN
,  ||| S:19109 E:19111 ||| ,
replace  ||| S:19111 E:19129 ||| VB
each  ||| S:19129 E:19134 ||| DT
missing  ||| S:19134 E:19142 ||| JJ
value  ||| S:19142 E:19148 ||| NN
with  ||| S:19148 E:19153 ||| IN
a  ||| S:19153 E:19155 ||| DT
set  ||| S:19155 E:19159 ||| NN
of  ||| S:19159 E:19162 ||| IN
plausible  ||| S:19162 E:19172 ||| JJ
values  ||| S:19172 E:19179 ||| NNS
that  ||| S:19179 E:19194 ||| WDT
represent  ||| S:19194 E:19204 ||| VBP
the  ||| S:19204 E:19208 ||| DT
uncertainty  ||| S:19208 E:19220 ||| NN
about  ||| S:19220 E:19226 ||| IN
the  ||| S:19226 E:19230 ||| DT
right  ||| S:19230 E:19236 ||| JJ
value  ||| S:19236 E:19242 ||| NN
to  ||| S:19242 E:19255 ||| TO
impute ||| S:19255 E:19261 ||| VB
.  ||| S:19261 E:19263 ||| .
The  ||| S:19263 E:19267 ||| DT
attraction  ||| S:19267 E:19278 ||| NN
of  ||| S:19278 E:19281 ||| IN
imputation  ||| S:19281 E:19292 ||| NN
is  ||| S:19292 E:19295 ||| VBZ
that  ||| S:19295 E:19300 ||| IN
once  ||| S:19300 E:19305 ||| RB
the  ||| S:19305 E:19319 ||| DT
missing  ||| S:19319 E:19327 ||| JJ
data  ||| S:19327 E:19332 ||| NNS
are  ||| S:19332 E:19336 ||| VBP
filled-in  ||| S:19336 E:19346 ||| JJ
( ||| S:19346 E:19347 ||| -LRB-
imputed ||| S:19347 E:19354 ||| LS
) ||| S:19354 E:19355 ||| -RRB-
,  ||| S:19355 E:19357 ||| ,
all  ||| S:19357 E:19361 ||| PDT
the  ||| S:19361 E:19365 ||| DT
statistical  ||| S:19365 E:19387 ||| JJ
tools  ||| S:19387 E:19393 ||| NNS
available  ||| S:19393 E:19403 ||| JJ
for  ||| S:19403 E:19407 ||| IN
the  ||| S:19407 E:19411 ||| DT
complete  ||| S:19411 E:19420 ||| JJ
data  ||| S:19420 E:19425 ||| NNS
may  ||| S:19425 E:19429 ||| MD
be  ||| S:19429 E:19432 ||| VB
applied ||| S:19432 E:19439 ||| VBN
.  ||| S:19439 E:19451 ||| .
Each  ||| S:19451 E:19456 ||| DT
method  ||| S:19456 E:19463 ||| NN
of  ||| S:19463 E:19466 ||| IN
( ||| S:19466 E:19467 ||| -LRB-
a ||| S:19467 E:19468 ||| LS
) ||| S:19468 E:19469 ||| -RRB-
,  ||| S:19469 E:19471 ||| ,
( ||| S:19471 E:19472 ||| -LRB-
b ||| S:19472 E:19473 ||| LS
)  ||| S:19473 E:19475 ||| -RRB-
and  ||| S:19475 E:19479 ||| CC
( ||| S:19479 E:19480 ||| -LRB-
c ||| S:19480 E:19481 ||| LS
)  ||| S:19481 E:19483 ||| -RRB-
in  ||| S:19483 E:19486 ||| IN
Table  ||| S:19486 E:19492 ||| NNP
2is  ||| S:19492 E:19496 ||| CD
a  ||| S:19496 E:19498 ||| DT
single  ||| S:19498 E:19515 ||| JJ
simple  ||| S:19515 E:19522 ||| JJ
imputation  ||| S:19522 E:19533 ||| JJ
method ||| S:19533 E:19539 ||| NN
,  ||| S:19539 E:19541 ||| ,
but  ||| S:19541 E:19545 ||| CC
together  ||| S:19545 E:19554 ||| RB
they  ||| S:19554 E:19559 ||| PRP
may  ||| S:19559 E:19563 ||| MD
be  ||| S:19563 E:19566 ||| VB
viewed  ||| S:19566 E:19583 ||| VBN
as  ||| S:19583 E:19586 ||| IN
a  ||| S:19586 E:19588 ||| DT
' ||| S:19588 E:19589 ||| POS
multiple  ||| S:19589 E:19598 ||| JJ
simple  ||| S:19598 E:19605 ||| JJ
imputation ||| S:19605 E:19615 ||| NN
'  ||| S:19615 E:19617 ||| POS
method  ||| S:19617 E:19624 ||| NN
( ||| S:19624 E:19625 ||| -LRB-
as  ||| S:19625 E:19628 ||| RB
opposed  ||| S:19628 E:19636 ||| VBN
to  ||| S:19636 E:19649 ||| TO
the  ||| S:19649 E:19653 ||| DT
' ||| S:19653 E:19654 ||| POS
proper  ||| S:19654 E:19661 ||| JJ
multiple  ||| S:19661 E:19670 ||| JJ
imputation ||| S:19670 E:19680 ||| NN
'  ||| S:19680 E:19682 ||| POS
method  ||| S:19682 E:19689 ||| NN
discussed  ||| S:19689 E:19699 ||| VBN
below ||| S:19699 E:19704 ||| IN
) ||| S:19704 E:19705 ||| -RRB-
.  ||| S:19705 E:19717 ||| .
The  ||| S:19717 E:19721 ||| DT
data  ||| S:19721 E:19726 ||| NNS
in  ||| S:19726 E:19729 ||| IN
Table  ||| S:19729 E:19735 ||| NNP
2only  ||| S:19735 E:19741 ||| NNP
had  ||| S:19741 E:19745 ||| VBD
one  ||| S:19745 E:19749 ||| CD
time-point  ||| S:19749 E:19760 ||| NNS
( ||| S:19760 E:19761 ||| -LRB-
Month  ||| S:19761 E:19767 ||| NNP
6 ||| S:19767 E:19768 ||| CD
)  ||| S:19768 E:19770 ||| -RRB-
for  ||| S:19770 E:19784 ||| IN
analysis ||| S:19784 E:19792 ||| NN
.  ||| S:19792 E:19804 ||| .
For  ||| S:19804 E:19808 ||| IN
longitudinal  ||| S:19808 E:19821 ||| JJ
data  ||| S:19821 E:19826 ||| NNS
with  ||| S:19826 E:19831 ||| IN
multiple  ||| S:19831 E:19840 ||| JJ
time-points ||| S:19840 E:19851 ||| NN
,  ||| S:19851 E:19853 ||| ,
the  ||| S:19853 E:19867 ||| DT
conventional  ||| S:19867 E:19880 ||| JJ
last-observation-carried-forward  ||| S:19880 E:19913 ||| NN
( ||| S:19913 E:19914 ||| -LRB-
LOCF ||| S:19914 E:19918 ||| NNP
)  ||| S:19918 E:19930 ||| -RRB-
approach  ||| S:19930 E:19939 ||| NN
is  ||| S:19939 E:19942 ||| VBZ
a  ||| S:19942 E:19944 ||| DT
common  ||| S:19944 E:19951 ||| JJ
practice  ||| S:19951 E:19960 ||| NN
of  ||| S:19960 E:19963 ||| IN
another  ||| S:19963 E:19971 ||| DT
simple  ||| S:19971 E:19988 ||| JJ
imputation ||| S:19988 E:19998 ||| NN
.  ||| S:19998 E:20000 ||| .
This  ||| S:20000 E:20005 ||| DT
approach  ||| S:20005 E:20014 ||| NN
was  ||| S:20014 E:20018 ||| VBD
used  ||| S:20018 E:20023 ||| VBN
by  ||| S:20023 E:20026 ||| IN
the  ||| S:20026 E:20030 ||| DT
authors  ||| S:20030 E:20038 ||| NNS
in  ||| S:20038 E:20051 ||| IN
Examples  ||| S:20051 E:20060 ||| NNP
3  ||| S:20060 E:20062 ||| CD
and  ||| S:20062 E:20066 ||| CC
5 ||| S:20066 E:20067 ||| CD
.  ||| S:20067 E:20069 ||| .
Attempting  ||| S:20069 E:20080 ||| VBG
to  ||| S:20080 E:20083 ||| TO
follow  ||| S:20083 E:20090 ||| VB
the  ||| S:20090 E:20094 ||| DT
principle  ||| S:20094 E:20104 ||| NN
of  ||| S:20104 E:20117 ||| IN
ITT  ||| S:20117 E:20121 ||| NNP
to  ||| S:20121 E:20124 ||| TO
account  ||| S:20124 E:20132 ||| VB
for  ||| S:20132 E:20136 ||| IN
all  ||| S:20136 E:20140 ||| DT
randomized ||| S:20140 E:20150 ||| NN
,  ||| S:20150 E:20152 ||| ,
LOCF  ||| S:20152 E:20157 ||| NNP
method  ||| S:20157 E:20164 ||| NN
includes  ||| S:20164 E:20183 ||| VBZ
every  ||| S:20183 E:20189 ||| DT
randomized  ||| S:20189 E:20200 ||| JJ
subject  ||| S:20200 E:20208 ||| NN
who  ||| S:20208 E:20212 ||| WP
has  ||| S:20212 E:20216 ||| VBZ
at  ||| S:20216 E:20219 ||| IN
least  ||| S:20219 E:20225 ||| JJS
one  ||| S:20225 E:20239 ||| CD
post-therapy  ||| S:20239 E:20252 ||| JJ
observation ||| S:20252 E:20263 ||| NN
.  ||| S:20263 E:20265 ||| .
LOCF  ||| S:20265 E:20270 ||| NNP
is  ||| S:20270 E:20273 ||| VBZ
popular  ||| S:20273 E:20281 ||| JJ
among  ||| S:20281 E:20297 ||| IN
practitioners  ||| S:20297 E:20311 ||| NNS
because  ||| S:20311 E:20319 ||| IN
it  ||| S:20319 E:20322 ||| PRP
is  ||| S:20322 E:20325 ||| VBZ
simple  ||| S:20325 E:20332 ||| JJ
to  ||| S:20332 E:20335 ||| TO
put  ||| S:20335 E:20339 ||| VB
into  ||| S:20339 E:20344 ||| IN
effect  ||| S:20344 E:20351 ||| NN
and  ||| S:20351 E:20365 ||| CC
because  ||| S:20365 E:20373 ||| RB
of  ||| S:20373 E:20376 ||| IN
a  ||| S:20376 E:20378 ||| DT
misconception  ||| S:20378 E:20392 ||| NN
that  ||| S:20392 E:20397 ||| IN
it  ||| S:20397 E:20400 ||| PRP
is  ||| S:20400 E:20403 ||| VBZ
conservative  ||| S:20403 E:20426 ||| JJ
( ||| S:20426 E:20427 ||| -LRB-
meaning  ||| S:20427 E:20435 ||| NN
working  ||| S:20435 E:20443 ||| VBG
against  ||| S:20443 E:20451 ||| IN
an  ||| S:20451 E:20454 ||| DT
effective  ||| S:20454 E:20464 ||| JJ
treatment  ||| S:20464 E:20474 ||| NN
group ||| S:20474 E:20479 ||| NN
) ||| S:20479 E:20480 ||| -RRB-
.  ||| S:20480 E:20492 ||| .
However ||| S:20492 E:20499 ||| RB
,  ||| S:20499 E:20501 ||| ,
every  ||| S:20501 E:20507 ||| DT
imputation  ||| S:20507 E:20518 ||| JJ
method  ||| S:20518 E:20525 ||| NN
implicitly  ||| S:20525 E:20536 ||| NNS
or  ||| S:20536 E:20539 ||| CC
explicitly  ||| S:20539 E:20560 ||| RB
assumes  ||| S:20560 E:20568 ||| VBZ
a  ||| S:20568 E:20570 ||| DT
model  ||| S:20570 E:20576 ||| NN
for  ||| S:20576 E:20580 ||| IN
the  ||| S:20580 E:20584 ||| DT
missing  ||| S:20584 E:20592 ||| JJ
data ||| S:20592 E:20596 ||| NNS
.  ||| S:20596 E:20598 ||| .
The  ||| S:20598 E:20602 ||| DT
LOCF  ||| S:20602 E:20607 ||| NNP
assumes  ||| S:20607 E:20625 ||| VBZ
( ||| S:20625 E:20626 ||| -LRB-
unrealistically ||| S:20626 E:20641 ||| LS
)  ||| S:20641 E:20643 ||| -RRB-
that  ||| S:20643 E:20648 ||| IN
the  ||| S:20648 E:20652 ||| DT
missing  ||| S:20652 E:20660 ||| JJ
data  ||| S:20660 E:20665 ||| NNS
after  ||| S:20665 E:20671 ||| IN
patient ||| S:20671 E:20678 ||| NN
's  ||| S:20678 E:20691 ||| POS
withdrawal  ||| S:20691 E:20702 ||| NN
are  ||| S:20702 E:20706 ||| VBP
the  ||| S:20706 E:20710 ||| DT
same  ||| S:20710 E:20715 ||| JJ
as  ||| S:20715 E:20718 ||| IN
the  ||| S:20718 E:20722 ||| DT
last  ||| S:20722 E:20727 ||| JJ
value  ||| S:20727 E:20733 ||| NN
observed  ||| S:20733 E:20742 ||| VBD
for  ||| S:20742 E:20756 ||| IN
that  ||| S:20756 E:20761 ||| DT
patient ||| S:20761 E:20768 ||| NN
.  ||| S:20768 E:20770 ||| .
The  ||| S:20770 E:20774 ||| DT
consequence  ||| S:20774 E:20786 ||| NN
of  ||| S:20786 E:20789 ||| IN
this  ||| S:20789 E:20794 ||| DT
assumption  ||| S:20794 E:20805 ||| NN
is  ||| S:20805 E:20808 ||| VBZ
that  ||| S:20808 E:20823 ||| IN
it  ||| S:20823 E:20826 ||| PRP
imputes  ||| S:20826 E:20834 ||| VBP
data  ||| S:20834 E:20839 ||| NNS
without  ||| S:20839 E:20847 ||| IN
giving  ||| S:20847 E:20854 ||| VBG
them  ||| S:20854 E:20859 ||| PRP
within-subject  ||| S:20859 E:20884 ||| JJ
variability  ||| S:20884 E:20896 ||| NN
and  ||| S:20896 E:20900 ||| CC
that  ||| S:20900 E:20905 ||| IN
it  ||| S:20905 E:20908 ||| PRP
alters  ||| S:20908 E:20915 ||| VBD
the  ||| S:20915 E:20919 ||| DT
sample  ||| S:20919 E:20926 ||| NN
size ||| S:20926 E:20930 ||| NN
.  ||| S:20930 E:20942 ||| .
Proper  ||| S:20942 E:20949 ||| JJ
multiple  ||| S:20949 E:20958 ||| JJ
imputation  ||| S:20958 E:20969 ||| NNS
( ||| S:20969 E:20970 ||| -LRB-
PMI ||| S:20970 E:20973 ||| NNP
)  ||| S:20973 E:20975 ||| -RRB-
methods  ||| S:20975 E:20983 ||| NNS
are  ||| S:20983 E:20987 ||| VBP
described  ||| S:20987 E:21007 ||| VBN
in  ||| S:21007 E:21010 ||| IN
[  ||| S:21010 E:21012 ||| -LRB-
10  ||| S:21012 E:21015 ||| CD
]  ||| S:21015 E:21017 ||| -RRB-
and  ||| S:21017 E:21021 ||| CC
[  ||| S:21021 E:21023 ||| -LRB-
11  ||| S:21023 E:21026 ||| CD
]  ||| S:21026 E:21028 ||| -RRB-
,  ||| S:21028 E:21030 ||| ,
which  ||| S:21030 E:21036 ||| WDT
use  ||| S:21036 E:21040 ||| VBP
regression  ||| S:21040 E:21051 ||| JJ
models  ||| S:21051 E:21058 ||| NNS
to  ||| S:21058 E:21071 ||| TO
create  ||| S:21071 E:21078 ||| VB
more  ||| S:21078 E:21083 ||| JJR
than  ||| S:21083 E:21088 ||| IN
one  ||| S:21088 E:21092 ||| CD
imputed  ||| S:21092 E:21100 ||| JJ
data  ||| S:21100 E:21105 ||| NN
sets  ||| S:21105 E:21110 ||| NNS
and  ||| S:21110 E:21114 ||| CC
thus  ||| S:21114 E:21119 ||| RB
provide  ||| S:21119 E:21137 ||| VB
variability  ||| S:21137 E:21149 ||| VBN
within  ||| S:21149 E:21156 ||| IN
and  ||| S:21156 E:21160 ||| CC
between  ||| S:21160 E:21168 ||| IN
imputations ||| S:21168 E:21179 ||| NN
.  ||| S:21179 E:21181 ||| .
PMI  ||| S:21181 E:21185 ||| NNP
method  ||| S:21185 E:21202 ||| NN
has  ||| S:21202 E:21206 ||| VBZ
long  ||| S:21206 E:21211 ||| RB
been  ||| S:21211 E:21216 ||| VBN
a  ||| S:21216 E:21218 ||| DT
preferred  ||| S:21218 E:21228 ||| JJ
approach  ||| S:21228 E:21237 ||| NN
in  ||| S:21237 E:21240 ||| IN
survey  ||| S:21240 E:21247 ||| NN
research ||| S:21247 E:21255 ||| NN
.  ||| S:21255 E:21267 ||| .
Its  ||| S:21267 E:21271 ||| PRP$
popularity  ||| S:21271 E:21282 ||| NN
has  ||| S:21282 E:21286 ||| VBZ
recently  ||| S:21286 E:21295 ||| RB
gainied  ||| S:21295 E:21303 ||| VBN
in  ||| S:21303 E:21306 ||| IN
clinical  ||| S:21306 E:21315 ||| JJ
trials  ||| S:21315 E:21332 ||| NNS
since  ||| S:21332 E:21338 ||| IN
the  ||| S:21338 E:21342 ||| DT
method  ||| S:21342 E:21349 ||| NN
became  ||| S:21349 E:21356 ||| VBD
automated  ||| S:21356 E:21366 ||| VBN
by  ||| S:21366 E:21369 ||| IN
commercial  ||| S:21369 E:21380 ||| JJ
computer  ||| S:21380 E:21399 ||| NN
software  ||| S:21399 E:21408 ||| NN
[  ||| S:21408 E:21410 ||| -LRB-
12  ||| S:21410 E:21413 ||| CD
13  ||| S:21413 E:21416 ||| CD
]  ||| S:21416 E:21418 ||| -RRB-
.  ||| S:21418 E:21420 ||| .
However ||| S:21420 E:21427 ||| RB
,  ||| S:21427 E:21429 ||| ,
the  ||| S:21429 E:21433 ||| DT
complexity  ||| S:21433 E:21444 ||| NN
of  ||| S:21444 E:21457 ||| IN
regression  ||| S:21457 E:21468 ||| JJ
models  ||| S:21468 E:21475 ||| NNS
used  ||| S:21475 E:21480 ||| VBN
in  ||| S:21480 E:21483 ||| IN
PMI  ||| S:21483 E:21487 ||| NNP
should  ||| S:21487 E:21494 ||| MD
be  ||| S:21494 E:21497 ||| VB
carefully  ||| S:21497 E:21507 ||| RB
thought  ||| S:21507 E:21525 ||| VBN
through  ||| S:21525 E:21533 ||| IN
by  ||| S:21533 E:21536 ||| IN
clinical  ||| S:21536 E:21545 ||| JJ
trial  ||| S:21545 E:21551 ||| NN
practitioners ||| S:21551 E:21564 ||| NNS
,  ||| S:21564 E:21566 ||| ,
because  ||| S:21566 E:21574 ||| IN
the  ||| S:21574 E:21588 ||| DT
method  ||| S:21588 E:21595 ||| NN
assumes  ||| S:21595 E:21603 ||| VBZ
that  ||| S:21603 E:21608 ||| IN
the  ||| S:21608 E:21612 ||| DT
missing  ||| S:21612 E:21620 ||| JJ
data  ||| S:21620 E:21625 ||| NN
process  ||| S:21625 E:21633 ||| NN
can  ||| S:21633 E:21637 ||| MD
be  ||| S:21637 E:21640 ||| VB
fully  ||| S:21640 E:21656 ||| RB
captured  ||| S:21656 E:21665 ||| VBN
by  ||| S:21665 E:21668 ||| IN
the  ||| S:21668 E:21672 ||| DT
regression  ||| S:21672 E:21683 ||| JJ
model  ||| S:21683 E:21689 ||| NN
employed  ||| S:21689 E:21698 ||| VBN
on  ||| S:21698 E:21701 ||| IN
observed  ||| S:21701 E:21720 ||| JJ
values ||| S:21720 E:21726 ||| NNS
.  ||| S:21726 E:21728 ||| .
This  ||| S:21728 E:21733 ||| DT
assumption  ||| S:21733 E:21744 ||| NN
is  ||| S:21744 E:21747 ||| VBZ
called  ||| S:21747 E:21754 ||| VBN
missing  ||| S:21754 E:21762 ||| VBG
at  ||| S:21762 E:21765 ||| IN
random  ||| S:21765 E:21782 ||| JJ
( ||| S:21782 E:21783 ||| -LRB-
MAR ||| S:21783 E:21786 ||| NNP
) ||| S:21786 E:21787 ||| -RRB-
.  ||| S:21787 E:21789 ||| .
MAR  ||| S:21789 E:21793 ||| NNP
essentially  ||| S:21793 E:21805 ||| RB
says  ||| S:21805 E:21810 ||| VBZ
that  ||| S:21810 E:21815 ||| IN
the  ||| S:21815 E:21819 ||| DT
cause  ||| S:21819 E:21825 ||| NN
of  ||| S:21825 E:21828 ||| IN
the  ||| S:21828 E:21832 ||| DT
missing  ||| S:21832 E:21850 ||| JJ
data  ||| S:21850 E:21855 ||| NNS
may  ||| S:21855 E:21859 ||| MD
be  ||| S:21859 E:21862 ||| VB
dependent  ||| S:21862 E:21872 ||| JJ
on  ||| S:21872 E:21875 ||| IN
observed  ||| S:21875 E:21884 ||| JJ
data  ||| S:21884 E:21889 ||| NNS
( ||| S:21889 E:21890 ||| -LRB-
such  ||| S:21890 E:21895 ||| JJ
as  ||| S:21895 E:21898 ||| IN
data  ||| S:21898 E:21903 ||| NNS
of  ||| S:21903 E:21916 ||| IN
previous  ||| S:21916 E:21925 ||| JJ
visits ||| S:21925 E:21931 ||| NNS
)  ||| S:21931 E:21933 ||| -RRB-
but  ||| S:21933 E:21937 ||| CC
must  ||| S:21937 E:21942 ||| MD
be  ||| S:21942 E:21945 ||| VB
independent  ||| S:21945 E:21957 ||| JJ
of  ||| S:21957 E:21960 ||| IN
the  ||| S:21960 E:21964 ||| DT
missing  ||| S:21964 E:21982 ||| JJ
value  ||| S:21982 E:21988 ||| NN
that  ||| S:21988 E:21993 ||| WDT
would  ||| S:21993 E:21999 ||| MD
have  ||| S:21999 E:22004 ||| VB
been  ||| S:22004 E:22009 ||| VBN
observed ||| S:22009 E:22017 ||| VBN
.  ||| S:22017 E:22019 ||| .
It  ||| S:22019 E:22022 ||| PRP
is  ||| S:22022 E:22025 ||| VBZ
a  ||| S:22025 E:22027 ||| DT
less  ||| S:22027 E:22042 ||| RBR
restrictive  ||| S:22042 E:22054 ||| JJ
model  ||| S:22054 E:22060 ||| NN
than  ||| S:22060 E:22065 ||| IN
MCAR ||| S:22065 E:22069 ||| NNP
,  ||| S:22069 E:22071 ||| ,
which  ||| S:22071 E:22077 ||| WDT
says  ||| S:22077 E:22082 ||| VBZ
that  ||| S:22082 E:22087 ||| IN
the  ||| S:22087 E:22091 ||| DT
missing  ||| S:22091 E:22109 ||| JJ
data  ||| S:22109 E:22114 ||| NNS
cannot  ||| S:22114 E:22121 ||| RB
be  ||| S:22121 E:22124 ||| VB
dependent  ||| S:22124 E:22134 ||| JJ
on  ||| S:22134 E:22137 ||| IN
either  ||| S:22137 E:22144 ||| RB
the  ||| S:22144 E:22148 ||| DT
observed  ||| S:22148 E:22157 ||| JJ
or  ||| S:22157 E:22160 ||| CC
the  ||| S:22160 E:22174 ||| DT
missing  ||| S:22174 E:22182 ||| JJ
data ||| S:22182 E:22186 ||| NNS
.  ||| S:22186 E:22188 ||| .
The  ||| S:22188 E:22192 ||| DT
design  ||| S:22192 E:22199 ||| NN
suggested  ||| S:22199 E:22209 ||| VBD
by  ||| S:22209 E:22212 ||| IN
Murray  ||| S:22212 E:22219 ||| NNP
and  ||| S:22219 E:22223 ||| CC
Findlay  ||| S:22223 E:22241 ||| NNP
[  ||| S:22241 E:22243 ||| -LRB-
14  ||| S:22243 E:22246 ||| CD
]  ||| S:22246 E:22248 ||| -RRB-
,  ||| S:22248 E:22250 ||| ,
which  ||| S:22250 E:22256 ||| WDT
forced  ||| S:22256 E:22263 ||| VBD
dropouts  ||| S:22263 E:22272 ||| VBN
upon  ||| S:22272 E:22277 ||| IN
observing  ||| S:22277 E:22297 ||| VBG
uncontrolled  ||| S:22297 E:22310 ||| JJ
BP ||| S:22310 E:22312 ||| NNP
,  ||| S:22312 E:22314 ||| ,
uses  ||| S:22314 E:22319 ||| VBZ
the  ||| S:22319 E:22323 ||| DT
MAR  ||| S:22323 E:22327 ||| NNP
principle ||| S:22327 E:22336 ||| NN
.  ||| S:22336 E:22338 ||| .
When  ||| S:22338 E:22343 ||| WRB
MAR  ||| S:22343 E:22347 ||| NNP
or  ||| S:22347 E:22350 ||| CC
MCAR  ||| S:22350 E:22365 ||| NNP
conditions  ||| S:22365 E:22376 ||| NNS
are  ||| S:22376 E:22380 ||| VBP
met ||| S:22380 E:22383 ||| VBN
,  ||| S:22383 E:22385 ||| ,
model-based  ||| S:22385 E:22397 ||| JJ
analyses  ||| S:22397 E:22406 ||| NNS
can  ||| S:22406 E:22410 ||| MD
be  ||| S:22410 E:22423 ||| VB
appropriately  ||| S:22423 E:22437 ||| RB
performed  ||| S:22437 E:22447 ||| VBN
based  ||| S:22447 E:22453 ||| VBN
on  ||| S:22453 E:22456 ||| IN
the  ||| S:22456 E:22460 ||| DT
observed  ||| S:22460 E:22469 ||| JJ
data  ||| S:22469 E:22474 ||| NNS
alone  ||| S:22474 E:22490 ||| RB
without  ||| S:22490 E:22498 ||| IN
further  ||| S:22498 E:22506 ||| RB
modeling  ||| S:22506 E:22515 ||| VBG
the  ||| S:22515 E:22519 ||| DT
missing  ||| S:22519 E:22527 ||| JJ
data  ||| S:22527 E:22532 ||| NN
process ||| S:22532 E:22539 ||| NN
.  ||| S:22539 E:22551 ||| .
Another  ||| S:22551 E:22559 ||| DT
imputation  ||| S:22559 E:22570 ||| JJ
method ||| S:22570 E:22576 ||| NN
,  ||| S:22576 E:22578 ||| ,
which  ||| S:22578 E:22584 ||| WDT
is  ||| S:22584 E:22587 ||| VBZ
in-between  ||| S:22587 E:22598 ||| JJ
the  ||| S:22598 E:22612 ||| DT
LOCF  ||| S:22612 E:22617 ||| NNP
and  ||| S:22617 E:22621 ||| CC
PMI ||| S:22621 E:22624 ||| NNP
,  ||| S:22624 E:22626 ||| ,
is  ||| S:22626 E:22629 ||| VBZ
the  ||| S:22629 E:22633 ||| DT
partial  ||| S:22633 E:22641 ||| JJ
imputation  ||| S:22641 E:22652 ||| NNS
( ||| S:22652 E:22653 ||| -LRB-
PI ||| S:22653 E:22655 ||| NNP
)  ||| S:22655 E:22657 ||| -RRB-
or  ||| S:22657 E:22660 ||| CC
improved  ||| S:22660 E:22679 ||| JJ
LOCF  ||| S:22679 E:22684 ||| NNP
method  ||| S:22684 E:22691 ||| NN
[  ||| S:22691 E:22693 ||| -LRB-
15  ||| S:22693 E:22696 ||| CD
]  ||| S:22696 E:22698 ||| -RRB-
.  ||| S:22698 E:22700 ||| .
The  ||| S:22700 E:22704 ||| DT
idea  ||| S:22704 E:22709 ||| NN
of  ||| S:22709 E:22712 ||| IN
this  ||| S:22712 E:22717 ||| DT
method  ||| S:22717 E:22724 ||| NN
is  ||| S:22724 E:22727 ||| VBZ
quite  ||| S:22727 E:22743 ||| RB
simple ||| S:22743 E:22749 ||| JJ
.  ||| S:22749 E:22751 ||| .
In  ||| S:22751 E:22754 ||| IN
LOCF ||| S:22754 E:22758 ||| NNP
,  ||| S:22758 E:22760 ||| ,
one  ||| S:22760 E:22764 ||| CD
imputes  ||| S:22764 E:22772 ||| CD
every  ||| S:22772 E:22778 ||| DT
missing  ||| S:22778 E:22786 ||| JJ
visit  ||| S:22786 E:22802 ||| NN
time-point  ||| S:22802 E:22813 ||| NN
by  ||| S:22813 E:22816 ||| IN
carrying  ||| S:22816 E:22825 ||| VBG
the  ||| S:22825 E:22829 ||| DT
last  ||| S:22829 E:22834 ||| JJ
observation  ||| S:22834 E:22846 ||| NNS
forward  ||| S:22846 E:22854 ||| RB
until  ||| S:22854 E:22870 ||| IN
the  ||| S:22870 E:22874 ||| DT
end  ||| S:22874 E:22878 ||| NN
of  ||| S:22878 E:22881 ||| IN
the  ||| S:22881 E:22885 ||| DT
study ||| S:22885 E:22890 ||| NN
.  ||| S:22890 E:22892 ||| .
Since  ||| S:22892 E:22898 ||| IN
LOCF  ||| S:22898 E:22903 ||| NNP
requires  ||| S:22903 E:22912 ||| VBZ
the  ||| S:22912 E:22916 ||| DT
strong  ||| S:22916 E:22933 ||| JJ
assumption  ||| S:22933 E:22944 ||| NN
of  ||| S:22944 E:22947 ||| IN
stability ||| S:22947 E:22956 ||| NN
,  ||| S:22956 E:22958 ||| ,
the  ||| S:22958 E:22962 ||| DT
more  ||| S:22962 E:22967 ||| JJR
it  ||| S:22967 E:22970 ||| PRP
imputes  ||| S:22970 E:22978 ||| VBD
the  ||| S:22978 E:22982 ||| DT
more  ||| S:22982 E:22997 ||| JJR
bias  ||| S:22997 E:23002 ||| NN
it  ||| S:23002 E:23005 ||| PRP
introduces  ||| S:23005 E:23016 ||| VBZ
if  ||| S:23016 E:23019 ||| IN
the  ||| S:23019 E:23023 ||| DT
assumption  ||| S:23023 E:23034 ||| NN
of  ||| S:23034 E:23037 ||| IN
stability  ||| S:23037 E:23047 ||| NN
does  ||| S:23047 E:23062 ||| VBZ
not  ||| S:23062 E:23066 ||| RB
hold ||| S:23066 E:23070 ||| VB
.  ||| S:23070 E:23072 ||| .
The  ||| S:23072 E:23076 ||| DT
method  ||| S:23076 E:23083 ||| NN
of  ||| S:23083 E:23086 ||| IN
PI  ||| S:23086 E:23089 ||| NNP
does  ||| S:23089 E:23094 ||| VBZ
not  ||| S:23094 E:23098 ||| RB
always  ||| S:23098 E:23105 ||| RB
carry  ||| S:23105 E:23111 ||| VB
the  ||| S:23111 E:23125 ||| DT
observations  ||| S:23125 E:23138 ||| NNS
to  ||| S:23138 E:23141 ||| TO
the  ||| S:23141 E:23145 ||| DT
end  ||| S:23145 E:23149 ||| NN
time-point  ||| S:23149 E:23160 ||| NN
of  ||| S:23160 E:23163 ||| IN
the  ||| S:23163 E:23167 ||| DT
study ||| S:23167 E:23172 ||| NN
,  ||| S:23172 E:23174 ||| ,
but  ||| S:23174 E:23178 ||| CC
just  ||| S:23178 E:23193 ||| RB
far  ||| S:23193 E:23197 ||| RB
enough  ||| S:23197 E:23204 ||| RB
to  ||| S:23204 E:23207 ||| TO
balance  ||| S:23207 E:23215 ||| VB
the  ||| S:23215 E:23219 ||| DT
dropout  ||| S:23219 E:23227 ||| JJ
patterns  ||| S:23227 E:23236 ||| NNS
between  ||| S:23236 E:23244 ||| IN
the  ||| S:23244 E:23258 ||| DT
treatment  ||| S:23258 E:23268 ||| NN
groups ||| S:23268 E:23274 ||| NNS
.  ||| S:23274 E:23276 ||| .
The  ||| S:23276 E:23280 ||| DT
underlying  ||| S:23280 E:23291 ||| JJ
principle  ||| S:23291 E:23301 ||| NN
is  ||| S:23301 E:23304 ||| VBZ
that  ||| S:23304 E:23309 ||| IN
when  ||| S:23309 E:23324 ||| WRB
the  ||| S:23324 E:23328 ||| DT
dropout  ||| S:23328 E:23336 ||| JJ
patterns  ||| S:23336 E:23345 ||| NNS
are  ||| S:23345 E:23349 ||| VBP
made  ||| S:23349 E:23354 ||| VBN
almost  ||| S:23354 E:23361 ||| RB
identical  ||| S:23361 E:23371 ||| JJ
between  ||| S:23371 E:23389 ||| IN
the  ||| S:23389 E:23393 ||| DT
treatment  ||| S:23393 E:23403 ||| NN
groups ||| S:23403 E:23409 ||| NNS
,  ||| S:23409 E:23411 ||| ,
the  ||| S:23411 E:23415 ||| DT
relative  ||| S:23415 E:23424 ||| JJ
comparison  ||| S:23424 E:23435 ||| NN
of  ||| S:23435 E:23438 ||| IN
the  ||| S:23438 E:23452 ||| DT
treatment  ||| S:23452 E:23462 ||| NN
effects  ||| S:23462 E:23470 ||| NNS
will  ||| S:23470 E:23475 ||| MD
be  ||| S:23475 E:23478 ||| VB
less  ||| S:23478 E:23483 ||| JJR
biased ||| S:23483 E:23489 ||| NN
.  ||| S:23489 E:23491 ||| .
Since  ||| S:23491 E:23497 ||| IN
PI  ||| S:23497 E:23500 ||| NNP
does  ||| S:23500 E:23505 ||| VBZ
less  ||| S:23505 E:23520 ||| JJR
imputation ||| S:23520 E:23530 ||| NN
,  ||| S:23530 E:23532 ||| ,
it  ||| S:23532 E:23535 ||| PRP
is  ||| S:23535 E:23538 ||| VBZ
less  ||| S:23538 E:23543 ||| JJR
biased  ||| S:23543 E:23550 ||| NN
than  ||| S:23550 E:23555 ||| IN
LOCF  ||| S:23555 E:23560 ||| NNP
because  ||| S:23560 E:23568 ||| IN
the  ||| S:23568 E:23582 ||| DT
assumption  ||| S:23582 E:23593 ||| NN
of  ||| S:23593 E:23596 ||| IN
stability  ||| S:23596 E:23606 ||| NN
usually  ||| S:23606 E:23614 ||| RB
does  ||| S:23614 E:23619 ||| VBZ
not  ||| S:23619 E:23623 ||| RB
hold ||| S:23623 E:23627 ||| VB
.  ||| S:23627 E:23629 ||| .
Some  ||| S:23629 E:23644 ||| DT
simulation  ||| S:23644 E:23655 ||| JJ
results  ||| S:23655 E:23663 ||| NNS
under  ||| S:23663 E:23669 ||| IN
various  ||| S:23669 E:23677 ||| JJ
missing  ||| S:23677 E:23685 ||| JJ
data  ||| S:23685 E:23690 ||| NN
processes  ||| S:23690 E:23710 ||| VBZ
demonstrated  ||| S:23710 E:23723 ||| VBN
the  ||| S:23723 E:23727 ||| DT
potential  ||| S:23727 E:23737 ||| JJ
usefulness  ||| S:23737 E:23748 ||| NN
of  ||| S:23748 E:23751 ||| IN
PI  ||| S:23751 E:23754 ||| NNP
over  ||| S:23754 E:23759 ||| IN
the  ||| S:23759 E:23773 ||| DT
methods  ||| S:23773 E:23781 ||| NNS
of  ||| S:23781 E:23784 ||| IN
using  ||| S:23784 E:23790 ||| VBG
all  ||| S:23790 E:23794 ||| DT
available  ||| S:23794 E:23804 ||| JJ
data  ||| S:23804 E:23809 ||| NNS
and  ||| S:23809 E:23813 ||| CC
LOCF  ||| S:23813 E:23818 ||| NNP
[  ||| S:23818 E:23820 ||| -LRB-
15  ||| S:23820 E:23823 ||| CD
]  ||| S:23823 E:23825 ||| -RRB-
.  ||| S:23825 E:23837 ||| .
However ||| S:23837 E:23844 ||| RB
,  ||| S:23844 E:23846 ||| ,
more  ||| S:23846 E:23851 ||| JJR
experience  ||| S:23851 E:23862 ||| NN
is  ||| S:23862 E:23865 ||| VBZ
still  ||| S:23865 E:23871 ||| RB
needed  ||| S:23871 E:23878 ||| VBN
to  ||| S:23878 E:23881 ||| TO
test  ||| S:23881 E:23886 ||| VB
this  ||| S:23886 E:23891 ||| DT
new  ||| S:23891 E:23905 ||| JJ
method  ||| S:23905 E:23912 ||| NN
in  ||| S:23912 E:23915 ||| IN
practice ||| S:23915 E:23923 ||| NN
.  ||| S:23923 E:23956 ||| .
Methods  ||| S:23956 E:23964 ||| NNS
based  ||| S:23964 E:23970 ||| VBN
on  ||| S:23970 E:23973 ||| IN
special  ||| S:23973 E:23981 ||| JJ
missing  ||| S:23981 E:23989 ||| JJ
data  ||| S:23989 E:23994 ||| NN
models  ||| S:23994 E:24009 ||| NNS
Other ||| S:24009 E:24014 ||| JJ
,  ||| S:24014 E:24016 ||| ,
more  ||| S:24016 E:24021 ||| RBR
sophisticated  ||| S:24021 E:24035 ||| JJ
methods  ||| S:24035 E:24043 ||| NNS
based  ||| S:24043 E:24049 ||| VBN
on  ||| S:24049 E:24052 ||| IN
statistical  ||| S:24052 E:24072 ||| JJ
models  ||| S:24072 E:24079 ||| NNS
are  ||| S:24079 E:24083 ||| VBP
available  ||| S:24083 E:24093 ||| JJ
[  ||| S:24093 E:24095 ||| -LRB-
16  ||| S:24095 E:24098 ||| CD
17  ||| S:24098 E:24101 ||| CD
18  ||| S:24101 E:24104 ||| CD
]  ||| S:24104 E:24106 ||| -RRB-
;  ||| S:24106 E:24108 ||| :
a  ||| S:24108 E:24110 ||| DT
technical  ||| S:24110 E:24120 ||| JJ
review  ||| S:24120 E:24127 ||| NN
can  ||| S:24127 E:24139 ||| MD
be  ||| S:24139 E:24142 ||| VB
found ||| S:24142 E:24147 ||| VBN
,  ||| S:24147 E:24149 ||| ,
for  ||| S:24149 E:24153 ||| IN
example ||| S:24153 E:24160 ||| NN
,  ||| S:24160 E:24162 ||| ,
in  ||| S:24162 E:24165 ||| IN
[  ||| S:24165 E:24167 ||| -LRB-
19  ||| S:24167 E:24170 ||| CD
]  ||| S:24170 E:24172 ||| -RRB-
and  ||| S:24172 E:24176 ||| CC
[  ||| S:24176 E:24178 ||| -LRB-
20  ||| S:24178 E:24181 ||| CD
]  ||| S:24181 E:24183 ||| -RRB-
.  ||| S:24183 E:24185 ||| .
No  ||| S:24185 E:24188 ||| DT
general  ||| S:24188 E:24204 ||| JJ
computer  ||| S:24204 E:24213 ||| NN
programs  ||| S:24213 E:24222 ||| NNS
are  ||| S:24222 E:24226 ||| VBP
available  ||| S:24226 E:24236 ||| JJ
to  ||| S:24236 E:24239 ||| TO
put  ||| S:24239 E:24243 ||| VB
them  ||| S:24243 E:24248 ||| PRP
into  ||| S:24248 E:24253 ||| IN
effect  ||| S:24253 E:24268 ||| NN
though ||| S:24268 E:24274 ||| RB
,  ||| S:24274 E:24276 ||| ,
because  ||| S:24276 E:24284 ||| IN
every  ||| S:24284 E:24290 ||| DT
so-called  ||| S:24290 E:24300 ||| JJ
informative  ||| S:24300 E:24312 ||| NNS
missing  ||| S:24312 E:24320 ||| VBG
data  ||| S:24320 E:24333 ||| NNS
set  ||| S:24333 E:24337 ||| NN
requires  ||| S:24337 E:24346 ||| VBZ
a  ||| S:24346 E:24348 ||| DT
unique  ||| S:24348 E:24355 ||| JJ
model  ||| S:24355 E:24361 ||| NN
to  ||| S:24361 E:24364 ||| TO
describe  ||| S:24364 E:24373 ||| VB
it ||| S:24373 E:24375 ||| PRP
.  ||| S:24375 E:24399 ||| .
Methods  ||| S:24399 E:24407 ||| NNS
based  ||| S:24407 E:24413 ||| VBN
on  ||| S:24413 E:24416 ||| IN
ranking  ||| S:24416 E:24424 ||| JJ
observations  ||| S:24424 E:24445 ||| NNS
A  ||| S:24445 E:24447 ||| DT
large  ||| S:24447 E:24453 ||| JJ
class  ||| S:24453 E:24459 ||| NN
of  ||| S:24459 E:24462 ||| IN
non-parametric  ||| S:24462 E:24477 ||| JJ
methods  ||| S:24477 E:24485 ||| NNS
is  ||| S:24485 E:24488 ||| VBZ
based  ||| S:24488 E:24494 ||| VBN
on  ||| S:24494 E:24497 ||| IN
the  ||| S:24497 E:24509 ||| DT
ranks  ||| S:24509 E:24515 ||| NNS
or  ||| S:24515 E:24518 ||| CC
' ||| S:24518 E:24519 ||| CD
scores ||| S:24519 E:24525 ||| NNS
'  ||| S:24525 E:24527 ||| ''
of  ||| S:24527 E:24530 ||| IN
the  ||| S:24530 E:24534 ||| DT
observations  ||| S:24534 E:24547 ||| NNS
instead  ||| S:24547 E:24555 ||| RB
of  ||| S:24555 E:24558 ||| IN
the  ||| S:24558 E:24562 ||| DT
actual  ||| S:24562 E:24577 ||| JJ
values ||| S:24577 E:24583 ||| NNS
.  ||| S:24583 E:24585 ||| .
Commonly  ||| S:24585 E:24594 ||| RB
used  ||| S:24594 E:24599 ||| VBN
non-parametric  ||| S:24599 E:24614 ||| JJ
methods  ||| S:24614 E:24622 ||| NNS
in  ||| S:24622 E:24625 ||| IN
clinical  ||| S:24625 E:24642 ||| JJ
trials  ||| S:24642 E:24649 ||| NNS
include  ||| S:24649 E:24657 ||| VBP
the  ||| S:24657 E:24661 ||| DT
Wilcoxon  ||| S:24661 E:24670 ||| JJ
signed-rank  ||| S:24670 E:24682 ||| JJ
test ||| S:24682 E:24686 ||| NN
,  ||| S:24686 E:24688 ||| ,
Mann-Whitney  ||| S:24688 E:24709 ||| JJ
test ||| S:24709 E:24713 ||| NN
,  ||| S:24713 E:24715 ||| ,
and  ||| S:24715 E:24719 ||| CC
so  ||| S:24719 E:24722 ||| RB
on ||| S:24722 E:24724 ||| IN
.  ||| S:24724 E:24726 ||| .
Example  ||| S:24726 E:24734 ||| NN
3  ||| S:24734 E:24736 ||| CD
also  ||| S:24736 E:24741 ||| RB
used  ||| S:24741 E:24746 ||| VBN
a  ||| S:24746 E:24748 ||| DT
ranking  ||| S:24748 E:24756 ||| JJ
method  ||| S:24756 E:24763 ||| NN
after  ||| S:24763 E:24777 ||| IN
LOCF  ||| S:24777 E:24782 ||| NNP
for  ||| S:24782 E:24786 ||| IN
a  ||| S:24786 E:24788 ||| DT
secondary  ||| S:24788 E:24798 ||| JJ
analysis ||| S:24798 E:24806 ||| NN
.  ||| S:24806 E:24808 ||| .
Incorporating  ||| S:24808 E:24822 ||| VBG
missing  ||| S:24822 E:24830 ||| JJ
data  ||| S:24830 E:24843 ||| NNS
into  ||| S:24843 E:24848 ||| IN
these  ||| S:24848 E:24854 ||| DT
methods  ||| S:24854 E:24862 ||| NNS
can  ||| S:24862 E:24866 ||| MD
be  ||| S:24866 E:24869 ||| VB
easily  ||| S:24869 E:24876 ||| RB
done ||| S:24876 E:24880 ||| VBN
,  ||| S:24880 E:24882 ||| ,
by  ||| S:24882 E:24885 ||| IN
ranking  ||| S:24885 E:24893 ||| VBG
the  ||| S:24893 E:24905 ||| DT
missing  ||| S:24905 E:24913 ||| JJ
data ||| S:24913 E:24917 ||| NNS
,  ||| S:24917 E:24919 ||| ,
according  ||| S:24919 E:24929 ||| VBG
to  ||| S:24929 E:24932 ||| TO
the  ||| S:24932 E:24936 ||| DT
reasons  ||| S:24936 E:24944 ||| NNS
for  ||| S:24944 E:24948 ||| IN
withdrawals  ||| S:24948 E:24960 ||| NNS
[  ||| S:24960 E:24962 ||| -LRB-
21  ||| S:24962 E:24973 ||| CD
]  ||| S:24973 E:24975 ||| -RRB-
,  ||| S:24975 E:24977 ||| ,
and ||| S:24977 E:24980 ||| CC
,  ||| S:24980 E:24982 ||| ,
in  ||| S:24982 E:24985 ||| IN
longitudinal  ||| S:24985 E:24998 ||| JJ
study  ||| S:24998 E:25004 ||| NN
cases ||| S:25004 E:25009 ||| NNS
,  ||| S:25009 E:25011 ||| ,
the  ||| S:25011 E:25015 ||| DT
time  ||| S:25015 E:25020 ||| NN
of  ||| S:25020 E:25031 ||| IN
withdrawal  ||| S:25031 E:25042 ||| NN
[  ||| S:25042 E:25044 ||| -LRB-
22  ||| S:25044 E:25047 ||| CD
]  ||| S:25047 E:25049 ||| -RRB-
.  ||| S:25049 E:25051 ||| .
For  ||| S:25051 E:25055 ||| IN
example ||| S:25055 E:25062 ||| NN
,  ||| S:25062 E:25064 ||| ,
death  ||| S:25064 E:25070 ||| NN
would  ||| S:25070 E:25076 ||| MD
be  ||| S:25076 E:25079 ||| VB
given  ||| S:25079 E:25085 ||| VBN
the  ||| S:25085 E:25097 ||| DT
worst  ||| S:25097 E:25103 ||| JJS
rank ||| S:25103 E:25107 ||| NN
,  ||| S:25107 E:25109 ||| ,
followed  ||| S:25109 E:25118 ||| VBN
by  ||| S:25118 E:25121 ||| IN
' ||| S:25121 E:25122 ||| POS
lack  ||| S:25122 E:25127 ||| NN
of  ||| S:25127 E:25130 ||| IN
efficacy ||| S:25130 E:25138 ||| NN
' ||| S:25138 E:25139 ||| POS
,  ||| S:25139 E:25141 ||| ,
then  ||| S:25141 E:25146 ||| RB
' ||| S:25146 E:25147 ||| POS
adverse  ||| S:25147 E:25163 ||| JJ
reaction ||| S:25163 E:25171 ||| NN
' ||| S:25171 E:25172 ||| POS
,  ||| S:25172 E:25174 ||| ,
' ||| S:25174 E:25175 ||| ''
patient  ||| S:25175 E:25183 ||| JJ
refusal ||| S:25183 E:25190 ||| NN
' ||| S:25190 E:25191 ||| POS
,  ||| S:25191 E:25193 ||| ,
and  ||| S:25193 E:25197 ||| CC
so  ||| S:25197 E:25200 ||| RB
on ||| S:25200 E:25202 ||| IN
.  ||| S:25202 E:25204 ||| .
Within  ||| S:25204 E:25211 ||| IN
the  ||| S:25211 E:25215 ||| DT
same  ||| S:25215 E:25228 ||| JJ
category  ||| S:25228 E:25237 ||| NN
of  ||| S:25237 E:25240 ||| IN
withdrawal ||| S:25240 E:25250 ||| NN
,  ||| S:25250 E:25252 ||| ,
early  ||| S:25252 E:25258 ||| JJ
dropouts  ||| S:25258 E:25267 ||| NNS
would  ||| S:25267 E:25273 ||| MD
be  ||| S:25273 E:25276 ||| VB
given  ||| S:25276 E:25282 ||| VBN
worse  ||| S:25282 E:25296 ||| JJR
ranks  ||| S:25296 E:25302 ||| NNS
than  ||| S:25302 E:25307 ||| IN
later  ||| S:25307 E:25313 ||| JJ
dropouts ||| S:25313 E:25321 ||| NNS
.  ||| S:25321 E:25323 ||| .
Ground  ||| S:25323 E:25330 ||| NN
rules  ||| S:25330 E:25336 ||| NNS
for  ||| S:25336 E:25340 ||| IN
the  ||| S:25340 E:25344 ||| DT
ranking  ||| S:25344 E:25360 ||| NN
should  ||| S:25360 E:25367 ||| MD
be  ||| S:25367 E:25370 ||| VB
set  ||| S:25370 E:25374 ||| VBN
prior  ||| S:25374 E:25380 ||| RB
to  ||| S:25380 E:25383 ||| TO
unmasking  ||| S:25383 E:25393 ||| VB
the  ||| S:25393 E:25397 ||| DT
treatment  ||| S:25397 E:25407 ||| NN
codes  ||| S:25407 E:25413 ||| NNS
for  ||| S:25413 E:25425 ||| IN
data  ||| S:25425 E:25430 ||| NNS
analyses  ||| S:25430 E:25439 ||| VBP
to  ||| S:25439 E:25442 ||| TO
avoid  ||| S:25442 E:25448 ||| VB
being  ||| S:25448 E:25454 ||| VBG
post-hoc ||| S:25454 E:25462 ||| JJ
.  ||| S:25462 E:25464 ||| .
After  ||| S:25464 E:25470 ||| IN
missing  ||| S:25470 E:25478 ||| VBG
data  ||| S:25478 E:25491 ||| NNS
are  ||| S:25491 E:25495 ||| VBP
replaced  ||| S:25495 E:25504 ||| VBN
by  ||| S:25504 E:25507 ||| IN
their  ||| S:25507 E:25513 ||| PRP$
ranks ||| S:25513 E:25518 ||| NNS
,  ||| S:25518 E:25520 ||| ,
the  ||| S:25520 E:25524 ||| DT
usual  ||| S:25524 E:25530 ||| JJ
testing  ||| S:25530 E:25538 ||| NN
procedure  ||| S:25538 E:25556 ||| NN
can  ||| S:25556 E:25560 ||| MD
be  ||| S:25560 E:25563 ||| VB
carried  ||| S:25563 E:25571 ||| VBN
out ||| S:25571 E:25574 ||| RP
.  ||| S:25574 E:25576 ||| .
One  ||| S:25576 E:25580 ||| CD
major  ||| S:25580 E:25586 ||| JJ
drawback  ||| S:25586 E:25595 ||| NN
in  ||| S:25595 E:25598 ||| IN
these  ||| S:25598 E:25604 ||| DT
methods  ||| S:25604 E:25612 ||| NNS
is  ||| S:25612 E:25623 ||| VBZ
that  ||| S:25623 E:25628 ||| IN
they  ||| S:25628 E:25633 ||| PRP
do  ||| S:25633 E:25636 ||| VBP
not  ||| S:25636 E:25640 ||| RB
provide  ||| S:25640 E:25648 ||| VB
any  ||| S:25648 E:25652 ||| DT
estimation  ||| S:25652 E:25663 ||| NN
of  ||| S:25663 E:25666 ||| IN
the  ||| S:25666 E:25670 ||| DT
treatment  ||| S:25670 E:25688 ||| NN
effect  ||| S:25688 E:25695 ||| NN
in  ||| S:25695 E:25698 ||| IN
the  ||| S:25698 E:25702 ||| DT
original  ||| S:25702 E:25711 ||| JJ
measurement  ||| S:25711 E:25723 ||| NN
unit ||| S:25723 E:25727 ||| NN
,  ||| S:25727 E:25729 ||| ,
because  ||| S:25729 E:25737 ||| IN
the  ||| S:25737 E:25741 ||| DT
data  ||| S:25741 E:25754 ||| NNS
are  ||| S:25754 E:25758 ||| VBP
replaced  ||| S:25758 E:25767 ||| VBN
by  ||| S:25767 E:25770 ||| IN
the  ||| S:25770 E:25774 ||| DT
ranks ||| S:25774 E:25779 ||| NNS
.  ||| S:25779 E:25789 ||| .
All  ||| S:25789 E:25793 ||| PDT
these  ||| S:25793 E:25799 ||| DT
methods ||| S:25799 E:25806 ||| NNS
,  ||| S:25806 E:25808 ||| ,
parametric  ||| S:25808 E:25819 ||| NN
or  ||| S:25819 E:25822 ||| CC
non-parametric ||| S:25822 E:25836 ||| JJ
,  ||| S:25836 E:25838 ||| ,
require  ||| S:25838 E:25854 ||| VBP
much  ||| S:25854 E:25859 ||| RB
closer  ||| S:25859 E:25866 ||| JJR
collaboration  ||| S:25866 E:25880 ||| NN
between  ||| S:25880 E:25888 ||| IN
medical  ||| S:25888 E:25896 ||| JJ
investigators  ||| S:25896 E:25910 ||| NNS
and  ||| S:25910 E:25922 ||| CC
statisticians ||| S:25922 E:25935 ||| NNS
.  ||| S:25935 E:25937 ||| .
In  ||| S:25937 E:25940 ||| IN
the  ||| S:25940 E:25944 ||| DT
parametric  ||| S:25944 E:25955 ||| JJ
case ||| S:25955 E:25959 ||| NN
,  ||| S:25959 E:25961 ||| ,
the  ||| S:25961 E:25965 ||| DT
observed  ||| S:25965 E:25974 ||| JJ
outcome  ||| S:25974 E:25990 ||| NN
cannot  ||| S:25990 E:25997 ||| NNS
provide  ||| S:25997 E:26005 ||| VBP
statistical  ||| S:26005 E:26017 ||| JJ
tests  ||| S:26017 E:26023 ||| NNS
to  ||| S:26023 E:26026 ||| TO
select  ||| S:26026 E:26033 ||| VB
the  ||| S:26033 E:26037 ||| DT
missing  ||| S:26037 E:26045 ||| JJ
data  ||| S:26045 E:26058 ||| NN
models ||| S:26058 E:26064 ||| NNS
.  ||| S:26064 E:26066 ||| .
In  ||| S:26066 E:26069 ||| IN
both  ||| S:26069 E:26074 ||| DT
cases ||| S:26074 E:26079 ||| NNS
,  ||| S:26079 E:26081 ||| ,
the  ||| S:26081 E:26085 ||| DT
validity  ||| S:26085 E:26094 ||| NN
of  ||| S:26094 E:26097 ||| IN
the  ||| S:26097 E:26101 ||| DT
various  ||| S:26101 E:26109 ||| JJ
models  ||| S:26109 E:26124 ||| NNS
or  ||| S:26124 E:26127 ||| CC
ranking  ||| S:26127 E:26135 ||| JJ
rules  ||| S:26135 E:26141 ||| NNS
requires  ||| S:26141 E:26150 ||| VBZ
an  ||| S:26150 E:26153 ||| DT
examination  ||| S:26153 E:26165 ||| NN
of  ||| S:26165 E:26168 ||| IN
the  ||| S:26168 E:26172 ||| DT
missing  ||| S:26172 E:26188 ||| JJ
data  ||| S:26188 E:26193 ||| NN
information  ||| S:26193 E:26205 ||| NN
and  ||| S:26205 E:26209 ||| CC
strong  ||| S:26209 E:26216 ||| JJ
faith  ||| S:26216 E:26222 ||| NN
in  ||| S:26222 E:26225 ||| IN
the  ||| S:26225 E:26229 ||| DT
reasons  ||| S:26229 E:26237 ||| NNS
given  ||| S:26237 E:26243 ||| VBN
for  ||| S:26243 E:26255 ||| IN
the  ||| S:26255 E:26259 ||| DT
patients ||| S:26259 E:26267 ||| NNS
'  ||| S:26267 E:26269 ||| POS
withdrawal ||| S:26269 E:26279 ||| NN
.  ||| S:26279 E:26281 ||| .
Still ||| S:26281 E:26286 ||| RB
,  ||| S:26286 E:26288 ||| ,
the  ||| S:26288 E:26292 ||| DT
main  ||| S:26292 E:26297 ||| JJ
issue  ||| S:26297 E:26303 ||| NN
is  ||| S:26303 E:26306 ||| VBZ
the  ||| S:26306 E:26318 ||| DT
question  ||| S:26318 E:26327 ||| NN
that  ||| S:26327 E:26332 ||| IN
these  ||| S:26332 E:26338 ||| DT
methods  ||| S:26338 E:26346 ||| NNS
are  ||| S:26346 E:26350 ||| VBP
addressing ||| S:26350 E:26360 ||| VBG
.  ||| S:26360 E:26362 ||| .
They  ||| S:26362 E:26367 ||| PRP
attempt  ||| S:26367 E:26375 ||| VBP
to  ||| S:26375 E:26386 ||| TO
follow  ||| S:26386 E:26393 ||| VB
the  ||| S:26393 E:26397 ||| DT
ITT  ||| S:26397 E:26401 ||| NNP
principle  ||| S:26401 E:26411 ||| NN
( ||| S:26411 E:26412 ||| -LRB-
but  ||| S:26412 E:26416 ||| CC
with  ||| S:26416 E:26421 ||| IN
missing  ||| S:26421 E:26429 ||| VBG
data ||| S:26429 E:26433 ||| NNS
)  ||| S:26433 E:26435 ||| -RRB-
to  ||| S:26435 E:26438 ||| TO
answer  ||| S:26438 E:26453 ||| VB
question  ||| S:26453 E:26462 ||| NN
( ||| S:26462 E:26463 ||| -LRB-
i ||| S:26463 E:26464 ||| FW
)  ||| S:26464 E:26466 ||| -RRB-
above ||| S:26466 E:26471 ||| RB
,  ||| S:26471 E:26473 ||| ,
hoping  ||| S:26473 E:26480 ||| VBG
that  ||| S:26480 E:26485 ||| IN
the  ||| S:26485 E:26489 ||| DT
dropouts  ||| S:26489 E:26498 ||| NNS
can  ||| S:26498 E:26510 ||| MD
hypothetically  ||| S:26510 E:26525 ||| RB
be  ||| S:26525 E:26528 ||| VB
removed  ||| S:26528 E:26536 ||| VBN
by ||| S:26536 E:26538 ||| IN
,  ||| S:26538 E:26540 ||| ,
say ||| S:26540 E:26543 ||| VBP
,  ||| S:26543 E:26545 ||| ,
a  ||| S:26545 E:26547 ||| DT
truly  ||| S:26547 E:26553 ||| JJ
ITT  ||| S:26553 E:26557 ||| NNP
design ||| S:26557 E:26563 ||| NN
,  ||| S:26563 E:26565 ||| ,
or  ||| S:26565 E:26576 ||| CC
by  ||| S:26576 E:26579 ||| IN
successfully  ||| S:26579 E:26592 ||| RB
using  ||| S:26592 E:26598 ||| VBG
concurrent  ||| S:26598 E:26609 ||| JJ
treatments  ||| S:26609 E:26620 ||| NNS
for  ||| S:26620 E:26624 ||| IN
intolerable  ||| S:26624 E:26644 ||| JJ
side  ||| S:26644 E:26649 ||| NN
effects  ||| S:26649 E:26657 ||| NNS
without  ||| S:26657 E:26665 ||| IN
affecting  ||| S:26665 E:26675 ||| VBG
the  ||| S:26675 E:26679 ||| DT
efficacy  ||| S:26679 E:26688 ||| NN
of  ||| S:26688 E:26691 ||| IN
the  ||| S:26691 E:26695 ||| DT
study  ||| S:26695 E:26709 ||| NN
medication ||| S:26709 E:26719 ||| NN
.  ||| S:26719 E:26743 ||| .
Composite  ||| S:26743 E:26753 ||| JJ
comparisons  ||| S:26753 E:26773 ||| NNS
Many  ||| S:26773 E:26778 ||| JJ
believe  ||| S:26778 E:26786 ||| VBP
that  ||| S:26786 E:26791 ||| IN
removing  ||| S:26791 E:26800 ||| VBG
the  ||| S:26800 E:26804 ||| DT
patient ||| S:26804 E:26811 ||| NN
's  ||| S:26811 E:26814 ||| POS
dropout  ||| S:26814 E:26822 ||| JJ
process  ||| S:26822 E:26838 ||| NN
is  ||| S:26838 E:26841 ||| VBZ
not  ||| S:26841 E:26845 ||| RB
plausible  ||| S:26845 E:26855 ||| JJ
in  ||| S:26855 E:26858 ||| IN
clinical  ||| S:26858 E:26867 ||| JJ
practice ||| S:26867 E:26875 ||| NN
.  ||| S:26875 E:26877 ||| .
In  ||| S:26877 E:26880 ||| IN
this  ||| S:26880 E:26885 ||| DT
case ||| S:26885 E:26889 ||| NN
,  ||| S:26889 E:26891 ||| ,
the  ||| S:26891 E:26903 ||| DT
dropout  ||| S:26903 E:26911 ||| JJ
process  ||| S:26911 E:26919 ||| NN
itself  ||| S:26919 E:26926 ||| PRP
may  ||| S:26926 E:26930 ||| MD
be  ||| S:26930 E:26933 ||| VB
an  ||| S:26933 E:26936 ||| DT
outcome  ||| S:26936 E:26944 ||| NN
of  ||| S:26944 E:26947 ||| IN
interest  ||| S:26947 E:26956 ||| NN
and  ||| S:26956 E:26968 ||| CC
not  ||| S:26968 E:26972 ||| RB
a  ||| S:26972 E:26974 ||| DT
nuisance  ||| S:26974 E:26983 ||| JJ
effect ||| S:26983 E:26989 ||| NN
.  ||| S:26989 E:26991 ||| .
For  ||| S:26991 E:26995 ||| IN
example ||| S:26995 E:27002 ||| NN
,  ||| S:27002 E:27004 ||| ,
the  ||| S:27004 E:27008 ||| DT
US  ||| S:27008 E:27011 ||| NNP
Federal  ||| S:27011 E:27019 ||| NNP
Drug  ||| S:27019 E:27032 ||| NNP
Association ||| S:27032 E:27043 ||| NNP
's  ||| S:27043 E:27046 ||| POS
draft  ||| S:27046 E:27052 ||| NN
guidance  ||| S:27052 E:27061 ||| NN
on  ||| S:27061 E:27064 ||| IN
diabetes  ||| S:27064 E:27073 ||| JJ
trials  ||| S:27073 E:27088 ||| NNS
specifically  ||| S:27088 E:27101 ||| RB
requested  ||| S:27101 E:27111 ||| VBD
the  ||| S:27111 E:27115 ||| DT
consideration  ||| S:27115 E:27129 ||| NN
of  ||| S:27129 E:27132 ||| IN
dropouts  ||| S:27132 E:27141 ||| NNS
as  ||| S:27141 E:27144 ||| IN
an  ||| S:27144 E:27155 ||| DT
endpoint  ||| S:27155 E:27164 ||| NN
[  ||| S:27164 E:27166 ||| -LRB-
23  ||| S:27166 E:27169 ||| CD
]  ||| S:27169 E:27171 ||| -RRB-
.  ||| S:27171 E:27173 ||| .
Therefore ||| S:27173 E:27182 ||| RB
,  ||| S:27182 E:27184 ||| ,
the  ||| S:27184 E:27188 ||| DT
problem  ||| S:27188 E:27196 ||| NN
becomes  ||| S:27196 E:27204 ||| VBZ
a  ||| S:27204 E:27214 ||| DT
' ||| S:27214 E:27215 ||| POS
composite  ||| S:27215 E:27225 ||| JJ
endpoints ||| S:27225 E:27234 ||| NN
'  ||| S:27234 E:27236 ||| POS
issue ||| S:27236 E:27241 ||| NN
.  ||| S:27241 E:27243 ||| .
This  ||| S:27243 E:27248 ||| DT
is  ||| S:27248 E:27251 ||| VBZ
the  ||| S:27251 E:27255 ||| DT
approach  ||| S:27255 E:27264 ||| NN
taken  ||| S:27264 E:27270 ||| VBN
in  ||| S:27270 E:27281 ||| IN
[  ||| S:27281 E:27283 ||| -LRB-
24  ||| S:27283 E:27286 ||| CD
25  ||| S:27286 E:27289 ||| CD
]  ||| S:27289 E:27291 ||| -RRB-
,  ||| S:27291 E:27293 ||| ,
and  ||| S:27293 E:27297 ||| CC
it  ||| S:27297 E:27300 ||| PRP
has  ||| S:27300 E:27304 ||| VBZ
lately  ||| S:27304 E:27311 ||| RB
been  ||| S:27311 E:27316 ||| VBN
extended  ||| S:27316 E:27325 ||| VBN
to  ||| S:27325 E:27328 ||| TO
modeling  ||| S:27328 E:27337 ||| VB
the  ||| S:27337 E:27349 ||| DT
joint  ||| S:27349 E:27355 ||| JJ
distribution  ||| S:27355 E:27368 ||| NN
of  ||| S:27368 E:27371 ||| IN
the  ||| S:27371 E:27375 ||| DT
longitudinal  ||| S:27375 E:27388 ||| NN
and  ||| S:27388 E:27392 ||| CC
time-to-event  ||| S:27392 E:27414 ||| JJ
data  ||| S:27414 E:27419 ||| NNS
( ||| S:27419 E:27420 ||| -LRB-
ie ||| S:27420 E:27422 ||| UH
,  ||| S:27422 E:27424 ||| ,
time  ||| S:27424 E:27429 ||| NN
to  ||| S:27429 E:27432 ||| TO
withdrawal ||| S:27432 E:27442 ||| NN
)  ||| S:27442 E:27444 ||| -RRB-
[  ||| S:27444 E:27446 ||| -LRB-
26  ||| S:27446 E:27449 ||| CD
27  ||| S:27449 E:27452 ||| CD
]  ||| S:27452 E:27454 ||| -RRB-
.  ||| S:27454 E:27456 ||| .
In  ||| S:27456 E:27459 ||| IN
this  ||| S:27459 E:27464 ||| DT
setting ||| S:27464 E:27471 ||| NN
,  ||| S:27471 E:27481 ||| ,
we  ||| S:27481 E:27484 ||| PRP
would  ||| S:27484 E:27490 ||| MD
compare  ||| S:27490 E:27498 ||| VB
the  ||| S:27498 E:27502 ||| DT
treatment  ||| S:27502 E:27512 ||| NN
groups  ||| S:27512 E:27519 ||| NNS
with  ||| S:27519 E:27524 ||| IN
two  ||| S:27524 E:27528 ||| CD
aspects  ||| S:27528 E:27544 ||| NNS
simultaneously ||| S:27544 E:27558 ||| RB
:  ||| S:27558 E:27560 ||| :
( ||| S:27560 E:27561 ||| -LRB-
a ||| S:27561 E:27562 ||| LS
)  ||| S:27562 E:27564 ||| -RRB-
the  ||| S:27564 E:27568 ||| DT
chance  ||| S:27568 E:27575 ||| NN
( ||| S:27575 E:27576 ||| -LRB-
or  ||| S:27576 E:27579 ||| CC
duration ||| S:27579 E:27587 ||| NN
)  ||| S:27587 E:27589 ||| -RRB-
of  ||| S:27589 E:27592 ||| IN
complying  ||| S:27592 E:27610 ||| VBG
with  ||| S:27610 E:27615 ||| IN
the  ||| S:27615 E:27619 ||| DT
prescribed  ||| S:27619 E:27630 ||| JJ
protocol  ||| S:27630 E:27639 ||| NN
and ||| S:27639 E:27642 ||| CC
,  ||| S:27642 E:27644 ||| ,
( ||| S:27644 E:27645 ||| -LRB-
b ||| S:27645 E:27646 ||| LS
)  ||| S:27646 E:27648 ||| -RRB-
the  ||| S:27648 E:27652 ||| DT
outcome  ||| S:27652 E:27660 ||| NN
measure  ||| S:27660 E:27676 ||| NN
( ||| S:27676 E:27677 ||| -LRB-
eg ||| S:27677 E:27679 ||| UH
,  ||| S:27679 E:27681 ||| ,
mean  ||| S:27681 E:27686 ||| JJ
change  ||| S:27686 E:27693 ||| NN
in  ||| S:27693 E:27696 ||| IN
systolic  ||| S:27696 E:27705 ||| JJ
blood  ||| S:27705 E:27711 ||| NN
pressure ||| S:27711 E:27719 ||| NN
)  ||| S:27719 E:27721 ||| -RRB-
given  ||| S:27721 E:27727 ||| VBN
the  ||| S:27727 E:27739 ||| DT
pattern  ||| S:27739 E:27747 ||| NN
of  ||| S:27747 E:27750 ||| IN
compliance ||| S:27750 E:27760 ||| NN
.  ||| S:27760 E:27762 ||| .
The  ||| S:27762 E:27766 ||| DT
comparison  ||| S:27766 E:27777 ||| NN
( ||| S:27777 E:27778 ||| -LRB-
a ||| S:27778 E:27779 ||| LS
)  ||| S:27779 E:27781 ||| -RRB-
is  ||| S:27781 E:27792 ||| VBZ
straightforward  ||| S:27792 E:27808 ||| VBN
by  ||| S:27808 E:27811 ||| IN
either  ||| S:27811 E:27818 ||| RB
the  ||| S:27818 E:27822 ||| DT
standard  ||| S:27822 E:27831 ||| JJ
binomial  ||| S:27831 E:27840 ||| NN
or  ||| S:27840 E:27843 ||| CC
survival  ||| S:27843 E:27860 ||| NN
techniques ||| S:27860 E:27870 ||| NNS
.  ||| S:27870 E:27872 ||| .
The  ||| S:27872 E:27876 ||| DT
comparison  ||| S:27876 E:27887 ||| NN
( ||| S:27887 E:27888 ||| -LRB-
b ||| S:27888 E:27889 ||| LS
)  ||| S:27889 E:27891 ||| -RRB-
requires  ||| S:27891 E:27900 ||| VBZ
the  ||| S:27900 E:27904 ||| DT
same  ||| S:27904 E:27909 ||| JJ
care  ||| S:27909 E:27914 ||| NN
as  ||| S:27914 E:27925 ||| RB
has  ||| S:27925 E:27929 ||| VBZ
been  ||| S:27929 E:27934 ||| VBN
discussed  ||| S:27934 E:27944 ||| VBN
here  ||| S:27944 E:27949 ||| RB
previously ||| S:27949 E:27959 ||| RB
,  ||| S:27959 E:27961 ||| ,
because ||| S:27961 E:27968 ||| RB
,  ||| S:27968 E:27970 ||| ,
given  ||| S:27970 E:27976 ||| VBN
the  ||| S:27976 E:27988 ||| DT
pattern  ||| S:27988 E:27996 ||| NN
of  ||| S:27996 E:27999 ||| IN
compliance ||| S:27999 E:28009 ||| NN
,  ||| S:28009 E:28011 ||| ,
the  ||| S:28011 E:28015 ||| DT
subgroup  ||| S:28015 E:28024 ||| NN
of  ||| S:28024 E:28027 ||| IN
patients  ||| S:28027 E:28036 ||| NNS
has  ||| S:28036 E:28040 ||| VBZ
already  ||| S:28040 E:28056 ||| RB
been  ||| S:28056 E:28061 ||| VBN
self-selected ||| S:28061 E:28074 ||| JJ
.  ||| S:28074 E:28076 ||| .
The  ||| S:28076 E:28080 ||| DT
randomization  ||| S:28080 E:28094 ||| JJ
mechanism  ||| S:28094 E:28104 ||| NN
used  ||| S:28104 E:28109 ||| VBN
for  ||| S:28109 E:28121 ||| IN
achieving  ||| S:28121 E:28131 ||| VBG
comparability  ||| S:28131 E:28145 ||| NN
between  ||| S:28145 E:28153 ||| IN
treatment  ||| S:28153 E:28163 ||| NN
groups  ||| S:28163 E:28170 ||| NNS
is  ||| S:28170 E:28173 ||| VBZ
broken  ||| S:28173 E:28188 ||| VBN
by  ||| S:28188 E:28191 ||| IN
the  ||| S:28191 E:28195 ||| DT
post-randomization  ||| S:28195 E:28214 ||| JJ
stratification  ||| S:28214 E:28229 ||| NN
of  ||| S:28229 E:28232 ||| IN
compliance ||| S:28232 E:28242 ||| NN
.  ||| S:28242 E:28244 ||| .
It  ||| S:28244 E:28255 ||| PRP
is  ||| S:28255 E:28258 ||| VBZ
then  ||| S:28258 E:28263 ||| RB
important  ||| S:28263 E:28273 ||| JJ
to  ||| S:28273 E:28276 ||| TO
check  ||| S:28276 E:28282 ||| VB
the  ||| S:28282 E:28286 ||| DT
key  ||| S:28286 E:28290 ||| JJ
outcome-correlated  ||| S:28290 E:28317 ||| JJ
baseline  ||| S:28317 E:28326 ||| NN
characteristics  ||| S:28326 E:28342 ||| NNS
between  ||| S:28342 E:28350 ||| IN
the  ||| S:28350 E:28354 ||| DT
treatment  ||| S:28354 E:28364 ||| NN
groups  ||| S:28364 E:28371 ||| NNS
for  ||| S:28371 E:28383 ||| IN
any  ||| S:28383 E:28387 ||| DT
incomparability  ||| S:28387 E:28403 ||| NN
among  ||| S:28403 E:28409 ||| IN
these  ||| S:28409 E:28415 ||| DT
subgroup  ||| S:28415 E:28424 ||| JJ
patients ||| S:28424 E:28432 ||| NNS
.  ||| S:28432 E:28434 ||| .
This  ||| S:28434 E:28439 ||| DT
was  ||| S:28439 E:28451 ||| VBD
done  ||| S:28451 E:28456 ||| VBN
in  ||| S:28456 E:28459 ||| IN
Example  ||| S:28459 E:28467 ||| NNP
4  ||| S:28467 E:28469 ||| CD
but  ||| S:28469 E:28473 ||| CC
not  ||| S:28473 E:28477 ||| RB
others ||| S:28477 E:28483 ||| NNS
.  ||| S:28483 E:28485 ||| .
Recognizing  ||| S:28485 E:28497 ||| VBG
that  ||| S:28497 E:28502 ||| IN
the  ||| S:28502 E:28514 ||| DT
subgroups  ||| S:28514 E:28524 ||| NNS
are  ||| S:28524 E:28528 ||| VBP
no  ||| S:28528 E:28531 ||| RB
longer  ||| S:28531 E:28538 ||| JJR
randomized ||| S:28538 E:28548 ||| NN
,  ||| S:28548 E:28550 ||| ,
we  ||| S:28550 E:28553 ||| PRP
should  ||| S:28553 E:28560 ||| MD
treat  ||| S:28560 E:28566 ||| VB
this  ||| S:28566 E:28579 ||| DT
portion  ||| S:28579 E:28587 ||| NN
as  ||| S:28587 E:28590 ||| IN
a  ||| S:28590 E:28592 ||| DT
semi-observational  ||| S:28592 E:28611 ||| JJ
study  ||| S:28611 E:28617 ||| NN
imbedded  ||| S:28617 E:28626 ||| NN
in  ||| S:28626 E:28629 ||| IN
the  ||| S:28629 E:28641 ||| DT
randomized  ||| S:28641 E:28652 ||| JJ
trial ||| S:28652 E:28657 ||| NN
.  ||| S:28657 E:28659 ||| .
Techniques  ||| S:28659 E:28670 ||| NNS
used  ||| S:28670 E:28675 ||| VBN
for  ||| S:28675 E:28679 ||| IN
analyzing  ||| S:28679 E:28697 ||| VBG
observational  ||| S:28697 E:28711 ||| JJ
studies  ||| S:28711 E:28719 ||| NNS
should  ||| S:28719 E:28726 ||| MD
be  ||| S:28726 E:28729 ||| VB
applied  ||| S:28729 E:28737 ||| VBN
to  ||| S:28737 E:28740 ||| TO
this  ||| S:28740 E:28745 ||| DT
part  ||| S:28745 E:28750 ||| NN
of  ||| S:28750 E:28761 ||| IN
comparison  ||| S:28761 E:28772 ||| NN
[  ||| S:28772 E:28774 ||| -LRB-
28  ||| S:28774 E:28777 ||| CD
]  ||| S:28777 E:28779 ||| -RRB-
.  ||| S:28779 E:28781 ||| .
Generally  ||| S:28781 E:28791 ||| RB
speaking ||| S:28791 E:28799 ||| VBG
,  ||| S:28799 E:28801 ||| ,
in  ||| S:28801 E:28804 ||| IN
an  ||| S:28804 E:28807 ||| DT
observational  ||| S:28807 E:28829 ||| JJ
study ||| S:28829 E:28834 ||| NN
,  ||| S:28834 E:28836 ||| ,
bias  ||| S:28836 E:28841 ||| NN
can  ||| S:28841 E:28845 ||| MD
only  ||| S:28845 E:28850 ||| RB
be  ||| S:28850 E:28853 ||| VB
reduced  ||| S:28853 E:28861 ||| VBN
but  ||| S:28861 E:28865 ||| CC
not  ||| S:28865 E:28869 ||| RB
entirely  ||| S:28869 E:28878 ||| RB
eliminated  ||| S:28878 E:28897 ||| VBN
by  ||| S:28897 E:28900 ||| IN
methods  ||| S:28900 E:28908 ||| NNS
of  ||| S:28908 E:28911 ||| IN
adjustment  ||| S:28911 E:28922 ||| NN
or  ||| S:28922 E:28925 ||| CC
matching ||| S:28925 E:28933 ||| NN
.  ||| S:28933 E:28935 ||| .
Sensitivity  ||| S:28935 E:28947 ||| JJ
analysis  ||| S:28947 E:28964 ||| NN
in  ||| S:28964 E:28967 ||| IN
this  ||| S:28967 E:28972 ||| DT
approach  ||| S:28972 E:28981 ||| NN
is  ||| S:28981 E:28984 ||| VBZ
to  ||| S:28984 E:28987 ||| TO
consider  ||| S:28987 E:28996 ||| VB
different  ||| S:28996 E:29006 ||| JJ
baseline  ||| S:29006 E:29023 ||| NN
covariates  ||| S:29023 E:29034 ||| NN
for  ||| S:29034 E:29038 ||| IN
matching  ||| S:29038 E:29047 ||| VBG
or  ||| S:29047 E:29050 ||| CC
adjustment ||| S:29050 E:29060 ||| NN
.  ||| S:29060 E:29084 ||| .
Conclusion  ||| S:29084 E:29103 ||| NN
The  ||| S:29103 E:29107 ||| DT
issue  ||| S:29107 E:29113 ||| NN
of  ||| S:29113 E:29116 ||| IN
what  ||| S:29116 E:29121 ||| WP
to  ||| S:29121 E:29124 ||| TO
do  ||| S:29124 E:29127 ||| VB
about  ||| S:29127 E:29133 ||| IN
missing  ||| S:29133 E:29141 ||| VBG
data  ||| S:29141 E:29146 ||| NNS
caused  ||| S:29146 E:29153 ||| VBN
by  ||| S:29153 E:29164 ||| IN
dropouts  ||| S:29164 E:29173 ||| NNS
in  ||| S:29173 E:29176 ||| IN
clinical  ||| S:29176 E:29185 ||| JJ
trials  ||| S:29185 E:29192 ||| NNS
is  ||| S:29192 E:29195 ||| VBZ
a  ||| S:29195 E:29197 ||| DT
research  ||| S:29197 E:29206 ||| NN
topic  ||| S:29206 E:29212 ||| NN
that  ||| S:29212 E:29217 ||| WDT
is  ||| S:29217 E:29228 ||| VBZ
still  ||| S:29228 E:29234 ||| RB
under  ||| S:29234 E:29240 ||| IN
development  ||| S:29240 E:29252 ||| NN
in  ||| S:29252 E:29255 ||| IN
statistical  ||| S:29255 E:29267 ||| JJ
literature ||| S:29267 E:29277 ||| NN
.  ||| S:29277 E:29279 ||| .
As  ||| S:29279 E:29282 ||| RB
has  ||| S:29282 E:29294 ||| VBZ
been  ||| S:29294 E:29299 ||| VBN
noted  ||| S:29299 E:29305 ||| VBN
in  ||| S:29305 E:29308 ||| IN
the  ||| S:29308 E:29312 ||| DT
ICH-E9  ||| S:29312 E:29319 ||| JJ
guideline  ||| S:29319 E:29329 ||| NN
[  ||| S:29329 E:29331 ||| -LRB-
9  ||| S:29331 E:29333 ||| CD
]  ||| S:29333 E:29335 ||| -RRB-
,  ||| S:29335 E:29337 ||| ,
' ||| S:29337 E:29338 ||| ''
no  ||| S:29338 E:29341 ||| DT
universally  ||| S:29341 E:29361 ||| JJ
applicable  ||| S:29361 E:29372 ||| JJ
methods  ||| S:29372 E:29380 ||| NNS
of  ||| S:29380 E:29383 ||| IN
handling  ||| S:29383 E:29392 ||| VBG
missing  ||| S:29392 E:29400 ||| JJ
values  ||| S:29400 E:29407 ||| NNS
can  ||| S:29407 E:29411 ||| MD
be  ||| S:29411 E:29422 ||| VB
recommended ||| S:29422 E:29433 ||| VBN
. ||| S:29433 E:29434 ||| .
'  ||| S:29434 E:29436 ||| POS
The  ||| S:29436 E:29440 ||| DT
issue  ||| S:29440 E:29446 ||| NN
of  ||| S:29446 E:29449 ||| IN
handling  ||| S:29449 E:29458 ||| VBG
missing  ||| S:29458 E:29466 ||| JJ
data  ||| S:29466 E:29471 ||| NN
is  ||| S:29471 E:29482 ||| VBZ
intrinsically  ||| S:29482 E:29496 ||| JJ
difficult  ||| S:29496 E:29506 ||| JJ
because  ||| S:29506 E:29514 ||| IN
it  ||| S:29514 E:29517 ||| PRP
requires  ||| S:29517 E:29526 ||| VBZ
a  ||| S:29526 E:29528 ||| DT
large  ||| S:29528 E:29542 ||| JJ
proportion  ||| S:29542 E:29553 ||| NN
of  ||| S:29553 E:29556 ||| IN
missing  ||| S:29556 E:29564 ||| VBG
data  ||| S:29564 E:29569 ||| NNS
to  ||| S:29569 E:29572 ||| TO
investigate  ||| S:29572 E:29584 ||| VB
a  ||| S:29584 E:29586 ||| DT
method ||| S:29586 E:29592 ||| NN
.  ||| S:29592 E:29594 ||| .
On  ||| S:29594 E:29597 ||| IN
the  ||| S:29597 E:29609 ||| DT
other  ||| S:29609 E:29615 ||| JJ
hand ||| S:29615 E:29619 ||| NN
,  ||| S:29619 E:29621 ||| ,
a  ||| S:29621 E:29623 ||| DT
large  ||| S:29623 E:29629 ||| JJ
proportion  ||| S:29629 E:29640 ||| NN
of  ||| S:29640 E:29643 ||| IN
missing  ||| S:29643 E:29651 ||| VBG
data  ||| S:29651 E:29656 ||| NNS
would  ||| S:29656 E:29662 ||| MD
make  ||| S:29662 E:29667 ||| VB
a  ||| S:29667 E:29677 ||| DT
clinical  ||| S:29677 E:29686 ||| JJ
study  ||| S:29686 E:29692 ||| NN
less  ||| S:29692 E:29697 ||| RBR
credible ||| S:29697 E:29705 ||| JJ
.  ||| S:29705 E:29707 ||| .
The  ||| S:29707 E:29711 ||| DT
best  ||| S:29711 E:29716 ||| RBS
available  ||| S:29716 E:29726 ||| JJ
advice  ||| S:29726 E:29733 ||| NN
is  ||| S:29733 E:29744 ||| VBZ
to  ||| S:29744 E:29747 ||| TO
minimize  ||| S:29747 E:29756 ||| VB
the  ||| S:29756 E:29760 ||| DT
chance  ||| S:29760 E:29767 ||| NN
of  ||| S:29767 E:29770 ||| IN
dropouts  ||| S:29770 E:29779 ||| NNS
at  ||| S:29779 E:29782 ||| IN
the  ||| S:29782 E:29786 ||| DT
design  ||| S:29786 E:29793 ||| NN
stage  ||| S:29793 E:29799 ||| NN
and  ||| S:29799 E:29811 ||| CC
during  ||| S:29811 E:29818 ||| IN
trial  ||| S:29818 E:29824 ||| NN
monitoring ||| S:29824 E:29834 ||| NN
.  ||| S:29834 E:29836 ||| .
A  ||| S:29836 E:29838 ||| DT
truly  ||| S:29838 E:29844 ||| JJ
ITT  ||| S:29844 E:29848 ||| NNP
design  ||| S:29848 E:29855 ||| NN
is  ||| S:29855 E:29858 ||| VBZ
absolutely  ||| S:29858 E:29877 ||| RB
encouraged ||| S:29877 E:29887 ||| VBN
.  ||| S:29887 E:29889 ||| .
This  ||| S:29889 E:29894 ||| DT
requires  ||| S:29894 E:29903 ||| VBZ
follow-up  ||| S:29903 E:29913 ||| JJ
data  ||| S:29913 E:29918 ||| NNS
to  ||| S:29918 E:29921 ||| TO
be  ||| S:29921 E:29924 ||| VB
collected  ||| S:29924 E:29942 ||| VBN
even  ||| S:29942 E:29947 ||| RB
after  ||| S:29947 E:29953 ||| IN
patients  ||| S:29953 E:29962 ||| NNS
discontinue  ||| S:29962 E:29974 ||| VB
the  ||| S:29974 E:29978 ||| DT
treatment ||| S:29978 E:29987 ||| NN
,  ||| S:29987 E:29989 ||| ,
whenever  ||| S:29989 E:29998 ||| WRB
the  ||| S:29998 E:30010 ||| DT
clinical  ||| S:30010 E:30019 ||| JJ
status  ||| S:30019 E:30026 ||| NN
of  ||| S:30026 E:30029 ||| IN
the  ||| S:30029 E:30033 ||| DT
patient  ||| S:30033 E:30041 ||| JJ
permits ||| S:30041 E:30048 ||| NNS
.  ||| S:30048 E:30050 ||| .
If  ||| S:30050 E:30053 ||| IN
it  ||| S:30053 E:30056 ||| PRP
is  ||| S:30056 E:30067 ||| VBZ
anticipated  ||| S:30067 E:30079 ||| VBN
that  ||| S:30079 E:30084 ||| IN
there  ||| S:30084 E:30090 ||| EX
will  ||| S:30090 E:30095 ||| MD
be  ||| S:30095 E:30098 ||| VB
many  ||| S:30098 E:30103 ||| JJ
dropouts ||| S:30103 E:30111 ||| NNS
,  ||| S:30111 E:30113 ||| ,
then  ||| S:30113 E:30118 ||| RB
perhaps  ||| S:30118 E:30134 ||| RB
the  ||| S:30134 E:30138 ||| DT
study ||| S:30138 E:30143 ||| NN
's  ||| S:30143 E:30146 ||| POS
duration  ||| S:30146 E:30155 ||| NN
should  ||| S:30155 E:30162 ||| MD
be  ||| S:30162 E:30165 ||| VB
shortened ||| S:30165 E:30174 ||| VBN
.  ||| S:30174 E:30176 ||| .
Alternatively ||| S:30176 E:30189 ||| RB
,  ||| S:30189 E:30199 ||| ,
the  ||| S:30199 E:30203 ||| DT
medical  ||| S:30203 E:30211 ||| JJ
procedure  ||| S:30211 E:30221 ||| NN
that  ||| S:30221 E:30226 ||| WDT
is  ||| S:30226 E:30229 ||| VBZ
deemed  ||| S:30229 E:30236 ||| VBN
to  ||| S:30236 E:30239 ||| TO
be  ||| S:30239 E:30242 ||| VB
the  ||| S:30242 E:30246 ||| DT
most  ||| S:30246 E:30251 ||| RBS
likely  ||| S:30251 E:30266 ||| JJ
cause  ||| S:30266 E:30272 ||| NN
of  ||| S:30272 E:30275 ||| IN
patients ||| S:30275 E:30283 ||| NNS
'  ||| S:30283 E:30285 ||| POS
withdrawal  ||| S:30285 E:30296 ||| NN
should  ||| S:30296 E:30303 ||| MD
be  ||| S:30303 E:30306 ||| VB
altered ||| S:30306 E:30313 ||| VBN
.  ||| S:30313 E:30315 ||| .
All  ||| S:30315 E:30319 ||| DT
data  ||| S:30319 E:30332 ||| NNS
after  ||| S:30332 E:30338 ||| IN
death  ||| S:30338 E:30344 ||| NN
of  ||| S:30344 E:30347 ||| IN
any  ||| S:30347 E:30351 ||| DT
cause  ||| S:30351 E:30357 ||| NN
should  ||| S:30357 E:30364 ||| MD
be  ||| S:30364 E:30367 ||| VB
given  ||| S:30367 E:30373 ||| VBN
a  ||| S:30373 E:30375 ||| DT
value  ||| S:30375 E:30381 ||| NN
of  ||| S:30381 E:30384 ||| IN
zero  ||| S:30384 E:30397 ||| CD
instead  ||| S:30397 E:30405 ||| RB
of  ||| S:30405 E:30408 ||| IN
a  ||| S:30408 E:30410 ||| DT
blank ||| S:30410 E:30415 ||| JJ
.  ||| S:30415 E:30417 ||| .
Consideration  ||| S:30417 E:30431 ||| NN
may  ||| S:30431 E:30435 ||| MD
also  ||| S:30435 E:30440 ||| RB
be  ||| S:30440 E:30443 ||| VB
given  ||| S:30443 E:30449 ||| VBN
to  ||| S:30449 E:30460 ||| TO
define  ||| S:30460 E:30467 ||| VB
an  ||| S:30467 E:30470 ||| DT
endpoint  ||| S:30470 E:30479 ||| NN
( ||| S:30479 E:30480 ||| -LRB-
event ||| S:30480 E:30485 ||| NN
) ||| S:30485 E:30486 ||| -RRB-
,  ||| S:30486 E:30488 ||| ,
instead  ||| S:30488 E:30496 ||| RB
of  ||| S:30496 E:30499 ||| IN
a  ||| S:30499 E:30501 ||| DT
measurement  ||| S:30501 E:30513 ||| NN
value ||| S:30513 E:30518 ||| NN
,  ||| S:30518 E:30528 ||| ,
as  ||| S:30528 E:30531 ||| IN
the  ||| S:30531 E:30535 ||| DT
primary  ||| S:30535 E:30543 ||| JJ
response  ||| S:30543 E:30552 ||| NN
variable ||| S:30552 E:30560 ||| NN
,  ||| S:30560 E:30562 ||| ,
which  ||| S:30562 E:30568 ||| WDT
can  ||| S:30568 E:30572 ||| MD
be  ||| S:30572 E:30575 ||| VB
determined  ||| S:30575 E:30594 ||| VBN
even  ||| S:30594 E:30599 ||| RB
if  ||| S:30599 E:30602 ||| IN
the  ||| S:30602 E:30606 ||| DT
patient  ||| S:30606 E:30614 ||| JJ
withdraws  ||| S:30614 E:30624 ||| NN
from  ||| S:30624 E:30629 ||| IN
the  ||| S:30629 E:30633 ||| DT
study ||| S:30633 E:30638 ||| NN
.  ||| S:30638 E:30640 ||| .
In  ||| S:30640 E:30643 ||| IN
an  ||| S:30643 E:30654 ||| DT
analysis ||| S:30654 E:30662 ||| NN
,  ||| S:30662 E:30664 ||| ,
one  ||| S:30664 E:30668 ||| PRP
should  ||| S:30668 E:30675 ||| MD
be  ||| S:30675 E:30678 ||| VB
clear  ||| S:30678 E:30684 ||| JJ
about  ||| S:30684 E:30690 ||| IN
the  ||| S:30690 E:30694 ||| DT
question  ||| S:30694 E:30703 ||| NN
or  ||| S:30703 E:30714 ||| CC
objective  ||| S:30714 E:30724 ||| NN
of  ||| S:30724 E:30727 ||| IN
the  ||| S:30727 E:30731 ||| DT
analysis  ||| S:30731 E:30740 ||| NN
with  ||| S:30740 E:30745 ||| IN
missing  ||| S:30745 E:30753 ||| VBG
data ||| S:30753 E:30757 ||| NNS
,  ||| S:30757 E:30759 ||| ,
and  ||| S:30759 E:30763 ||| CC
conduct  ||| S:30763 E:30779 ||| VB
sensitivity  ||| S:30779 E:30791 ||| JJ
analysis  ||| S:30791 E:30800 ||| NN
with  ||| S:30800 E:30805 ||| IN
a  ||| S:30805 E:30807 ||| DT
set  ||| S:30807 E:30811 ||| NN
of  ||| S:30811 E:30814 ||| IN
plausible ||| S:30814 E:30823 ||| JJ
,  ||| S:30823 E:30825 ||| ,
pre-specified  ||| S:30825 E:30847 ||| JJ
models  ||| S:30847 E:30854 ||| NNS
of  ||| S:30854 E:30857 ||| IN
the  ||| S:30857 E:30861 ||| DT
missing  ||| S:30861 E:30869 ||| JJ
data ||| S:30869 E:30873 ||| NNS
.  ||| S:30873 E:30897 ||| .
Competing  ||| S:30897 E:30907 ||| VBG
interests  ||| S:30907 E:30925 ||| NNS
None  ||| S:30925 E:30930 ||| NN
declared ||| S:30930 E:30938 ||| VBD
.  ||| S:30938 E:30962 ||| .
Abbreviations  ||| S:30962 E:30984 ||| NNP
BP  ||| S:30984 E:30987 ||| NNP
=  ||| S:30987 E:30989 ||| SYM
blood  ||| S:30989 E:30995 ||| NN
pressure ||| S:30995 E:31003 ||| NN
;  ||| S:31003 E:31005 ||| :
HCTZ  ||| S:31005 E:31010 ||| NNP
=  ||| S:31010 E:31012 ||| SYM
hydrochlorothiazide ||| S:31012 E:31031 ||| FW
;  ||| S:31031 E:31033 ||| :
DBP  ||| S:31033 E:31037 ||| NNP
=  ||| S:31037 E:31047 ||| SYM
diastolic  ||| S:31047 E:31057 ||| JJ
blood  ||| S:31057 E:31063 ||| NN
pressure ||| S:31063 E:31071 ||| NN
;  ||| S:31071 E:31073 ||| :
ITT  ||| S:31073 E:31077 ||| NNP
=  ||| S:31077 E:31079 ||| SYM
intent  ||| S:31079 E:31086 ||| NN
to  ||| S:31086 E:31089 ||| TO
treat ||| S:31089 E:31094 ||| VB
;  ||| S:31094 E:31096 ||| :
MCAR  ||| S:31096 E:31101 ||| NNP
=  ||| S:31101 E:31111 ||| NNP
missing  ||| S:31111 E:31119 ||| VBG
completely  ||| S:31119 E:31130 ||| RB
at  ||| S:31130 E:31133 ||| IN
random ||| S:31133 E:31139 ||| JJ
;  ||| S:31139 E:31141 ||| :
ICH  ||| S:31141 E:31145 ||| NNP
=  ||| S:31145 E:31147 ||| NNP
International  ||| S:31147 E:31169 ||| NNP
Conference  ||| S:31169 E:31180 ||| NNP
on  ||| S:31180 E:31183 ||| IN
Harmonization ||| S:31183 E:31196 ||| NNP
;  ||| S:31196 E:31198 ||| :
LOCF  ||| S:31198 E:31211 ||| NNP
last-observation-carried-forward ||| S:31211 E:31243 ||| NNP
;  ||| S:31243 E:31245 ||| :
PMI  ||| S:31245 E:31249 ||| NNP
=  ||| S:31249 E:31251 ||| SYM
proper  ||| S:31251 E:31258 ||| JJ
multiple  ||| S:31258 E:31275 ||| JJ
imputation ||| S:31275 E:31285 ||| NN
;  ||| S:31285 E:31287 ||| :
MAR  ||| S:31287 E:31291 ||| NNP
=  ||| S:31291 E:31293 ||| SYM
missing  ||| S:31293 E:31301 ||| JJ
at  ||| S:31301 E:31304 ||| IN
random ||| S:31304 E:31310 ||| JJ
;  ||| S:31310 E:31312 ||| :
PI  ||| S:31312 E:31315 ||| NNP
=  ||| S:31315 E:31317 ||| SYM
partial  ||| S:31317 E:31333 ||| JJ
imputation ||| S:31333 E:31343 ||| NN
.  ||| S:31343 E:31360 ||| .
